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Abstract 
The brown planthopper (Nilaparvata lugens Stål) is one of the most 
economically important pests of rice across Asia. The control of this pest has mainly 
relied upon the use of insecticides. However, rice ecosystems across Asia are being 
put at severe risk due to the over-reliance on certain insecticides, mainly imidacloprid 
(neonicotinoid) and ethiprole (phenylpyrazole), which the pest is now showing 
widespread resistance against. The evolution of resistance represents a tangible 
threat to the long-term sustainable control of this species.  
Field strains were placed under selection separately with imidacloprid and 
ethiprole, leading to increased resistance within these strains. Selection with 
ethiprole was demonstrated to cause cross-resistance to another phenylpyrazole, 
fipronil. A de novo transcriptome was generated and was used to search for 
differentially expressed genes between susceptible and insecticide resistant 
populations. This transcriptome also allowed assembly of insecticide target sites, that 
were then screened for mutations. 
The most recent class of insecticide to show decreased efficacy against the 
brown planthopper was the phenylpyrazoles (Fiproles). Potential mechanisms for 
resistance, both metabolic and target site were studied with the use of a model 
organism, Drosophila melanogaster. These have implicated a mutation, A301S, in the 
Rdl channel in ethiprole resistance, but not in causing significant fipronil resistance.  
Point mutations that occurs at the target site for imidacloprid and previously 
linked with resistance, were not witnessed in the field strains monitored for this PhD. 
However, it was discovered that a single cytochrome P450 gene (CYP6ER1) was 
markedly overexpressed in all the imidacloprid resistant strains tested. This gene 
displayed considerable coding sequence variation between the susceptible and 
resistant strains. Of the eight CYP6ER1 variants found, two were highly expressed. 
Studies in vivo showed these CYP6ER1 variants conferred significant resistance to 
imidacloprid compared to a CYP6ER1 variant from susceptible N. lugens. It was 
concluded that coding sequence changes in CYP6ER1 were the primary role for 
imidacloprid resistance, with overexpression contributing in a secondary role. 
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Chapter I Introduction 
 
1.1 Global food security 
The task of providing worldwide food security is one of the greatest 
challenges facing humanity in the 21st century. The necessity to increase global food 
production to feed an ever-expanding population, but to do so more sustainably than 
currently, is an incredibly complex challenge. The current global population is 7.3 
billion and there is a well-documented prediction that it will rise by a further 2 billion 
in the next 30 years. However, even now there are approximately 790 million 
malnourished people, with inadequate access to protein and micronutrients 
(FAOSTAT, 2017b). A host of factors are threatening global food security; these 
include the impact of climate change and the increase in competition for land, water 
and energy use (Godfray et al., 2010). The growing demand for meat and dairy 
products from rapidly developing countries such as China is also putting pressure on 
food production systems (The Royal Society, 2009).  
One strategy proposed to tackle this issue has been sustainable 
intensification (The Royal Society, 2009). This is generally described as producing 
more food from the land than currently, but at the same time reducing the 
environmental impact of modern agriculture (Godfray et al., 2010). Part of this will 
involve closing the yield gap. Godfray et al. describe this as the disparity between the 
yields that are theoretically possible from a combination of inputs and the production 
that is physically realised. There are many reasons for this gap, ranging from biotic 
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factors such as weeds, fungus and insect pests to abiotic factors including, water, soil 
quality, sunlight and salinity.  
The main grain crops (maize, rice, wheat and barley cereals) are the most 
intensively produced crops in the world. Of these rice is estimated to be the major 
staple for half the world’s population. The advent of the green revolution in the 
1960s led to a large increase in rice yields, primarily through the use of high yielding 
rice varieties, synthetic fertiliser and pesticide application (Bottrell and Schoenly, 
2012). In 2014 there were 741 million tonnes of rice produced, second in volume only 
to maize (FAOSTAT, 2017a). This rice was produced at an average of 4.5 tonnes per 
hectare, well below the theoretical average of 8.5 tonnes per hectare (Cassman, 
1999). A major factor for this disparity between actual and potential yield was due to 
the impact of insect pests.   
1.2 Insect pests of rice 
Rice is targeted by more than 100 species of insects, and within this there are 
approximately 20 pest species that are capable of inflicting damage above economic 
thresholds (Pathak and Khan, 1994). Classified within this group are the stem borers, 
planthoppers, leafhoppers and gall midges. With the advent of the green revolution 
and a shift to high yielding cultivars of rice there was a significant shift in associated 
pest damage. Species such as brown planthopper, white-backed planthopper and 
leaffolders had been relatively minor pests compared to the stem borers, but became 
major rice pests with the introduction of high yielding rice varieties (Pathak and Khan, 
1994).  
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1.3 Nilaparvata lugens 
The brown planthopper, Nilaparvata lugens Stål (Hemiptera: Delphacidae), is 
today one of the most significant pests of rice throughout Asia, causing yield and 
economic losses. N. lugens (Fig.1.1A) is a monophagous herbivore and can limit yield 
potential in the rice crop through two mechanisms. Firstly, it is a sucking pest and 
causes nutrient depletion in the plant via direct phloem-sap feeding. When levels of 
N. lugens reach high infestation levels this feeding can cause a series of deleterious 
effects known as ‘hopperburn’ (Gorman et al., 2008). This phenomenon is visualised 
by characteristic stunting, wilting and browning of the crop (Fig. 1.1B). Secondly, N. 
lugens also acts as an efficient vector for various rice pathogens, including rice ragged 
stunt virus and rice stripe cereal viruses (Cabauatan, Cabunagan and Choi, 2009). The 
combination of these two effects causes rice yield to be substantially reduced 
(Cheng, 2009). 
 
© A) Visual Communication Unit, Rothamsted Research B) International Rice Research 
Institute (IRRI, 2017) 
Fig. 1.1 A) An adult brown planthopper, Nilaparvata lugens. B) ‘Hopperburn’. 
The earliest reputed outbreak of N. lugens was recorded in circa AD 18 in 
Korea (Dyck and Thomas, 1979), with further outbreaks documented in AD 697 or 
701 in Japan (Grist and Lever, 1969). Since N. lugens was not taxonomically defined 
until 1854 (Dupo and Barrion, 2009), it is not possible to confirm these early reported 
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incidents as being definitively N. lugens.  During the 1960s, with the implementation 
of green revolution technologies for rice production, N. lugens became a key threat 
to rice production (Bottrell and Schoenly, 2012). Before the 1960s there had been 
sporadic recorded outbreaks of N. lugens, usually in temperate areas, such as Japan 
and Korea (Dyck and Thomas, 1979), but it was not regarded as a major pest of rice 
during this time.  
The life cycle of N. lugens is divided into three distinct phases: egg, nymph 
and adult. The eggs are laid directly into the tissue of the lower part of the rice plant, 
predominantly into the leaf sheaths (Mochida and Okada, 1979). Depending on 
temperature the egg phase lasts 7-11 days in the tropics of Asia. The nymphal phase, 
which consists of 5 development stages - from 1st to 5th instars, lasts approximately 
10-15 days (Mochida and Okada, 1979). Mochida and Okada also record that at 25oC 
the time between emergence of an adult in one generation to that of the subsequent 
generation is 28-32 days. However, at higher temperatures (28oC) this can be 
reduced to as little as 23-25 days. This variation in development time is reflected in 
the number of generations per year recorded in the tropics compared with 
temperate regions. The tropic regions can host 12 generations per year (Dyck et al., 
1979), whilst temperate regions can only sustain up to 3 generations of N. lugens per 
year (Perfect and Cook, 1994).  
Short generation times is one the key factors that makes N. lugens such a 
damaging pest, another is its ability to disperse over large areas to infest rice crops 
(Fig. 1.2). The key to its successful long distance migratory nature is that N. lugens is 
a wing dimorphic pest, displaying both macropterous and brachypterous adults. 
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Wing dimorphism is a feature that is seen across many insect species (Roff and 
Fairbairn, 1991). The frequencies of brachypterous/macropterous adults within a 
population depends on the population density and nutrient availability. A higher 
population density within the nymphal stage will lead to a comparatively higher level 
of macropterous adults (Mochida and Okada, 1979). The macropterous adults 
become abundant when N. lugens depletes its current food source, and therefore 
needs to migrate to fresh rice crops to survive. This long distance migratory potential 
enables N. lugens to reach rice in temperate regions where it cannot overwinter and 
so it also infest crops in Japan, Korea, northern India and China (Perfect and Cook, 
1994). Once migrated the subsequent generations of adult N. lugens will be 
predominantly brachypterous, due to their enhanced rates of fecundity compared 
with macropterous adults (Denno, 1994). This enables the pest to rapidly reach high 
levels of infestation in the newly invaded areas.  
A combination of factors explains the evolution of N. lugens from occasional 
pest to an endemic pest that consistently threatens rice production. The modern 
practice of growing rice all year round in a monoculture means there is always an 
ample supply of habitat for N. lugens to thrive on, and is a significant contributing 
factor to this pest’s status (Bottrell and Schoenly, 2012). Bottrell et al also argue that 
the extensive use of nitrogen fertiliser is another contributing factor, since it 
increases N. lugens’s reproductive potential (Dyck and Thomas, 1979), allowing it to 
cause more damage to rice crops. The heavy use of chemical insecticides over a long 
period, and the consequent depletion of natural enemies is the other key factor in 
this pest’s emergence as the greatest current threat to rice production throughout 
Asia. 
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Source: www.cabi.org/isc/datasheet/36301  
Fig. 1.2 A map demonstrating the distribution of N. lugens. Blue dots represent widespread 
existance of N. lugens, with red dots representing reports of N. lugens without further 
details 
1.4 Integrated pest management of N. lugens 
The threat of N. lugens to rice production in Asia led to a conference being 
organised by the International Rice Research Institute (IRRI, 1979) to analyse the 
main contributing factors responsible for N. lugens outbreaks and to formulate a plan 
to better control this pest. This conference decided that an integrated pest 
management (IPM) programme must be implemented to contain the damage that N. 
lugens could inflict upon rice yields (Bottrell and Schoenly, 2012).  An IPM strategy 
aims to utilise multiple methods of control including biological, chemical, cultural and 
physical, instead of over reliance on a single method. 
Tropical Asia adopted such a scheme in 1980 for management of rice pests 
(Gallagher, Ooi and Kenmore, 2009). This scheme highlighted the importance of 
preserving populations of natural enemies and a reduction in application of chemical 
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compounds. There was a substantive drive to provide training to farmers to reduce 
pesticide use, whilst maintaining rice yield (Matteson, 2000).  
Current guidelines for controlling planthoppers are provided by the Rice 
Knowledge Bank (IRRI, 2017). These broadly follow the same pattern as seen in the 
original IPM strategies, which work to prevent outbreaks from occurring in the first 
place, and if there is an outbreak to use mechanical/biological methods first. 
 There are many natural enemies (244) of N. lugens, including species classed 
as predators and others as parasitoids that can act as biological control (Gurr et al., 
2011). The green mirid bug, Cyrtorhinus lividipennis, is an important predator of eggs 
and early instars (Lakshmi, Krishnaiah and Katti, 2010). Other predators include the 
linyphiid, Atypena formosana and the lycosid Pardosa pseudoannulata (Sigsgaard, 
2007). Parasitoids belonging to Hymenoptera, including the families Dryinidae and 
Mymaridae can also disrupt N. lugens populations (Gurr et al., 2011). Effectively 
maintaining levels of natural enemies in the field, could help contribute to keeping 
N. lugens mediated damage below economic thresholds. 
The Rice Knowledge Bank advice regarding chemical control is that it should 
only be applied if the following criteria apply: more than one N. lugens per stem, N. 
lugens outnumber natural enemies and that seedbed flooding is not a viable option.  
1.5 Chemical control of insect pests 
Throughout our recent history the predominant method of insect pest control 
has been chemical compounds. The use of such compounds is widespread and has 
been used for centuries to negate the effect of insects upon crops, livestock and 
humans. Nowadays this equates to the mass production and deployment of synthetic 
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chemicals. The first such synthetic chemical was the organochlorine insecticide DDT, 
which was widely used to control agricultural pests. DDT was also the key chemical 
used to control mosquitos that were the vector for the Plasmodium sp parasite 
responsible for malaria in humans. The majority of compounds used for chemical 
control are neuroactive insecticides that result in a rapid kill (Casida and Durkin, 
2013). Since these target the nervous system of insects there are only a few suitable 
targets available. The four major nerve targets are acetylcholinesterase (AChE), 
nicotinic acetylcholine receptor (nAChR), voltage-gated sodium channel (VGSC) and 
the GABA-gated chloride channel (Casida and Durkin, 2013). The chemical classes 
that have become the most successful (in terms of sales) are the pyrethroids, 
organophosphates and neonicotinoids. These chemical classes each target a 
different specific nerve target within the insect nervous system. 
1.6 Insecticides used to treat N. lugens 
Heinrichs gives a summary of the early compounds used against N. lugens, 
from 1670 to the 1970s. The use of whale oil became commonplace in Japan by 1840, 
after its discovery in 1670 as an effective chemical control agent, and was later 
replaced in 1897 by kerosene (Heinrichs, 1979). Subsequent compounds (what we 
now consider as modern insecticides) included DDT dust and BHC (benzene 
hexachloride), with BHC credited as the first insecticide used for N. lugens control in 
Japan (Nagata, 1984).  However, it wasn’t until the 1950s that one of the first major 
insecticide classes, the organophosphates, was introduced for control of various 
insect rice pests. This included compounds such as malathion, parathion and 
diazinon. The 1960s saw the introduction of the carbamate insecticides, which 
replaced organophosphates within Japan (Heinrichs, 1979; Nagata, 1984).  The next 
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major class of insecticide developed and employed in planthopper control were the 
synthetic pyrethroids (Noda, 2009), which were eventually superseded in the 1990s, 
when the neonicotinoid class of insecticides became commercially available and 
were widely adopted to control N. lugens within rice (Matsumura et al., 2008). 
Following on from the neonicotinoids there was a shift to the use of phenylpyrazoles 
(ethiprole and fipronil), which steadily rose to prominence as the primary insecticides 
used for N. lugens control (Bayer CropScience, 2007). Recently, in the last decade, an 
anti-feedant (pymetrozine) has been included in the arsenal of chemical compounds 
used against N. lugens (He et al., 2011). The diverse range of chemical compounds 
introduced over the past five decades for N. lugens control have, unfortunately, all 
had their effectiveness compromised at some stage by the evolution of insecticide 
resistance in N. lugens.  
Currently the neonicotinoids (e.g. imidacloprid), phenylpyrazoles (ethiprole, 
fipronil) and anti-feedants (pymetrozine) are the key classes of insecticides being 
used for chemical control of N. lugens. 
1.7 Neonicotinoids 
The neonicotinoid class of insecticides belongs to group 4A in the Insecticide 
Resistance Action Committee’s Mode of Action (MoA) classification scheme, and act 
as agonists of the postsynaptic nicotinic acetylcholine receptor (nAChR) in the central 
nervous system of insects (Nauen et al., 2001; Jeschke and Nauen, 2008). The nAChRs 
are pentameric membrane proteins (Fig. 1.3A) that cause rapid membrane 
depolarisation at synapses, and are mediated by the excitatory neurotransmitter 
acetylcholine (ACh) (Fig. 1.3B) (Matsuda et al., 2009). Within this pentameric 
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structure there are six separate loops (A-F) that form the ACh binding site (Fig. 1.3C) 
(Matsuda et al., 2005). Located within these loops are the key amino acid residues 
that allow docking of the endogenous agonist (ACh) and other agonists. Stimulation 
of the nAChR is terminated by acetylcholinesterase (AChE) which catalyses the 
breakdown of ACh into acetate and choline, so removing the agonist from the nAChR 
channel. However, when a neonicotinoid insecticide binds, the insecticide cannot be 
removed by AChE and so remains permanently bound to nAChR. This causes 
overstimulation of the nervous system which in turn leads to paralysis of the insect 
and then death. Extensive studies have been conducted demonstrating that the 
binding site of the neonicotinoids is the insect nAChR channel (Buckingham et al., 
1997). Since then a wide range of models have been developed that predict binding 
mechanisms of neonicotinoids to insect nAChR (Jeschke and Nauen, 2008; Jeschke, 
Nauen and Beck, 2013).  
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Source: Matsuda et al., 2005 
Fig. 1.3 A schematic display of nAChR. A) Side view. B) Top view. C) The ligand binding site 
within nAChR. 
In the 1970s a compound, nithiazine, discovered by scientists working for 
Shell, displayed promising insecticidal activity. This compound is now regarded as the 
fore-runner of the modern day neonicotinoids (Soloway et al., 1979). However, 
despite having low mammalian toxicity and effective systemic action within plants 
(Tomizawa and Casida, 2003) nithiazine was not viable as a widespread chemical 
control compound as it lacked photostability, and was therefore rapidly degraded 
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under field conditions (Soloway et al., 1979). Nevertheless, studies on this compound 
eventually led to the development of the photostable derivative imidacloprid 
(Kagabu, 1997).  
There are currently seven commercially available neonicotinoid compounds 
on the market. These can be subdivided into two categories: cyclic compounds (that 
include imidacloprid, thiacloprid, thimethoxam) and open chain compounds 
(nitenpyram, acetamiprid, clothianidin, dinotefuran) (Fig 1.4). These compounds 
command a large share of worldwide insecticide sales (28.5% of US$ 12.75 billion in 
2011) (Jeschke, Nauen and Beck, 2013). Imidacloprid was the first compound 
commercially available, developed and patented in the late 1980s by Bayer 
CropScience. It quickly became one of the most successful compounds ever utilised 
for insect pest control. The primary reason for the popularity and widespread use of 
the neonicotinoid class is their specific activity against insects, and low mammalian 
toxicity (Tomizawa and Casida, 2003). The neonicotinoid compounds were also seen 
as more environmentally benign than older, more toxic compounds such as the 
pyrethroids, carbamates and organophosphates (Jeschke, Nauen and Beck, 2013). A 
third reason for the rapid adoption of the neonicotinoids was the fact that this class 
was not affected by resistance that had developed to older (preceding) insecticide 
classes (Denholm et al., 2002).   
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Source: Jeschke, Nauen and Beck, 2013 
Fig. 1.4 Chemical structures of the seven commercially available neonicotinoids. 
1.8 Phenylpyrazoles 
The phenylpyrazole (fiprole) family of insecticides consists of three 
compounds; fipronil, ethiprole and pyriprole. They belong to group 2B of the IRAC 
MoA classification scheme, and their mode of action is as non-competitive blockers 
of the GABA-gated chloride channel (Cole, Nicholson and Casida, 1993; Bloomquist, 
2001). The binding of the phenylpyrazoles inhibits the influx of chloride ions in nerve 
cells, causing hyperexcitation of the nervous system (Nakao et al., 2013). The channel 
is encoded for by the Resistance to dieldrin (Rdl) gene, and was originally cloned from 
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Drosophilia melanogaster (ffrench-Constant et al., 1991). This channel has also been 
the target of older insecticidal chemistries, primarily the cyclodiene hydrochlorines. 
Insect GABA receptors differ significantly from vertebrate GABAA receptors. 
Vertebrate GABAA receptors are formed from different combinations of α, β or ϒ 
subunits, creating a complex pentamer structure (ffrench-Constant et al., 2016). 
Insect GABA receptors are homo-oligomeric channels composed of five RDL subunits 
(Buckingham et al., 2005).  Each of these subunits has a large extracellular agonist-
binding N-terminal domain (Nakao et al., 2013). The GABA gated chloride channel 
also contains four transmembrane regions, designated M1-M4 (Whiting, 2003). It has 
been predicted that non-competitive antagonists (NCA) of this channel bind to the 
M2 transmembrane region. The crucial amino acids for binding of the NCA 
compounds are predicted to be: A301, T305 and L309 (all within M2) (Hisano et al., 
2007; Casida and Tomizawa, 2008). Molecular modelling studies have been 
conducted in silico to further analyse the docking of phenylpyrazoles in the RDL 
channel (Remnant et al., 2014). Remnant et al. found that fipronil bound best to the 
lower part of the channel pore (Fig. 1.5A), via interaction with A301, L302 and T305, 
which were previously predicted to be the key amino acids involved in 
phenylpyrazole binding. Furthermore, their modelling studies conclude that the 
C(O)CF3 group of phenylpyrazoles can form hydrogen bonds with T305 in three 
subunits of RDL (Fig. 1.5B) (Remnant et al., 2014).  
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Source: Remnant et al., 2014 
Fig. 1.5 Fipronil bound to the transmembrane region of RDL A) A view looking down 
through the GABA gated chloride channel into the cytoplasm. B) A side view displaying the 
binding of fipronil to T305 of multiple subunits. 
 
The forerunner phenylpyrazole was fipronil, developed by Syngenta and released 
commercially in 1993. (Remnant et al., 2014). Fipronil demonstrates efficacy against 
a wide range of pests, both in a veterinary and agricultural setting. Ethiprole 
(developed by Bayer CropScience (Bayer CropScience, 2007)), and pyriprole 
(introduced by Novartis in 2000) are effective against a narrower range of pests. 
Pyriprole is currently specifically licenced as a veterinary product effective against 
various tick species and fleas (Barnett et al., 2008).  
Both fipronil and ethiprole have been extensively used as a control agent 
against N. lugens across Asia (Garrood et al., 2016). Caboni et al. completed an in 
depth analysis comparing ethiprole and fipronil, studying their photochemistry, 
metabolism and GABAergic action (Caboni, Sammelson and Casida, 2003). In contrast 
to the neonicotinoid family, which has a diverse range of structures, the compounds 
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in the phenylpyrazole family are highly similar in structure. The only difference 
between ethiprole and fipronil is an ethylsulfinyl substituent replacing the 
trifluoromethylsulfinyl moiety (Fig. 1.6) (Caboni, Sammelson and Casida, 2003). Due 
to this minor structural difference ethiprole is considerably less lipophilic than 
fipronil. Sunlight exposure causes ethiprole to undergo oxidation, reduction and 
desethylsulfinylation, whilst for fipronil the major reaction is desulfinylation (Caboni, 
Sammelson and Casida, 2003). However, despite these differences, the study 
concluded that both compounds are very similar in insecticidal potency.  
 
Source: Garrood et al., 2017 
Fig. 1.6 Chemical structure of A) Fipronil. B) Ethiprole. 
1.9 Anti-feedant (pymetrozine) 
One of the few insecticides registered for N. lugens control that has not yet 
been affected by high levels of resistance is the neuroactive pyridine azomethine 
derivative, pymetrozine (Fig. 1.7). It belongs to group 9 of the IRAC MoA classification 
scheme. Known as an anti-feedant (Harrewijn and Kayser, 1997), it does not cause 
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rapid kill but rather impacts upon feeding and reproduction capability (Tsujimoto et 
al., 2015). Pymetrozine increases the duration of non-probing periods and inhibits 
phloem ingestion (He et al., 2011). Studies performed on locusts revealed that 
pymetrozine affects insect chordotonal mechanoreceptors (Ausborn et al., 2005), 
but until recently the precise mechanism by which this insecticide acts on sucking 
insects had not been fully characterised. However, studies have now concluded that 
pymetrozine modifies a transient receptor potential (TRP) ion channel complex, 
found only in insect stretch receptor cells (Nesterov et al., 2015).  
 
Source: Chem Service inc, PA, USA 
Fig. 1.7 Chemical structure of pymetrozine. 
Since, due to its mode of action, this insecticide is much slower acting, it 
requires a different method of bioassay assessment for possible resistance. The 
current IRAC Susceptibility Test Method (method number 5) for N. lugens (IRAC, 
2012), is a rather inefficient bioassay for anti-feedant insecticides, taking a long time 
to carry out and often leading to ambiguity in interpretation of the results. A more 
effective method has been demonstrated for anti-feedants using fluorescent dyes, 
e.g. for Bemisia tabaci (Cameron et al., 2013). For N. lugens a method was recently 
developed that combined topical application and measurement of offspring number 
(Tsujimoto et al., 2015), which produces a median effective dose (ED50) value. 
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Tsujimoto et al. argue that the benefit of this is that it provides a value of ‘pesticide 
directly applied to insects per gram of body weight’.  
1.10 Other insecticides 
There are two other insecticides that are relevant to brown planthopper 
control. The first is buprofezin (Fig. 1.8A), an insect growth regulator that was 
registered for use in the 1980s. Buprofezin is a chitin synthesis inhibitor developed 
by Nihon-Nohyaku (Wang et al., 2008), which belongs to group 16 of the IRAC MoA 
classification scheme. It is renowned for its effectiveness against Homopteran insect 
pests, with low environmental and mammalian toxicity (Asai et al., 1985; Nagata, 
1986). It does not cause a rapid kill but rather disrupts chitin deposition during the 
molting process and prevents the insects from shedding the exuviae, causing death 
at the nymphal stage (Izawa et al., 1985; Uchida, Asai and Sugimoto, 1985). It is also 
affects fecundity and egg hatching, causing a reduction in population growth (Uchida, 
Asai and Sugimoto, 1985; Ishaaya, Mendelson and Melamed-Madjar, 1988; Wang et 
al., 2008). It was often used for N. lugens control in China until it was replaced by 
imidacloprid. 
The second insecticide is triflumezopyrim (Fig. 1.8B). This compound has only 
recently been developed and marketed by DuPont Crop Protection, and has been 
assigned to a novel class of insecticides, the mesoionics (Group 4E of IRAC MoA 
classification scheme). Cordova et al. demonstrated that the mesoionics inhibit the 
orthosteric binding site of nAChR, in contrast to neonicotinoids (also group 4 
insecticides) which activate the nAChRs (Cordova et al., 2016). 
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Source: A) Sigma-aldrich. B) Cordova et al., 2016 
Fig. 1.8 Chemical structures of A) Buprofezin. B) Triflumezopyrim. 
 
1.11 Insecticide resistance 
The over-reliance on and the repeated use of insecticides of the same 
chemical class without consideration for the need for MoA (IRAC group 1-29) rotation 
has had the inevitable consequence of resistance arising within pest populations. 
IRAC’s given definition of resistance (IRAC, 2016) is ‘a heritable change in the 
sensitivity of a pest population that is reflected in the repeated failure of a product 
to achieve the expected level of control when used according to the label 
recommendation for that pest species’. 
  The earliest scientific study highlighting resistance was conducted by 
Melander, who noted that applications of the inorganic insecticide, sulfur-lime, were 
not as effective as previously against the San José scale and brown mites (Melander, 
1914). The following decades saw further reports of incidents of resistance, in red 
scale against hydrogen cyanide (Quayle, 1938) and the codling moth against lead 
arsenate (Hough, 1928). However, the onset of resistance to DDT, an organo-chlorine 
insecticide, in house-flies (Wiesmann, 1947; Harrison, 1950) demonstrated that 
resistance could likely arise against any compound used as a control agent. This has 
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ultimately proved to be the case for every new class of insecticide released to combat 
insect pests.  
The phenomenon of insecticide resistance can be viewed as the best example 
of natural selection available, as it is a relatively rapid phenomenon, sometimes 
occurring within a few generations. How quickly resistance develops depends on a 
combination of factors involving the chemical used for control and the biology of the 
pest species. On the pest side the generation time, ability to migrate and host range, 
as well as the number of nearby susceptible populations are key factors. These 
combine with the specificity of the chemical used, when it is applied, how often and 
also the concentration used (IRAC, 2013) as key factors that determine how quickly 
resistance is selected for.  
The nature of the mechanisms responsible for insecticide resistance have 
been extensively studied, leading to a complex and diverse picture of the genetic 
causes. The genetics can be monogenic or polygenic in nature (ffrench-Constant, 
2013), though primarily monogenic mechanisms have been found. There are two 
major ways whereby resistance has arisen; 1) target site alteration, called target-site 
resistance, and 2) enhanced activity of detoxification enzymes, termed metabolic 
resistance. Other less common mechanisms are penetration resistance and 
behavioural resistance. All four of these mechanisms will be discussed briefly later.  
Insects can utilise many of these mechanisms within a single individual, giving 
them resistance to a range of compounds. The clearest example of this is seen in the 
history of insecticide resistance in Myzus persicae, the peach potato aphid (Bass et 
al., 2014). No less than seven mechanisms have been attributed to causing resistance 
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in this pest, starting with overexpression of E4/FE4 esterase against 
organophosphates (Devonshire and Moores, 1982). A mutation, S431F, in AChE 
causes resistance to dimethyl carbamates (Nabeshima et al., 2003), whilst multiple 
mutations (L1014F, M918T and M918L) in VGSC have been attributed to resistance 
against pyrethroids (Williamson et al., 1996; Eleftherianos et al., 2008; Fontaine et 
al., 2011). A further target-site mutation, A301G, in the GABA gated chloride channel 
implements resistance against cyclodienes (Anthony et al., 1998). Overexpression of 
a P450 enzyme, CYP6CY3, causes resistance to nicotine and cross resistance to 
neonicotinoids (Puinean, Denholm, et al., 2010; Bass et al., 2013). Resistance to 
neonicotinoids may also be mediated by reduced penetration of neonicotinoids 
(Puinean, Denholm, et al., 2010; Bass et al., 2013), as well as a target-site mutation, 
R81T, in nAChR (Bass et al., 2011). Consequently, some M. persicae populations can 
at any one time be resistant to a range of different chemical compounds or have 
more than one mechanism that makes them resistant to an individual chemistry. This 
versatility against insecticides, displayed by M. persicae, gives a snapshot of the 
different mechanisms that can evolve in an insect pest against xenobiotics. For the 
brown planthopper there have also been a range of mechanisms shown to provide 
insecticide resistance.  Gene amplification, increased expression and activity of an 
esterase (Nl-EST1) caused resistance to organophosphates and carbamates, whilst a 
GST, (nlgst1-1) was shown to confer resistance to pyrethroids (Vontas et al., 2002). 
Resistance to neonicotinoids has been linked to overexpression of P450s (Bass, 
Carvalho, et al., 2011), and mutations in the Rdl gene have been linked with 
resistance to phenylpyrazoles (Y Zhang et al., 2016; Garrood et al., 2017) 
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1.12 Metabolic resistance 
There are three enzyme families that are most commonly associated with 
metabolic resistance; cytochrome P450 monooxygenases (P450s), glutathione S-
transferases (GSTs) and the carboxylesterases (CCEs). The primary way these 
enzymes cause metabolic resistance is through overexpression in response to the 
presence of a xenobiotic compound (Small and Hemingway, 2000; Vontas, Small and 
Hemingway, 2000, 2001; Vontas et al., 2002; Bass et al., 2011).  This increased 
abundance of enzyme is then able to disrupt the xenobiotic and prevent it from 
reaching its intended target site. The mechanisms underlying this change in 
expression are varied, with gene amplification the most regularly reported 
(Devonshire and Field, 1991; Feyereisen, 1995; Bass and Field, 2011). Another 
mechanism is mediated by regulatory cis- and trans- elements that influence levels 
of gene expression (Grant and Hammock, 1992; Feyereisen, 1995). Other than 
enhanced expression of an enzyme, there can also be mutations present in the 
enzymes coding sequence that result in an increased metabolism of insecticide 
(Claudianos, Russell and Oakeshott, 1999). An overview of each of the three enzyme 
families, and respective roles in insecticide resistance is given below. 
The P450s are recorded as one of the largest and oldest gene super-families, 
containing a very diverse range of enzymes (Feyereisen, 1999). D. melanogaster, the 
first insect genome sequenced, was found to have 85 CYP (cytochrome P450) genes 
(Tijet, Helvig and Feyereisen, 2001; Feyereisen, 2006). Feyereisen discusses the 
differences in the numbers of CYP genes found across insect orders. For example, 
Apis mellifera (hymenoptera) has only 46 CYP genes, in contrast Tribolium castaneum 
(coleoptera) has 143 CYP genes (Feyereisen, 2006). N. lugens has a comparatively low 
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number of CYP genes (67) (Xue et al., 2014). The CYP genes within each insect order 
are separated into four distinct clades; CYP2, CYP3, CYP4 and mitochondrial 
(Feyereisen, 2006).  
Examples of P450 mediated resistance are now widespread throughout the 
literature, including CYP6G1 against imidacloprid in D. melanogaster (Daborn, J. L. 
Yen, et al., 2002), CYP6CY3 against neonicotinoids in M. persicae (Puinean et al., 
2010) and CYP6CM1 against imidacloprid in B and Q biotypes of B. tabaci (Karunker 
et al., 2008). These mechanisms all fall into the previously discussed category of 
overexpression of P450 enzyme. However, more research has now been conducted 
on coding sequence variation of CYP genes, showing resistance caused by P450s can 
be more varied than just overexpression. A study into pyrethroid resistance in 
Anopheles funestus, a key vector of malaria in Africa, indicated that allelic variation 
in P450s was responsible for this resistance (Ibrahim et al., 2015). Analysis of two 
genes, CYP6P9a and CYP6P9b, revealed that different alleles were associated with 
the resistant A. funestus populations compared to the susceptible, and that these 
genes were undergoing directional selection. Qualitative changes in CYP6P9b (V109I, 
D335E and N384S) were identified as being crucial in causing pyrethroid resistance 
through enhancing the metabolic activity of the P450 enzyme (Ibrahim et al., 2015).  
GSTs have been demonstrated as a mechanism of resistance against OPs, 
organochlorines and pyrethroids. GSTs are phase II metabolic enzymes that 
conjugate reduced glutathione (GSH) to the electrophilic centres of lipophilic 
compounds (Li, Schuler and Berenbaum, 2007). As with the previously discussed 
P450 mediated resistance, GST mediated resistance is primarily caused by elevated 
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levels of enzyme activity. A DDT resistant strain of D. melanogaster (PSU-R) displayed 
heightened levels of a Delta GST, DmGSTD1 (Tang and Tu, 1994), whilst an OP 
resistant M. domestica strain had increased levels of MdGSTD3 transcripts (Syvanen, 
Zhou and Wang, 1994). Various mosquito species have also displayed elevated GST 
levels conferring resistance to DDT, for example AgGSTE2 in A. gambiae (Ortelli et 
al., 2003) and AaGSTE2-2 in A. aegypti (Lumjuan et al., 2005). A mutation (L119F) in 
GSTe2 was also seen in A. funestus that was demonstrated to underlie resistance to 
DDT and pyrethroids (Riveron et al., 2014). An enlarged DDT-binding cavity in the 
enzyme with the L119F mutation was behind the resistance to DDT.  
The carboxylesterase enzymes hydrolyse ester bonds via the addition of 
water (Wheelock, Shan and Ottea, 2005). Xenobiotic compounds that are esters (e.g. 
carbamates, OPs and pyrethroids) have been particularly prone to CCE mediated 
resistance. As previously discussed, resistance is generally caused via elevated 
enzyme levels and/or a change in the coding sequence of the enzyme. Extensive 
study of the Australian sheep blowfly, Lucilia cuprina, indicated that OP resistance 
was conferred by a mutated carboxylesterase. A G137D mutation in the esterase 
isozyme, E3, caused the enzyme to lose carboxylesterase activity and gain the ability 
to hydrolyse an OP, diazinon (Newcomb et al., 1997). A further mutation in E3, 
W251L, demonstrates hydrolysis activity against the OP malathion (Campbell et al., 
1998). The overview of insecticide resistance in M. persicae, provided earlier in this 
introduction, mentioned the role of esterases (E4 and FE4) in insecticide resistance. 
In this case the esterase genes were greatly amplified (up to 80 copies) and the level 
of amplification correlates broadly with the increasing levels of resistance seen in the 
aphids clones (R1, R2 and R3) (Field et al., 1999; Bass et al., 2014). The amount of 
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esterase produced can be substantial, up to 3% of total protein in the most resistant 
clones (R3), which can have a detrimental fitness cost in the absence of insecticide 
(Bass et al., 2014). This is also an example of an esterase that sequesters, rather than 
hydrolyses the xenobiotic. Esterase gene amplification also occurs in the mosquito’s 
Culex tritaeniorhynchus and C. quinquefasciatus, with CtrESTβ1 (orthologous to C. 
quinquefasciatus ESTβs) showing elevated levels of activity due to gene amplification 
(Karunaratne et al., 1998). One of the co-amplified genes, ESTβ2, in C. 
quinquefasciatus has also shown highly active promoter activity in the resistant Pel-
RR strain (using a luciferase expression system) when compared with the wild-type 
promoter (Hawkes and Hemingway, 2002; Li, Schuler and Berenbaum, 2007).  
 A further gene family involved in metabolic resistance is the ABC gene family. 
These are part of phase III metabolism of detoxification, after phase I (P450s and 
CCEs) and phase II (GSTs) (Dermauw and Van Leeuwen, 2014). The ABC gene family 
encode for ABC (ATP binding cassette) transporters that are responsible for removal 
of metabolites of earlier phases of detoxification. There has been limited evidence 
provided so far for a role of this gene family in neonicotinoid or phenylpyrazoles 
resistance (Dermauw and Van Leeuwen, 2014). Dermauw et al. provide a summary 
of the possible cases of ABC transporters involvement in neonicotinoid and fiproles 
resistance. Apis mellifera saw increased mortality to imidacloprid, acetamiprid and 
thiacloprid, when verapamil (used as a synergist for ABC transporters) was applied 
(Hawthorne and Dively, 2011). However, no specific ABC subfamily has been linked 
with this, and so more evidence would be needed before calling ABC transporters a 
significant mechanism in resistance here. Implication of ABC transporters in 
resistance through upregulation in microarray/RNA-seq studies are also seen. 
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Upregulation of an ABCG transporter gene in B. tabaci thiamethoxam resistant 
population has been identified (Yang et al., 2013), whilst multiple ABC transporters 
are upregulated in resistant strains of L. striatellus (Sun et al., 2017). For a fipronil 
resistant strain of P. xylostella multiple ABC transporters were seen as upregulated 
(You et al., 2013). 
 1.13 Target-site resistance 
Target-site resistance occurs when an alteration in the target protein 
prevents the insecticide from binding/acting in the way it should. Most cases 
involving target-site resistance are due to a mutation in the gene encoding the 
insecticide target site (SNP resulting in an amino acid substitution) leading to a 
conformational change in the binding site. The proteins that are most well 
documented for developing this form of resistance are the transmembrane proteins 
and enzymes that exist throughout the insect nervous system, since these have 
traditionally been the main target for most insecticide classes developed for insect 
pest control. This mechanism is widespread and examples exist for all the major 
classes of insecticide.  
The first report of a structural change in an insecticide target causing 
resistance was a substitution of an alanine to a serine (A301S) in the GABA-gated 
chloride channel, linked to a high level resistance to cyclodienes in D. melanogaster 
(ffrench-Constant et al., 1993). This A301S mutation had independently arisen in 
several insect species (Thompson, Steichen and ffrench-Constant, 1993). This 
mutation has also been shown to arise independently multiple times within the same 
species, demonstrated in the red flour beetle, Tribolium castaneum (Andreev et al., 
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1999). The A301 position (Fig. 1.9) is a hotspot for mutations, with various 
substitutions linked to resistance (A301S/G/N) (Le Goff et al., 2005; Nakao et al., 
2011, 2012). It has also been shown that other mutations can arise in the RDL GABA 
receptor in tandem with A301S, such as T350M in D. simulans (Fig. 1.9) (Le Goff et 
al., 2005). 
 Knockdown resistance (kdr) confers resistance to DDT and pyrethroids. This 
resistance is caused by a substitution of leucine to phenylalanine at AA position 1014 
(L1014F) within the VGSC, and was first described in the house fly, Musca domestica 
(Williamson et al., 1996). Higher resistance levels to pyrethroids were seen when a 
second mutation (M918T) was present in conjunction with L1014F, and this is termed 
super-kdr (Ingles et al., 1996; Williamson et al., 1996). Similarly to A301S in the GABA-
gated chloride channel, L1014F has been seen in a wide range of insect species 
(Davies et al., 2007).  
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Source: Le Goff et al., 2005 
Fig. 1.9 A cartoon representation of the RDL subunit, demonstrating the location of two 
mutation sites, A301 and T350 (highlighted in black). 
A few cases of target site alteration conferring neonicotinoid resistance have 
been reported. The first is a point mutation (Y151S) in two nAChR subunits of N. 
lugens that reduced the ability of imidacloprid to bind to the receptor (Liu et al., 2005, 
2006). This was the first demonstrated target-site resistance mechanism for 
neonicotinoids, but has never been found in the field. Detoxification via P450s has 
been the dominant mechanism of neonicotinoid resistance seen in field populations. 
A novel mutation (R81T) in loop D of the nAChR β1, was linked with neonicotinoid 
resistance in field collected M. persicae (Bass, Puinean, et al., 2011). Downregulation 
of the nAChR α8 subunit was linked to imidacloprid resistance in N. lugens (Y. Zhang 
et al., 2015).   
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1.14 Penetration resistance 
Penetration resistance is far less common than either metabolic or target-site 
resistance. It occurs when a resistant insect is much slower to absorb the insecticide 
in comparison to a susceptible insect. Overexpression of several cuticular proteins in 
M. periscae, leading to reduced cuticular penetration of neonicotinoids, was seen as 
contributing to resistance, as well as an overexpressed P450 (Puinean, Foster, et al., 
2010). Another example is seen in Plutella xylostella, with reduced uptake of S-
fenvalerate (pyrethroid) in resistant strains (Noppun, Saito and Miyata, 1989). 
Recently penetration resistance has been linked with pyrethroid resistance in A. 
gambiae (Bass and Jones, 2016). Resistant mosquitoes had a thicker epicuticular 
layer than susceptible insects, and also a larger cuticular hydrocarbon content 
(Balabanidou et al., 2016). 
1.15 Behavioural resistance 
IRAC defines behavioural resistance as the ability of ‘resistant insects to 
detect or recognise a danger and avoid the toxin’ (IRAC, 2016). A classic example of 
this resistance is seen in the control of German cockroaches, Blatella germanica. 
There glucose based gel baits were no longer effective since the pest simply avoided 
eating the baits (Wang, Scharf and Bennett, 2004). The potential rise of behavioural 
resistance in mosquitos has been modelled and it was demonstrated that it would 
significantly hamper malaria control (Gatton et al., 2013). Currently there is not 
believed to be any clear evidence for behavioural resistance in mosquitoes and has 
been argued that there are mosquito taxa that are behaviourally resilient rather than 
resistant (Govella, Chaki and Killeen, 2013). It has also been argued that the definition 
of behavioural resistance is too vague and new experimental approaches are 
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required (Zalucki and Furlong, 2017). There is a general lack of information regarding 
behavioural resistance currently, since it is more complex to quantify than 
physiological resistance and harder to screen in field populations.  
1.16 Objectives 
The aim of this project was to increase the understanding of how the rice 
pest, N. lugens, is able to become resistant to insecticide resistance. With a more 
complete picture of why chemical control has broken down for the brown 
planthopper, there can be a more structured approach to dealing with this major 
pest. It is hoped that the body of research presented in this thesis will help future 
research into insecticide resistance of N. lugens and future control programmes. 
 Chapter II is broad description of the general materials and methods used 
throughout this PhD. Chapter III monitors the levels of resistance of various N. lugens 
field strains to compounds that have become inefficient at controlling them. Chapter 
IV focuses on the assembly of a transcriptome and the gene expression analysis 
performed between a susceptible and resistant N. lugens populations. Chapter V 
focuses on the attempts to elucidate the mechanism(s) behind ethiprole/fipronil 
resistance by studying the gene (Rdl) that encodes these insecticides’ target site. 
Chapter VI will describe the analysis of potential metabolic resistance mechanisms. 
This predominantly focuses on metabolic resistance to imidacloprid, but also 
encompasses cross-resistance mechanism studies for imidacloprid and ethiprole. 
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Chapter II  General Materials and Methods 
 
2.1 Nilaparvata lugens rearing 
Live N. lugens strains kept at Rothamsted Research were reared in the 
laboratory on whole 5 to 10 weeks old rice plants (Oryza sativa L. ssp.) under 
controlled environmental conditions (26 oC, 16 h photoperiod and 70% relative 
humidity). Mesh cages were set up and a pot (1.1 L) of rice was added to a deep tray 
that was filled with water. Approximately 75-100 adults were used to populate the 
new cage, and fresh whole rice plants were added when instars appeared, and when 
older plants showed considerable signs of damage.  
2.2 N. lugens strains 
All strains were provided by Bayer CropScience (Monheim, Germany), and 
were collected from across South and East Asia. A summary of all the strains used in 
this PhD is shown below. 
Table 2.1 N. lugens strains.  
Strain Year collected Country of origin Region/area 
Bayer-S 1984 Japan  
Nl9 August 2009 Thailand  
Nl31A October 2010 Taiwan Yulin County 
Nl33 November 2010 Vietnam Trà Vinh Province, Southern Vietnam 
Nl39 August 2011 Vietnam Hau Giang 
Nl40 August 2011 Indonesia Anjatan District, Indramayu 
Nl44 August 2011 Indonesia Parnanukan District, Subang 
Nl45A September 2011 India Raipur, Chhattisgarth 
Nl52A March 2012 India Koppal District, Karnataka State 
Nl55 February 2012 India East Godavari District, Andhra Pradesh 
Nl56A April 2012 India East Godavari District, Andhra Pradesh 
Nl57 September 2012 India Kanagala District, Karnataka State 
Nl58A September 2012 India Mudhapur, Karnataka State 
Nl59A September 2012 India Sidhikerra, Karnataka State 
ANo live laboratory cultures, insects used had been preserved at -80oC 
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2.3 Drosophila melanogaster rearing 
Fly strains were maintained on standard food (Bloomington formulation) at 
24oC. Approximately 6 mL of standard food was added to standard Drosophila vials 
(Dutscher Scientific, Brentwood, Essex, UK). Flies were anaesthesised with CO2 and 
10-15 flies were transferred to the fresh vial. 2.5 – 3 weeks later 10-15 flies are again 
transferred into fresh vials. 
2.4 D. melanogaster insecticide bioassays 
3-5 day old adult females were used in insecticide bioassays to assess the 
susceptibility of different fly strains to technical compounds. The flies were subjected 
to the insecticide in a contact/feeding bioassay. Standard Drosophila vials (Dutscher 
Scientific, Brentwood, Essex, UK) were filled with agar solution (4ml/vial) containg 
2% w/v agar (Dutscher Scientific), 1.2% w/v food grade sucrose and 0.4% v/v glacial 
acetic acid (Sigma Aldrich, St. Louis, MO, USA). 18 h prior to bioassay the agar vials 
were spread with 100 µL of insecticide solution and vortexed vigorously. For each 
concentration vials were prepared in triplicate for each fly strain with flies 
anaesthesised with CO2 and 10 female flies added to each vial. The vials were kept 
upside down until all flies became active to avoid flies getting trapped in agar. The 
bioassay was assessed after 48 h (neonicotinoids) or 72 h (fiproles and dieldrin), dead 
flies as well as seriously affected flies i.e. those displaying no coordinated movement, 
that were unable to walk up the vial, or unable to get to their feet were cumulatively 
scored as ‘affected’. 
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2.5 Bioassay data analysis 
Raw data was corrected for control mortality using Abbott’s formula (Abbott, 
1925). Probit analysis was performed with the the GenStat® (2014, 17th Edition, 
©VSN International Ltd, Hemel Hempstead, UK) statistical software to generate LC50 
values. Resistance ratios were calculated by dividing the LC50 of any given strain by 
the  LC50 of the susceptible strain. 
2.6 Genomic DNA extraction 
DNA was extracted from single insects using 20 µL microlysis plus extraction 
buffer (Microzone Ltd., Haywards Heath, Sussex, UK) using the manufacturer’s 
protocol for tough cells. Samples were placed in a thermal cycler and the following 
profile run: 65oC for 15 min, 96oC for 2 min, 65oC for 4 min, 96oC for 1 min, 65oC for 
1 min and 96oC for 30 s. This procedure releases DNA from the insects, but does not 
purify it, so estimation of DNA yield via spectrophotometer was not possible. DNA 
extracted in this manner was suitable for use in PCR. 
2.7 Total RNA extraction 
Live adults were collected and flash frozen in liquid nitrogen and stored at        
-80oC before extraction of RNA. Total RNA was extracted using Isolate RNA mini kit 
(Bioline, London, UK) per the manufacturer’s recommended protocol. A total of 5 
insects (up to 30 mg tissue) were ground up using a pestle in 350 µL of Lysis buffer. 
This was centrifuged at 16 000 x g to pellet insect debris. This lysate was then filtered 
and 350 µL of 70% ethanol was combined with the filtrate. The RNA was then bound 
to the membrane of a fresh column, by centrifuging at 11 000 x g. The membrane 
was desalted with 350 µL of Membrane Desalting Buffer. The addition of DNase l 
removed any genomic DNA from the sample. The silica membrane was washed three 
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times and the RNA eluted into a nuclease-free 1.5 mL collection tube using 30 µL of 
RNase-free water. The quality and quantity of RNA was assessed via a ND-1000 
spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). RNA was always 
stored at -80oC to prevent degradation. 
2.8 cDNA synthesis 
RNA was used for first strand cDNA synthesis using Superscript III Reverse 
Transcriptase kit (Invitrogen, Carlsbad, CA, USA). 1-5 µg of total RNA was mixed with 
0.5 µL of random primers, 0.5 µL of oligo(dT)20, 1 µL 10 mM dNTP Mix and made up 
to 13 µL with sterile, distilled water. The mixture was incubated at 65oC for 5 min 
before being placed on ice for at least 1 min. To this 4 µL of 5X First-Strand Buffer, 1 
µL 0.1 M DTT, 1 µL RNaseOUTTM Recombinant RNase Inhibitor and 1 µL of 
SuperScriptTM III RT was added, giving a final working volume of 20 µL. Due to the 
inclusion of random primers, a first incubation step at 25oC for 5 min was included 
and followed by a further 45 min at 50oC. The reaction was inactivated by heating to 
70oC for 15 min. The cDNA was stored at -20oC. 
2.9 Primer design 
Primers were designed to be 20-30 nucleotides in length, with a GC content 
between 40-60% and a salt adjusted Tm of 58-60oC. An online tool OligoCalc 
(http://biotools.nubic.northwestern.edu/OligoCalc.html) (Kibbe, 2007) was used 
to calculate these properties.  
2.10 Standard PCR protocol   
A typical PCR reaction (25 µL) contained 12.5 µL Dreamtaq (Thermo Fisher, 
Waltham, MA, USA) containing Taq polymerase, 2x PCR buffer and 4 mM MgCl2 (2 
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mM final Concentration), 1 µL of forward primer (10 µM), 1 µL reverse primer (10 
µM), 0.5-2 µL of gDNA/cDNA and sterile distilled water up to 25 µL. Cycling conditions 
were 95oC for 2 min (initial denaturation) followed by 25-35 cycles of 95oC for 30 s 
(denaturation), 5oC below the lowest primer’s Tm ( generally 50-60oC ) for 30 s 
(annealing) and 72oC for 1 min/kb (extension), with a final elongation at 72oC for 5 
min. A negative control was also run without the addition of gDNA/cDNA to check for 
possible contamination.  
2.11 Agarose gel electrophoresis 
Agarose gels were made by dissolving molecular biology grade agarose 
(Thermo Fisher, Waltham, MA, USA) in 1x TBE buffer (0.89 M Tris Borate pH 8.3 and 
20 mM Na2EDTA; National Diagnostics, Atlanta, GA, USA) to make 1-1.2% gels w/v. 
0.5 µg/mL of ethidium bromide (Sigma Aldrich, St. Louis, MO, USA) was added prior 
to casting gels. PCR products (5 µL) were loaded into the wells of the gel and placed 
within an electrophoresis tank filled with 1x TBE buffer. These were run at 80V/200 
mA for 1 hour. 5 µL of GeneRuler 1 kb DNA ladder (Thermo Fisher, Waltham, MA, 
USA) was loaded into the first well. Gels were visualised using a UV trans-illuminator 
(Syngene, MD, USA). 
2.12 Purification of PCR products 
PCR purification was performed using Wizard® SV Gel and PCR Clean-up 
System (Promega, Madison, WI, USA) as per the manufacturer’s guidelines. For gels 
that contained more than one band, the desired (correct sized) band was excised 
using a clean razor blade and placed in a 1.5 mL microcentrifuge tube. Membrane 
Binding Solution was added in the ratio of 10 µL per 10 mg of gel slice and incubated 
at 60oC until dissolved. This dissolved gel solution or prepared PCR product was then 
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added to a minicolumn and incubated for 1 min at room temperature before 
centrifuging at 16 000 x g. The column was washed twice with Membrane Wash 
solution before the DNA was eluted in 30 µL of nuclease-free water. Quality and 
Quantity were then assessed using a ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, DE, USA). DNA was then stored at -20oC.  
2.13 DNA sequencing 
PCR products were sent to MWG Eurofins, Germany, for sequencing per their 
specifications of template concentration, dependent on product size, combined with 
2 µL of 10 pmol µL-1 primer. 
2.14 PCR Cloning 
PCR products were cloned using the StrataClone cloning PCR kit (Agilent 
Technologies, Santa Clara, CA, USA) as per manufacturer’s guidelines. A ligation 
reaction was assembled containing 3 µL of StrataClone cloning buffer, 2 µL of PCR 
product (5-50 ng), 1 µL of pSC-A-amp/kan cloning vector. and incubated at room 
temperature for 5 min before being placed on ice. 1 µL of the ligation reaction was 
added to StrataClone SoloPack competent cells that had been thawed on ice. This 
transformation mixture was left on ice for 20 min, before being heat-shocked at 42oC 
for 30 s. This was then placed back on ice for 2 min before 250 µL of pre-warmed LB 
medium (10 g NaCl, 10 g tryptone and 5 g yeast extract per Litre) was added. This 
was then left to recover for at least an hour at 37oC with agitation (~250 rpm). LB-
Ampicillin agar plates (1 mL of 100 mg/mL ampicillin per Litre) were plated out and 
spread with 40 µL of 2% X-Gal. 100 µL of the recovered cells were then spread onto 
the agar plates and left in a 37oC incubator overnight. White colonies were picked for 
screening whilst dark blue colonies were avoided. The colonies were collected on a 
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pipette tip and streaked onto a new LB-Ampicillin plate (from which material could 
be collected for plasmid preparation), then the tip was placed in 20 µL of sterile 
water. 2 µL of this water template was then used in a colony PCR reaction (same 
mixture as described in standard PCR protocol). Generic cloning primers, M13_F and 
M13_R, were used. The conditions for the cloning PCR were: 95oC for 3 min followed 
by 30 cycles of 94oC for 30 s, 60oC for 30s, 72oC for 1 min/Kb and a final 70oC for 5 
min. The samples were then assessed in the same style as for the standard PCR 
protocol by agarose gel electrophoresis.       
2.15 Plasmid purification 
Plasmids were purified using a GeneJET plasmid miniprep kit (Thermo Fisher, 
Waltham, MA, USA). Single colonies that had been identified as containing the 
correct insert were picked using a pipette tip from the colony record plate and added 
to 3 mL of LB ampicillin medium (1 mL of 100 mg/mL ampicillin per Litre) in a 15-mL 
falcon tube. This was incubated for 16 h at 37oC with agitation (250 rpm) in a shaking 
incubator. The bacterial cells were harvested by centrifugation at 3000 x g for 10 min 
at room temperature. The supernatant was removed by pipetting, and the pelleted 
cells were re-suspended in 250 µL of resuspension solution by vortexing. The cells 
were transferred to a sterile 1.5 mL Eppendorf tube and mixed by inverting the tube 
with 250 µL of lysis solution to lyse the cells. Mixing was done by inverting the tube 
to avoid shearing of chromosomal DNA. This reaction was terminated within 5 min 
(to prevent denaturation of supercoiled plasmid DNA) by the addition of 350 µL of 
neutralisation solution and mixed via tube inversion. Cell debris and chromosomal 
DNA was pelleted by centrifuging at 16 000 x g for 5 min. The supernatant was 
transferred to a fresh GeneJet spin column via pipetting, with care being taken not 
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to disturb the precipitate. This was centrifuged at 16 000 x g for 1 min, before 
undergoing two wash steps with wash solution. A further centrifugation step was 
then necessary to remove any residual ethanol contamination of the miniprep. The 
spin column was placed in a new 1.5 mL tube and the DNA eluted using 50 µL of 
sterile distilled water. The quality and quantity of the plasmids were then assessed 
via spectrophotometer. The purified plasmid was then stored at -20oC.       
2.16 Real-time quantitative RT PCR 
Primers were designed to amplify a 90-200 bp region of the gene using 
Primer3 program (Untergasser et al., 2007). Multiple pairs of primers were designed 
per gene to increase the chance of finding a primer pair with an adequate efficiency, 
discussed later. 
PCR reactions (15 µL) contained 5 µL of cDNA (2.5ng), 7.5 µL of SYBR Green 
JumpStart Taq Readymix (Sigma Aldrich, St. Louis, MO, USA), and 0.25 µM of forward 
and reverse primer. Samples were run on a Rotor-Gene Q (Qiagen, Venlo, Limburg, 
Netherlands) using the temperature cycling conditions of: 10 minutes at 95°C 
followed by 40 cycles of 95°C for 15 seconds, 57°C for 15 seconds and 72°C for 20 
seconds. A final melt-curve step was included post-PCR (ramping from 72°C-95°C by 
1°C every 5 seconds) to check for non-specific amplification.  
To validate the primers for the experimental qRT-PCR, standard curves were 
created. This involved running a dilution series of cDNA at five different 
concentrations ranging from 50 ng/µL to 0.005 ng/µL, with three technical replicates 
per concentration. This allows an efficiency for the primer pair to be calculated based 
on the assumption that after each cycle in the program the quantity of DNA should 
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have precisely doubled. Therefore, primers were only chosen for assessing gene 
expression if they fell in the range of 0.9-1.1, with 1 representing optimal efficiency.  
Each qRT-PCR experiment consisted of three independent biological 
replicates with two technical replicates for each. Technical replication was limited to 
two replicates as 1) PCR reactions were set up using a liquid handling robot (CAS 
1200, Corbett Research) which provided high levels of technical reproducibility and 
2) to allow us to employ a sample maximisation strategy (i.e. running as many 
samples as possible in the same run, to minimise technical run-to-run variation). Data 
were analysed according to the ΔΔCT method (Pfaffl, 2001) to calculate relative gene 
expression values. For normalisation, two reference genes were used for each strain. 
For N. lugens samples, actin and α2-tubulin were used, whereas for D. melanogaster 
samples, Rpl32 (Ribosomal protein L32) and SDHA (succinate dehydrogenase 
complex flavoprotein subunit A) were used as the reference genes. The geometric 
means of the selected genes were then used to normalise the test samples by a 
previously described strategy (Vandesompele et al., 2002) 
2.17 SNP calling of RNA-seq reads 
The RNA-seq was designed to allow a comparison of gene expression 
between susceptible and insecticide resistant populations. The Bayer-S strain was 
contrasted with two field populations (Nl33 and Nl55) and the laboratory ethiprole 
selected counterparts (Nl33-eth and Nl55-eth). The levels of differential expression 
of the transcripts assembled by Trinity were then analysed for transcripts that could 
potentially be involved in insecticide resistance. 
Raw reads of each N. lugens strain were mapped to curated consensus 
sequences of interest to conduct single nucleotide polymorphism (SNP) analysis. 
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Geneious R8’s (Biomatters, Auckland, New Zealand) map to reference function was 
used with the consensus sequence of interest as the reference. The settings applied 
were: 5% gaps, maximum mismatches: 10%, minimum overlap identity: 80%, index 
word length: 14, maximum ambiguity: 4. 
2.18 Locomotor activity level monitoring (trikinetics) 
Glass behaviour tubes were filled with 2-3 cm of agar by filling a beaker slowly 
with molten agar and placing the tubes in. The tubes were then capped, with a rubber 
cap, to hold the agar in place. The tubes were then allowed to cool before the agar 
was spread with 50 µL of insecticide solution and vortexed, then left to dry overnight. 
The following day 10 adult male flies, aged 2-7 days after eclosion, were added to 
each tube and the tubes stoppered with cotton wool. A range of five insecticide 
concentrations was used, with two replicates per concentration. The tubes were 
loaded into a DAM2 activity monitor (Trikinetics, Inc., Waltham, MA, USA), ensuring 
that food was not blocking the infrared beam. The loaded monitor was placed in a 
dark incubator and connected to the DAMSystem308 software installed on a 
computer. The system was set to record in 5 mins sections for all of the tubes. The 
experiment was left to run, maintained in darkness, for a minimum of 24 h.   
2.19 D. melanogaster germline transformation 
D. melanogaster germline transformations were performed using a modified 
protocol (http://carroll.molbio.wisc.edu/methods/Miscellaneous/injection.pdf). 
from N. Gompel This protocol was optimised for our purposes by a postdoctoral 
researcher, Christoph Zimmer. The D. melanogaster transformations were 
performed to allow us to functionally validate the candidate genes found in N. lugens 
using an in vivo experimental approach. 
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2 days before first injection the flies (~300) were transferred to an egg laying 
cage to acclimatise to conditions and incubated at 24oC. The egg laying plate which 
was made using grape agar premix (Flystuff, San Diego, CA, USA), was streaked with 
fresh yeast paste and changed twice a day.  
On the day that injection took place the egg laying plates were changed 3 
times in the 2 h preceding the first harvest period, to flush out old embryos from the 
flies. Embryos were harvested in a 30-45 min laying period and transferred to a mesh 
basket. After through rinsing with tap water, the embryos were transferred to a 
coverslip and aligned along one edge, with the posterior pole pointing to the edge. 
Each coverslip was packed with approximately 100 embryos lying side by side. The 
embryos were left to dry to attach to the coverslip, before being covered with a 
minimal amount of halocarbon oil mix (2.5 mL series 27 + 5 mL series 700, both 
Sigma-Aldrich). This was left for 8 min to penetrate between the chorion and the 
vitelline membrane.  
The injections were done using an inverted microscope (eclipse Ti-U Nikon, 
Japan) equipped with a 10x/0.25 lens, 10x/22 eyepiece and fluorescence 
illumination. To deliver the injection mix a micromanipulation set-up of a motorised 
micromanipulator express microinjector (Eppendorf, Hamburg, Germany) and a 
FemtoJet express microinjector (Eppendorf, Hamburg, Germany) were used. 
Injection needles were prepared by C. Zimmer using a Stoelting APP-1 52500 All 
Purpose Puller (Stoelting, Dublin, Ireland) and thin wall glass capillaries (100 mm 
length, 1.5 mm OD, 1.12 mm ID, from World Precision Instruments, Sarasota, FL, USA) 
in accordance with previous research (Miller, Holtzman and Kaufman, 2002).  
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To inject the embryos, the filled needle was positioned so that the tip was 
alongside the posterior pole of the embryos. Before injecting, the injection time and 
pressure were calibrated so that a small droplet of liquid could be seen emerging 
from the needle when injecting. The embryo was gently impaled by the needle tip, 
taking care to remain in the first 1/5th of the embryo (where the germ cells are), and 
a small droplet of liquid injected. The needle was then removed in a swift motion and 
the injection stage moved to the next embryo to be injected. Any embryo that was 
overdeveloped or in the wrong orientation was over-injected to prevent further 
development. 
After all embryos had been injected the oil was drained from the coverslip 
and placed into a food vial, so that the embryos were positioned just above the food. 
The vial was left horizontally for the first 48 h after injection at 24oC, before being 
stored vertically at 24oC. When the adult flies hatched, they were collected and 
crossed to the appropriate fly strain. Each male survivor from the injection would be 
crossed to 3 virgin females and vice versa for the surviving female
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Chapter III Resistance monitoring in N. lugens 
 
Some of the results presented in this chapter have been published in peer reviewed 
journals (reprints attached in Appendix B and C) 
Garrood, W. T., Zimmer, C. T., Gorman, K. J., Nauen, R., Bass, C. and Davies, T. G. E. 
(2016). ‘Field-evolved resistance to imidacloprid and ethiprole in populations of 
brown planthopper Nilaparvata lugens collected from across South and East Asia’, 
Pest Management Science, 72, 140-9. 
Garrood, W. T., Zimmer, C. T., Gutbrod, O., Lüke, B., Williamson, M. S., Bass, C., 
Nauen, R. and Davies, T. G. E. (2017) ‘Influence of the RDL A301S mutation in the 
brown planthopper Nilaparvata lugens on the activity of phenylpyrazole 
insecticides’, Pesticide Biochemistry and Physiology. Rothamsted Research Ltd, pp. 
1–8. doi: 10.1016/j.pestbp.2017.01.007. 
3.1 Introduction 
The control of the brown planthopper Nilaparvata lugens (Stål) (Hemiptera: 
Delphacidae) has for decades relied on the application of synthetic insecticides. This 
led to a situation in which N. lugens populations emerged which are resistant to 
several of the major insecticide classes applied, including the organophosphates, 
carbamates and pyrethroids (Hemingway, Karunaratne and Claridge, 1999; Nagata et 
al., 2002). When these insecticide classes were no longer able to provide effective 
control in the field, the neonicotinoids became the insecticides of choice against N. 
lugens. 
Chapter III 
44 
 
Since the mid-1990s, the neonicotinoid insecticide imidacloprid has been very 
widely used to control N. lugens, and this has inevitably led to the appearance of 
resistance to this insecticide class in the population, first witnessed in 2003 
(Matsumura et al., 2008). More recent monitoring has demonstrated that very high 
levels of resistance to imidacloprid are now present in N. lugens populations across 
Asia (Wen et al., 2009; Zhang et al., 2014; Garrood et al., 2016). Resistance 
monitoring across nine regions of China revealed that imidacloprid resistance levels 
had increased to much higher levels by 2012 compared to 2009, with resistance 
ratios (RR) as high as 616.6 being reported (Zhang et al., 2014). Levels of imidacloprid 
resistance in N. lugens immigrating into Japan showed near identical resistance ratios 
of 615.5, when comparing LD50 from 2012 with 1992 (Matsumura et al., 2013). 
Matsumura et al. also tested two other neonicotinoids for resistance in their study, 
thiamethoxam and dinotefuran. For thiamethoxam there was a significant increase 
in LD50 between 2006 and 2011, from 0.27 µg g-1 to 4.7 µg g-1, representing a 21-fold 
increase, whereas dinotefuran values were all below 1 µg g-1 between 2005-2012, 
but the values seen in 2012 were ~3-fold higher than in 2005. Zhang et al. also 
monitored resistance to other neonicotinoids in addition to imidacloprid, namely 
thiamethoxam and nitenpyram. In China, N. lugens resistance to thiamethoxam was 
at a moderate level (RR 13.9 ~ 36.7-fold) in 2011, like that seen for N. lugens 
immigrating into Japan. Testing for nitenpyram resistance in 2011 revealed that all 
N. lugens populations tested across China displayed susceptibility to nitenpyram (RR 
0.96 ~ 2.4-fold), though they note that in 2012 this had increased slightly to RR 1.4 ~ 
3.7-fold, and they surmise that resistance to nitenpyram could be at an early stage 
of development.  (Zhang et al., 2014). 
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Since there was significant resistance being displayed to neonicotinoid 
insecticides, most notably against imidacloprid, a switch to a new class of insecticide 
was necessitated to maintain control of N. lugens populations. The insecticides of 
choice in this instance were the phenylpyrazoles (fiproles) insecticides, with the main 
products deployed being ethiprole and fipronil. Ethiprole, like imidacloprid, was first 
developed by Bayer CropScience (Bayer CropScience, 2007). However, the 
increasingly widespread use of these fiprole compounds inevitably led to resistance 
to this alternative chemistry emerging. By the end of the last decade N. lugens 
populations in China displayed resistance to fipronil (23.8-43.3-fold resistance) and 
cross-resistance to ethiprole (47.1-100.9-fold) (Wang et al., 2009; Zhao et al., 2011). 
High levels of resistance to ethiprole in N. lugens populations has also been seen 
across a number of countries in South and East Asia (Punyawattoe et al., 2013; 
Garrood et al., 2016). 
To further explore the extent of resistance to neonicotinoid & fiprole 
insecticides in N. lugens populations, bioassays with the insecticides imidacloprid, 
ethiprole and fipronil were conducted on the N. lugens populations held at 
Rothamsted Research. Various of the field collected strains housed in the 
Rothamsted insectary also underwent further selection with neonicotinoid and 
fiprole insecticides in the laboratory to increase the resistance in these strains. 
Resistance bioassays were then performed to allow a comparison to the unselected 
(field collected) strains and to assess the extent of cross-resistance, if any, between 
the three compounds mentioned above.  
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3.2 Materials and methods 
3.2.1 Topical application bioassay 
Adult macropterous (long-winged) N. lugens were taken from age-structured 
populations and were less than 10 days old. Approximately 15 adults were lightly 
anaesthetised and dosed with the required concentration of technical grade 
imidacloprid (Sigma Aldrich, St. Louis, MO, USA) on the upper surface (pronotum) of 
the prothorax using 0.2 μL of acetone as the solvent carrier, delivered using a hand-
held Burkard microapplicator (Burkard Manufacturing Co. Ltd, Rickmansworth, UK) 
fitted with a 1 cm3 all-glass syringe (Fig.3.1). Control insects were dosed with 0.2 μL 
of acetone only. Treated individuals were placed in 50 mL specimen tubes containing 
untreated five-week-old rice stems (cut into 10 cm lengths) and contained using a 
ventilated lid. A small hole (3 mm diameter) was drilled in the base of each of the 
tubes, which were then stored vertically in a water bath (submerging only the base 
of each rice stem) in a 16 h photoperiod at 26 oC for 48 h (Fig. 3.2). Insect mortality 
at 48 h was assessed by eye; adults showing no sign of movement were scored as 
dead. Bioassays consisted of three replicates at each concentration. Data analysis 
was conducted as outlined previously (Chapter II, Section 2.5). 
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Source: Burkard 
Fig. 3.1 Hand microapplicator (Burkard Scientific) and syringe. 
 
3.2.2 Leaf-dip bioassay 
 
Adults were taken from age-structured populations and were aged less than 
10 days old. Rice stems (10 cm cut length) were dipped into the required 
concentrations of formulated insecticide for 20 s, air-dried and placed in a 50 mL 
specimen tube. Approximately 15 adults were aspirated directly into each tube and 
sealed with a ventilated lid. A small hole (3 mm diameter) was drilled in the base of 
each of the tubes, which were then stored vertically in a water bath (submerging only 
the base of each stem) in a 16 h photoperiod at 26 °C for 72 h. Insect mortality at 72 
h was assessed by eye, adults showing no sign of movement were scored as dead. 
Bioassays consisted of 3 replicates at each concentration. Data analysis was 
conducted as outlined previously (Chapter II, Section 2.5). 
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Source: T. G. Emyr Davies 
Fig. 3.2 Bioassay set-up used to assess responses of N. lugens to insecticide applications. 
 
3.2.3 Laboratory selection with imidacloprid 
Field strains demonstrating relatively high levels of resistance to imidacloprid 
were placed under further selection with imidacloprid in the laboratory. Rice plants 
were treated with a soil drench, whereby a solution of formulated (200 g L-1 Confidor) 
imidacloprid (100 mL) was applied to the soil of a rice plant and left to be absorbed. 
One strain (Nl9) was reared on rice plants that were treated with progressively higher 
concentrations (ranging from 10 to 180 mg L-1) of imidacloprid over 13 generations. 
The other strain (Nl39) was reared directly onto rice plants treated with 200 mg L-1 
of imidacloprid. A second culture of Nl9 and Nl39 was maintained on untreated rice 
plants.  
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3.2.4 Laboratory selection with ethiprole  
Three strains (Nl33, Nl39 and Nl55) that demonstrated high levels of 
resistance to ethiprole were placed under further selection with ethiprole in the 
laboratory. These strains were reared on rice plants that were sprayed with 
progressively higher concentrations (ranging between 7.5 and 100 mg L-1) of 
ethiprole (SC 200) over 5 generations. Populations were then reared onto a 100 mg 
L-1 rice plant every other generation. A second culture of Nl33, Nl39 and Nl55 was 
maintained on untreated rice plants. 
3.3 Results and discussion 
3.3.1 Imidacloprid resistance testing 
Four of the strains had very high resistance (RR >160-fold) to imidacloprid 
(Table 3.1), whilst Nl55 displayed only moderate resistance. For all strains resistance 
was maintained in the absence of insecticide selection pressure for many generations 
suggesting that there was not a heavy fitness cost (under optimal laboratory 
conditions) involved in the resistance mechanism.  
Table 3.1 Dose-response data for N. lugens laboratory susceptible and imidacloprid-
resistant strains against imidacloprid topically applied to adults. 
Compound Strain 
Generations 
without selection 
LD50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Imidacloprid Bayer-S 130 0.6 0.50-0.70 1.822 ± 0.158 1 
 Nl9 12 97 3.40–434.00 0.762 ± 0.239 161.7 
 Nl33 46 170.2 46.44-5095 0.655 ± 0.221 283.7 
 Nl39 43 284.3 128.7-435.9 2.413 ± 0.698 473.8 
 Nl40 42 119.9 nc 10.1 ± 20.7 199.8 
  Nl55 32 14.49 4.55-30.81 0.653 ± 0.134 24.2 
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3.3.2 Ethiprole resistance testing 
The earliest collected field strain (Nl9) showed high levels of resistance to 
ethiprole (Table 3.2), whilst the later collected strains demonstrated very high 
resistance (RR >300-fold). As seen with the imidacloprid bioassays, resistance to 
ethiprole in these populations can be maintained over many generations without 
further exposure to ethiprole. However, for Nl55 resistance reduced over time in the 
absence of further exposure to the insecticide. The second Nl55 bioassay (LC50 2.74), 
was remarkably lower than the first bioassay (LC50 112.7), with a four-generation gap 
between the two bioassays.  
Table 3.2 Concentration-response data for N. lugens laboratory susceptible and fiprol-
resistant strains against ethiprole applied as a leaf dip to adults. 
Compound Strain 
Generations without 
selection 
LC50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Ethiprole Bayer-S 174 0.34 0.24-0.44 2.671 ± 0.432 1 
 Nl9 2 25.56 5.23-62.57 1.125 ± 0.243 75.2 
 Nl33 27 138.3 90.82-198.3 1.32 ± 0.148 406.8 
 Nl39 22 337.6 140.9-1892 0.781 ± 0.149 993 
 Nl40 25 312.4 nc 1.098 ± 0.541 918.8 
 Nl55 18 112.7 54.03-281.8 0.693 ± 0.124 331.5 
  Nl55 22 2.74 0.46-7.17 0.719 ± 0.141 8.1 
 
 
3.3.3 Fipronil resistance testing 
A second phenylpyrazole, fipronil, was tested against the N. lugens strains. 
Resistance to this alternative fiprol was present (Table 3.3), however, the level was 
markedly lower than seen for ethiprole, and this was common across all the strains.  
Nl33 and Nl39 (both Vietnam) displayed the moderate resistance (>30-fold), when 
compared to Bayer-S. Both strains had been previously exposed to fipronil spraying 
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in the field and it appears that the resistance has been maintained in the absence of 
insecticide pressure. Nl40 was remarkedly resistant to fipronil, when compared to 
the other field strains. It is not clear why this population was able to demonstrate 
high resistance in mortality bioassays, but was not possible to sustain a population in 
the laboratory when creating insecticide selected laboratory populations (described 
later, Section 3.3.5). 
However, the value for Nl55 was considerably lower (RR 3-fold) than the 
other field strains. This mirrors the trend seen for Nl55 against ethiprole, since this 
population appears to have lost its resistance mechanism(s) to fipronil. Nl55 had also 
been exposed to fipronil spraying (two sprays) in the field, and so must have been 
able to survive field rates of fipronil at the time of collection. However, after 29 
generations of non-selection in the laboratory, this resistance has broadly been lost. 
Again, Nl55 contrasts with Nl33 and Nl39 which have been able to maintain moderate 
levels of resistance to fipronil despite an even longer period of non-selection (> 44 
generations). Unfortunately, no fipronil bioassays were conducted for Nl55 around 
the time of the 1st ethiprole bioassay (18 generations of non-selection), so we do not 
know if it had higher levels of resistance to fipronil then, before the sudden loss of 
ethiprole resistance. 
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Table 3.3 Concentration-response data for N. lugens laboratory susceptible and fiprol-
resistant strains against fipronil applied as a leaf dip to adults. 
Compound Strain 
Generations 
without selection 
LC50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Fipronil Bayer-S 174 1.16 0.70-1.66 10.858 ± 0.864 1 
 Nl9 6 14.49 7.34-27.56 0.659 ± 0.078 12.5 
 Nl33 46 37.13 1.06-137.3 1.259 ± 0.453 32.1 
 Nl39 44 62.7 1.46-571 1.008 ± 0.412 54.1 
 Nl40 51 295.1 176.4-3186 2.329 ± 0.974 254.4 
  Nl55 29 3.46 0.77-8.21 0.966 ± 0.197 3 
 
3.3.4 Laboratory selection with imidacloprid 
To study the resistance mechanisms behind imidacloprid resistance, it was 
decided to put two of the field strains under further selection with imidacloprid. The 
strains, Nl9 and Nl39, were respectively selected with imidacloprid (by T.G.E. Davies) 
up to final concentrations of 180 and 200 mg L-1. These selected populations (Nl9-imi 
and Nl39-imi) could then be contrasted with the unselected (Nl9 and Nl39) cultures 
of these strains.  
3.3.5 Laboratory selection with ethiprole 
Selections with ethiprole were also performed to increase resistance in the 
populations. This was attempted for four strains (Nl33, Nl39, Nl40 and Nl55), 
producing three populations of highly ethiprole resistant N. lugens. For the Nl40 
population, despite showing high resistance in the bioassays, it was not possible to 
sustain a population treated with ethiprole. However, having three selected 
populations was deemed sufficient material for studying the mechanism(s) of 
ethiprole resistance.   
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3.3.6 Imidacloprid resistance of the laboratory insecticide selected strains 
Selection of Nl9 and N39 with imidacloprid led to an increase in imidacloprid 
resistance in both populations (Table 3.4). The increase between Nl9 and Nl9-imi was 
modest (RR 162 versus 186), whereas for the Nl39-imi population the resistance to 
imidacloprid increased dramatically (LD50 >1000) compared with the unselected Nl39 
populations (LC50 284).  
Interestingly the Nl33-eth population (LD50 434) did see an increase in 
resistance to imidacloprid compared to the NL33 population (LD50 170). However, 
this finding was not repeated for the Nl39-eth population, which is seen to be slightly 
less resistant than the Nl39 population (LD50 284).  
Despite the variation in response to insecticide selection across the populations there 
is a clear trend whereby all the populations kept under insecticide exposure 
throughout this PhD display very high resistance to imidacloprid when compared to 
the susceptible population. 
 
Table 3.4 Dose-response data for N. lugens laboratory selected strains against imidacloprid 
topically applied to adults. 
Compound Strain 
LD50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Imidacloprid Nl9-imi 111.7 66.05-212 0.891 ± 0.11 186.2 
 Nl39-imi >1000 - - >1600 
 Nl33-eth 433.8 101.3-14915 0.539 ± 0.161 723 
 Nl39-eth 255.5 69.5-768 2.273 ± 0.854 425.8 
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3.3.7 Ethiprole resistance of the selected strains 
Selection with ethiprole (Nl33-eth, Nl39-eth and Nl55-eth populations) led to 
a drastic increase in resistance to >14000-fold, compared to the susceptible Bayer-S 
strain (Table 3.5), in these populations. The resistance was so high that it was not 
possible to formulate LC50 values for these strains since there was negligible 
mortality, even at the highest dose (5000 mg L-1) applied. For the Nl9-imi strain, that 
had not been selected with ethiprole, the resistance to ethiprole also markedly 
increased (LC50 410) compared with Nl9 (LC50 25.56). Such an increase in resistance 
to ethiprole, despite being selected with imidacloprid, could suggest there is cross 
resistance between the two compounds.  
Table 3.5 Concentration-response data for N. lugens laboratory selected strains against 
ethiprole applied as a leaf dip to adults. 
Compound Strain 
LC50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Ethiprole Nl9-imi 410 273.3-1618 1.856 ± 0.580 >1200 
 Nl39-imi 23.27 5.19-51.27 1.239 ± 0.303 68.4 
 Nl33-eth >5000 - - >14000 
 Nl39-eth >5000 - - >14000 
  Nl55-eth >5000 - - >14000 
 
3.3.8 Fipronil resistance of the selected strains 
The three ethiprole selected strains also displayed a large increase in 
resistance to fipronil, when contrasted with the unselected populations (Table 3.6), 
giving approximately 860-fold resistance when compared with the susceptible Bayer-
S population. The Nl9-imi strain also saw a rise in fipronil resistance, compared with 
Nl9. However, the levels of resistance (56.4-fold) was far below those of the ethiprole 
selected strains. An interesting note from this is that selection with ethiprole clearly 
also causes increased resistance to fipronil. This led to the hypothesis that there 
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could be a resistance mechanism that could cause cross-resistance between these 
two compounds. Chapter V discusses these potential mechanisms involved in the 
resistance to fiproles in N. lugens and whether such a cross-resistance mechanism 
exists.  
Table 3.6 Concentration-response data for N. lugens laboratory selected strains against 
fipronil applied as a leaf dip to adults. 
Compound Strain 
LC50-value 
[mg L-1] 
95% limits Slope (± SD) RR 
Fipronil Nl9-imi 65.340 26.41-157.3 1.016 ± 0.230 56.4 
 Nl33-eth >1000 - - >860 
 Nl39-eth >1000 - - >860 
  Nl55-eth >1000 - - >860 
 
3.4 Conclusions  
This chapter demonstrates the resistance of N. lugens to various insecticides 
that have been utilised for brown planthopper control. This builds on previous 
monitoring for field resistance that was conducted at Rothamsted Research (Gorman 
et al., 2008). For all three compounds assessed (imidacloprid, ethiprole and fipronil) 
there was considerable resistance displayed in the field populations compared to the 
susceptible strain. This is clear from both the discriminating dose bioassays and the 
dose response bioassays. The high resistance to imidacloprid, ethiprole and fipronil 
demonstrated by the strains collected from 2010 onwards shows that these 
compounds are now mostly ineffective as control agents of N. lugens and should not 
be applied. 
The most notable observation from the selection experiments described in 
this chapter was that selecting a population with ethiprole also increased resistance 
to fipronil. Given the structural similarity between these two phenylpyrazole 
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insecticides, it is not unsurprising that there appears to be cross-resistance between 
the two compounds. This has been seen previously when fipronil resistant N. lugens 
in China demonstrated high levels of cross-resistance to ethiprole (Zhao et al., 2011). 
They found that selection with fipronil increased fipronil resistance (7.3-fold to 41.3-
fold), but also caused an increase in ethiprole resistance (16.3-fold to 65.6-fold). A 
similar trend was found in the small brown planthopper, Laodelphax striatellus, with 
a laboratory-selected fipronil resistant strain showing moderate cross resistance to 
ethiprole (Wei et al., 2016). This finding is of field relevance because it suggests that 
fipronil would not be a viable replacement for ethiprole (and vice versa) in regions 
where ethiprole (or fipronil) was no longer able to demonstrate control of N. lugens 
within economic thresholds.  
The finding that most populations, except for Nl55, maintain high resistance 
to the test compounds, in the absence of further exposure to insecticide is a key 
finding. There is a widely held assumption that resistance to xenobiotics will carry a 
fitness cost in the absence of xenobiotics (ffrench-Constant and Bass, 2017). For N. 
lugens there was a link between imidacloprid resistance and fitness. A highly 
imidacloprid resistant strain had clear reproductive disadvantages when compared 
to a susceptible strain, with the authors concluding that absence of imidacloprid 
would quickly cause the population to regain imidacloprid sensitivity (Liu and Han, 
2006). Reasons for supposed fitness cost would be that producing high levels of 
detoxification enzymes would have a significant energy cost (Kliot and Ghanim, 2012; 
ffrench-Constant and Bass, 2017). Target-site mutations (kdr and Rdl) have been 
linked with fitness cost in Anopheles gambiae (Platt et al., 2015), but it has also been 
suggested that A301S has no significant fitness cost due to its ability to persist in 
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absence of xenobiotic selection (Thompson, Steichen and ffrench-Constant, 1993; 
Aronstein, Ode and ffrench-Constant, 1995; Holbrook et al., 2003; Bass et al., 2004). 
The clear majority of research conducted on fitness costs is performed in a 
laboratory, rather than field, setting so is difficult to predict the impact of insecticide 
resistance related fitness costs on field populations of pests. The fact that three of 
the strains tested here (Nl33, Nl39 and Nl40) showed an ability to maintain resistance 
in absence of insecticide exposure in the laboratory, does not mean the same finding 
would occur in the field. However, if the costs associated with the insecticide 
resistance seen here are minor then this has important implications for insecticide 
resistance management strategies. Since resistance has already evolved to these 
compounds, one of the aims of any IRM programme would be to attempt to regain 
lost susceptibility of N. lugens to these insecticides. However, if it is possible to 
maintain resistance to insecticides in the field (in the absence of exposure to these 
insecticides) then it may prove unviable in the long term to try to reintroduce these 
compounds for control.  
Understanding the mechanisms that lie behind insecticide resistance is a core 
concept behind resistance management strategies urgently needed to control brown 
plant hopper. This allows for diagnostics to be developed to assess how resistant a 
field population of N. lugens might be; crucial information that can lead to a more 
sustainable programme of insecticide application. This is needed, due to the simple 
fact that it is inefficient to apply insecticides that will not be able to provide control, 
and only exacerbates the problem of insecticide resistance. 
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Therefore, insecticide resistance management strategies for N. lugens are a 
mix of sustainable pesticide use, biological control and resistant rice varieties. It has 
been argued that pesticide use should not be a core component of IPM strategies for 
rice, but instead allow natural enemies to confer  biological control (Matteson, 2000). 
Since there is now widespread resistance to insecticides there is interest in other 
means of containing N. lugens outbreaks, specifically parasitoids and predators (Gurr 
et al., 2011). Unfortunately the extensive use of pesticides has had a large 
detrimental effect on natural enemy populations (Matteson, 2000; Bottrell and 
Schoenly, 2012). However it has been shown by IRRI that effective landscape 
management and reduced pesticide use can cause control of insect pests of rice by 
allowing natural enemies to thrive (Settele, Biesmeijer and Bommarco, 2008; Gurr et 
al., 2011). However, implementing such strategies across such a large geographical 
area are complex and so judicious use of pesticide is still recommended by IRAC for 
rice hopper control, as well as the biological control discussed here.   
The potential mechanisms that could underlie the resistance discussed in this 
chapter, will be discussed in chapters IV-VI.  
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Chapter IV Generation of a new de novo 
transcriptome for analysis of insecticide resistance in N. 
lugens 
 
4.1 Introduction 
The advent of next generation sequencing has drastically transformed the 
field of molecular biology (Behjati and Tarpey, 2013) and revolutionised the methods 
of studying insecticide resistance. The ability to sequence an insect’s entire mRNA, 
and therefore all its transcripts, at the point of collection, allows for the generation 
of a transcriptome. This represents a valuable resource for researchers working on 
the topic of insecticide resistance and can be mined for candidate genes or genetic 
variation potentially associated with resistance. 
RNA-seq (RNA sequencing) is the most widely used method to sample gene 
transcripts, replacing previous approaches such as hybridisation-based microarrays 
(Kukurba and Montgomery, 2015). The advantages of RNA-seq over previous 
technologies are numerous: no prior knowledge of gene/ transcript sequences are 
required, increased detail of gene expression, analysis of alternate splicing and no 
issues with cross-hybridisation artefacts (Kukurba and Montgomery, 2015). The ever-
increasing affordability of RNA-seq, as sequencing technology has improved, has 
allowed it to become commonplace in the study of insecticide resistance. 
At the start of this PhD in 2013, there were already some genetic resources 
available for N. lugens. Although, there was no draft or reference genome for N. 
lugens available at this point the transcriptomic resources that were available 
covered a broad range of life stages and tissues of N. lugens. The first N. lugens 
Chapter IV 
60 
 
genomic resource contained 37,000 ESTs (Noda et al., 2008) and this was later 
incorporated into a transcriptome pyrosequencing assembly of 8,911 contigs and 
10,620 singletons (Bass, Hebsgaard and Hughes, 2012). A further three unique 
transcriptomes had been published, generated from different tissues: midgut (Peng 
et al., 2011), intestine (Bao et al., 2012) and salivary glands (Ji et al., 2013). December 
2013 saw the publishing of another N. lugens transcriptome of whole insects at 
different life stages (Wan et al., 2014). In 2015, a genomic and transcriptomic study 
was published analysing the P450 gene family in N. lugens (Lao et al., 2015). This 
involved the application of sub-lethal doses of imidacloprid, triazophos and 
deltamethrin respectively before performing RNA-seq. This found that there was 
significant overexpression ( >3-fold) for CYP6CS1v2 and CYP4CE1v2, whislt CYP4DE1, 
CYP417A1v2 and CYP439A1 were >2-fold expressed compared to the control.The end 
of 2014 saw the publication of the first N. lugens genome (Xue et al., 2014). This 
produced an assembled genome size of 1.14 Gb, with 27,571 protein coding genes of 
which 10,245 had gene ontology (GO) terms. This assembled genome had a contig 
N50 of 24.2 and a scaffold N50 of 356.6.  
This chapter highlights the creation of a de novo transcriptome which was 
used to analyse differential gene expression between insecticide susceptible and 
resistant strains. This transcriptome also allowed the manual curation of several 
insecticide target sites which could then be characterised in more detail, discussed 
in chapters five and six. 
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4.2 Material and methods 
4.2.1 Gene assembly from bioinformatics resources 
Galaxy and Geneious were used to assemble partial genes from single read 
archives (SRA). The bioinformatics department at Rothamsted Research kindly 
downloaded the required SRA datasets and normalised them, before uploading them 
to Decypher. This is a dedicated server for DNA/protein similarity searches and was 
built and supported by Timelogic (Carlsbad, CA, USA). Conserved AA sequences could 
then be blasted against these SRA datasets, using tera-blastx (AA versus translated 
nucleic) to return matching hits. These hits were then downloaded into Geneious and 
de-novo assembly performed to return consensus sequences. These sequences were 
then set as references and mapped against the NL SRA database to extend the 
sequences. De novo assembly of the reads returned from this extended mapping was 
performed and the resulting consensus sequence was analysed for potential ORFs 
which could be mapped to a reference sequence.  
4.2.2 Illumina sequencing 
Total RNA was extracted from pooled homogenates of six insects from Bayer-
S, Nl33, Nl55, Nl33-eth and Nl55-eth (4 biological replicates per strain) using the 
Bioline Isolate RNA mini kit (Chapter II, Section 2.8). Total RNA was used as a template 
for the generation of barcoded libraries (TrueSeq RNA library preparation, Illumina). 
These libraries were sequenced by The Genome Analysis Centre (TGAC, Norwich, UK) 
with replicates multiplexed for sequencing on an Illumina HiSeq 2500 flowcell (100 
bp paired reads) to generate at least 15 million reads per biological replicate. FastQC 
(version 0.11.2) was used to check the quality of the raw reads obtained, and reads 
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were trimmed of low quality sequence and adapter sequence using Trimmomatic 
(Bolger, Lohse and Usadel, 2014). 
4.2.3 Trinity de-novo assembly 
Trinity is a method designed for assembling RNA-seq data into a 
transcriptome without the need for a reference genome (Grabherr et al., 2011). 
Trinity is a combination of three independent software modules: Inchworm, Chrysalis 
and Butterfly. Inchworm is the first step to be applied to the RNA-seq raw reads and 
it assembles transcripts using a k-mer based approach. This entails establishing each 
read as a set of overlapping k-mers (default k = 25), and removing k-mers that likely 
contain sequencing errors. A seed k-mer (the most abundant k-mer) is set as the basis 
for constructing transcripts. This is done by a greedy expansion based on frequencies 
of overlapping k-mers. This continues until no k-mers are left and full length 
transcripts for dominant isoforms are reported. This data is then used by Chrysalis to 
create de Bruijn graphs from clusters of the minimally overlapping Inchworm contigs. 
Finally, Butterfly is run to reconstruct full length transcripts from the de Bruijn graphs 
generated by Chrysalis. This is broken down into two phases, with the first phase 
being graph simplification by trimming the edges in the de Bruijn graph. The second 
phase is defined as plausible path scoring. This is where the paths (possible 
transcripts) are analysed to see which are plausible based on the reads that assign to 
them. This then produces a list of linear transcripts, with information on spliced 
isoforms provided. This program was run on a linux server at Rothamsted Research 
by sending command line prompts using UNIX commands. The Trinity parameters 
were paired ends mode and the CPUs assigned were 2 for Inchworm and 32 for 
Butterfly.  
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4.2.4 Annotation of transcriptome 
The Galaxy server was used to run a tera-blastx search against the non-
redundant protein database (NCBI 06/01/15). The parameters of this search were an 
e-value of 1 x 10-3 and a minimum score of 50. This was performed for the combined 
transcriptome assembly (assembled from all five populations sequenced). This 
analysis produced an XML file that was imported into Blast2GO (Conesa et al., 2005) 
to process the blast results from Galaxy. Contigs of interest identified from this were 
then imported into Geneious for further analysis.    
4.2.5 Calculating differentially expressed genes between N. lugens populations 
The de novo assembled transcriptome was used as a reference to map raw 
reads and quantify levels of gene expression of assembled transcripts. RNA-seq by 
Expectation Maximization (RSEM) was used for this, since it has the major benefit of 
not needing a reference genome, and can decipher transcript abundancies solely 
from RNA-seq data (Li and Dewey, 2011). RSEM utilises Bowtie, an ultrafast 
alignment program (Langmead et al., 2009), to align the reads to the transcripts and 
present an estimate of each transcript’s expression level. This data was then 
processed using two individual packages designed to identify transcripts that have 
been differentially expressed: EdgeR (FDR 0.05, fold change <0.5 and >2)(Robinson, 
McCarthy and Smyth, 2009) and DESeq2 (Love, Huber and Anders, 2014). Both 
software programmes work on a negative binomial model for analysing expression. 
EdgeR is similar to a previous procedure, Limma (Smyth, 2004), designed for 
differential expression analysis. EdgeR uses the table of counts produced from RSEM, 
and an over dispersed Poisson model, and can separate biological and technical 
variation. Gene-wise dispersions are calculated by conditional maximum likelihood, 
Chapter IV 
64 
 
with an empirical Bayes procedure used to create a consensus value. The differential 
expression value given for each gene is derived from an exact test (analogous to 
Fisher’s exact test) that has been modified for over dispersed data (Robinson, 
McCarthy and Smyth, 2009). DESeq2 differs from EdgeR in its method of estimating 
the gene dispersal. DESeq2’s methodology is advantageous for experiments with 
small sample sizes. This is because smaller sample sizes can cause high levels of 
variation in dispersal estimates per gene. DESeq2 solves this problem by sharing 
information across genes, with the underlying assumption that genes with similar 
expression strength will have similar dispersion (Love, Huber and Anders, 2014). This 
then gives a more accurate gauge of fold change for genes. 
4.2.6 GO enrichment analysis 
To attempt to define the biological properties (cellular component, biological 
process and molecular function) of the differentially expressed transcripts, GO-term 
enrichment was performed. The enrichment analysis of GO-terms (for the 
differentially expressed transcripts), was conducted using Fisher’s exact test within 
Blast2GO software with a False Discovery Rate of <0.05. The GO-terms of the 
differentially expressed transcripts were compared to the GO-terms of the reference 
transcriptome (assembly 1). This was performed separately for the six sets of 
differentially expressed transcripts derived from the EdgeR and DESeq2 analysis. 
4.2.7 Database submission 
Sequence data used in this study have been deposited at the National Center 
for Biotechnology Information as follows: 
BioProject (accession no PRJNA331084) 
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BioSample (accession numbers SAMN05437238, SAMN05437239, SAMN05437240, 
SAMN05437241, SAMN05437242)  
Run (accession no SRP079631)  
4.3 Results and Discussion 
4.3.1 Sequencing and de novo transcriptome assembly 
Total RNA from five populations of N. lugens (four biological replicates per 
population) were sequenced using paired-end Illumina. This produced a total of 
approximately 964 million 100 bp long reads, which were then used to create a 
reference transcriptome (Table 4.1, assembly 1). FastQC was performed prior to 
assembly to assess base quality and all samples scored greater than 30. A non-
normalised assembly was run using Trinity, which produced 233,800 contigs of an 
average length of 833 bp, of which 169,709 were denoted as Trinity ‘genes’. This is 
clearly far higher than the number of genes predicted from the genome assembly 
(27,571 protein coding genes). The availability of the N. lugens genome had led to 
hopes that genome guided trinity transcriptome assembly could be performed. This 
should have significantly improved identification of full length transcripts from the 
RNA-seq data, which remains complex (Boley et al., 2014). However, multiple 
attempts to perform this pipeline were unsuccessful. It appeared that the GFF file 
available was unusable for our purposes, and attempts to create our own one was 
thwarted by a lack of local computing power. Although six assemblies were created 
from the RNA-seq data, full statistics given in Table 4.1, the assembly that was 
predominantly used was assembly 1. This was because it was assembled using all the 
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raw reads, therefore providing the most complete reference transcriptome to use for 
differential gene expression analyses.  
  
 
 
 
Table 4.1 A comparison of transcriptome assemblies. 
Assembly ID 1 2 3 4 5 6 
Population(s) Combined Bayer-S Nl33 Nl55 Nl33-eth Nl55-eth 
Raw reads 963,705,042 198,351,440 179,331,150 179,451,430 217,279,840 189,291,182 
Mean Q30 to base 101 101 101 101 101 101 
Contigs 233,800 121,710 133,027 127,221 138,082 128,325 
Trinity 'genes' 169,709 93,308 100,757 95,863 104,301 97,158 
GC content 39.7 39.6 39.7 39.8 39.4 39.2 
Min contig length 201 201 201 201 201 201 
Max contig length 26,366 26,929 25,646 26,089 26,948 26,953 
Mean contig length 833 901 906 900 915 879 
Median contig length 393 435 439 449 440 434 
N50 1,645 1,728 1,730 1,683 1,765 1,640 
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4.3.2 Annotation of the reference transcriptome 
A blast analysis of the N. lugens sequences produced by the Trinity assembly 
revealed that 21% (49118) of the contigs had at least one hit against the NCBI nr 
protein database. These contigs had an average read length of 2063 bp. The 
remaining 79% of contigs (average read length 506 bp) that could not be assigned a 
BLAST hit, highlight the limitations of a BLAST tool for analysing transcriptomes. 
Karatolos et al discuss these limitations (Karatolos et al., 2011). It is likely that 
ongoing sequencing projects on related insect species will allow improved future 
annotation of these genes. 
The number of contigs in the assembled transcriptome with assigned BLAST 
hits is considerably higher than the number of genes predicted by the genome 
annotation, this is most likely a result of multiple contigs being generated for many 
genes depending on alternate splicing/allelic variation. Another reason for the high 
number of contigs would be the low quality of the assembly, with a large number of 
small contigs being assembled that are unlikely to have any biological significance. 
4.3.3 GOIs for metabolic resistance  
The primary reason for conducting this RNA-seq experiment was to study 
genes encoding potential insecticide detoxification enzymes. The gene families of key 
interest were the P450s, CCEs and GSTs and these were manually curated from the 
transcriptome. Within the Trinity transcriptome there were 220 contigs that returned 
BLAST hits to P450s, 49 to CCEs and a further 31 to GSTs. The N. lugens genome study 
published in 2014 provided an extensive comparison of these detoxification families 
between N. lugens and various other insect genomes (Xue et al., 2014). They highlight 
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that there are 67 genes encoding P450s in N. lugens and only 11 encoding GSTs, 
which is significantly fewer than that seen for most other insect species studied. Of 
those 67 P450 found in the genome, the trinity assembly returned full-length 
sequence for 48 of these and partial for a further six (Table 4.2) However, when 
performing a de novo assembly of the 67 P450s from the genome, the result is 55 
unique sequences, meaning the trinity assembly has very good coverage of the P450 
repertoire. The GSTs coverage of the trinity assembly assembles 7/11 sequences 
from the genome. As for the CCEs, the nine available sequences in GenBank all de 
novo assemble into one contig. However, none of the 49 transcripts assigned with 
CCEs BLAST hit align to this sequence. 
A further study published in 2015 gave an overview of the cytochrome P450 
monooxygenase repertoire in N. lugens (Lao et al., 2015) and also suggested reasons 
for the paucity of N. lugens P450 genes. They argue that since N. lugens is a 
monophagous (rice phloem sap) pest, it does not encounter as many plant secondary 
metabolites as more polyphagous insect species and therefore does not require such 
a large pool of detoxification genes. As mentioned in section 4.3.3 the high number 
of contigs matching P450s is probably due to allelic variation, multiple isoforms of 
many genes and poor quality assembly.  
Table 4.2 A summary of the detoxification genes (P450s, GSTs and CCEs) found in the Trinity 
assembly compared to the N. lugens genome. 
    P450s GSTs CCEs 
 Genome 67 11 9 
Trinity 
assembly 
Full sequence 48 6 0 
Partial sequence 3 1 1 
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4.3.4 Screening for differentially expressed transcripts 
Extensive gene expression analysis was conducted to identify candidate 
genes that could potentially be involved in metabolic resistance to xenobiotics. The 
assembled transcriptome was used as a reference for the Illumina raw reads to be 
mapped against using bowtie. This provided count matrices of abundance for the 
transcripts for all 20 biological replicates. Two programmes were used for estimating 
differential expression, EdgeR and DESeq2. A false discovery rate of < 0.05 for EdgeR 
and a padj of < 0.05 for DESeq2 was used. The transcripts from both analyses were 
merged to show which transcripts were DE in both tests (Table 4.3), which revealed 
that a huge number of transcripts were differentially expressed between N. lugens 
populations. Between Bayer-S and the two ethiprole selected populations, Nl33-eth 
and Nl55-eth, there were 11455/6806 (Fig. 4.1) transcripts showing > 2-fold 
expression respectively. Even between a selected and unselected population (Nl33 
and Nl33-eth) there were a high number (2634, FC > 2) of DE transcripts (Fig. 4.2). 
The only exception to such large numbers of DE transcripts was in the comparison 
between Nl55 and Nl55-eth that saw a moderate level of 161 (FC > 2) DE transcripts 
(Fig. 4.2). For a summary of the top 20 expressed transcripts in each comparison see 
the appendix (Tables A9-14). 
Table 4.3 A summary of transcripts differentially expressed in both EdgeR and DESeq2. 
  FDR 0.05        FDR 0.01 
  FC <0.5 & >2 FC > 2 FC <0.5 & >2 FC > 2 
Bayer-S vs Nl33 12448 7111 8041 4696 
Bayer-S vs Nl33-eth 18169 11455 11790 7806 
Nl33 vs Nl33-eth 3852 2634 1992 1437 
Bayer-S vs Nl55 10898 6014 6691 3839 
Bayer-S vs Nl55-eth 11513 6806 7412 4601 
Nl55 vs Nl55-eth 227 161 112 39 
In all* 703 640 417 394 
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*Excluding Nl55 vs Nl55-eth 
 
 
Fig. 4.1 Top: Venn diagram showing differentially expressed transcripts in multiple RNA-
Seq comparisons of susceptible vs resistant N. lugens (B=Bayer-S). Bottom: the number of 
differentially expressed transcripts (FC > 2) in each pairwise comparison.  
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Fig. 4.2 Top: Venn diagram showing differentially expressed transcripts (FC > 2) in RNA-Seq 
between unselected and selected populations of N. lugens. Bottom: differentially 
expressed transcripts in each comparison. 
 
Such levels of DE transcripts were far above the levels we were expecting to 
see when this RNA-Seq experiment was designed. There are a few possible reasons 
for these high gene counts. Firstly, there may be significant genetic variation between 
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strains due to length of time since field collection and location of origin. The 
susceptible reference strain (Bayer-S) is from Japan, NL55 is from India and NL33 is 
from Vietnam. Furthermore, Bayer-S has been laboratory reared for an extended 
period (> 15 years). During this time is it plausible that a significant number of the 
genes that are still essential for N. lugens in the field, are no longer being expressed 
in the laboratory populations. Secondly, as previously discussed, there are a huge 
number of transcripts in this transcriptome compared to predicted gene number. It 
is possible that allelic variants that are categorised as different isoforms could be 
skewing the number of transcripts that are genuinely differentially expressed.  
Gene enrichment analysis was performed but ultimately proved unsuccessful 
at revealing which GO terms were enriched in the differentially expressed transcript 
sets against the reference transcriptome dataset. At an FDR of < 0.05 there were no 
statistically significant enriched GO terms returned for Bayer-S vs Nl33-eth, Nl33 vs 
Nl33-eth and Nl55 vs Nl55-eth. For the remaining three experimental comparisons 
(Bayer-S vs Nl33, Bayer-S vs Nl55 and Bayer-S vs Nl55-eth) there were some GO terms 
enriched. However, these were all for viral processes (data not shown) and were seen 
as having limited relevance to our study of insecticide resistance.  
Despite the large number of transcripts being shown as DE, it was possible to 
narrow down candidate genes by looking for transcripts that were DE in all 
experimental conditions in both EdgeR and DESeq2 (Table 4.3). Nl55 vs Nl55-eth was 
excluded from this analysis due to the very low number of DE genes in this 
comparison. If Nl55 vs Nl55-eth was left in this analysis then there were only three 
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DE transcripts, none of which were strong candidates for a role in resistance. This 
analysis produced 703 transcripts, of which 257 were assigned a BLAST hit.  
Of the 257 differentially expressed transcripts, three were identified as 
putative candidate genes in xenobiotic resistance. However, I included a further five 
candidate genes (all carboxylesterases) since they were all overexpressed in EdgeR 
analysis, and overexpressed in most experimental conditions in the DESeq2 analysis. 
We decided it was necessary to analyse these as well, as a previous study had 
implicated esterases in ethiprole resistance in N. lugens (Punyawattoe et al., 2013). 
This narrowing of candidate genes assumes that the same resistance mechanism(s) 
caused resistance in all the resistant strains. Table 4.4 gives an overview of the 
candidate detoxification genes identified from the combination of EdgeR and DESeq2 
analysis. The fold change values displayed are for those from the EdgeR analysis. All 
eight transcripts are significantly overexpressed compared to the Bayer-S strain, and 
show low levels of overexpression when comparing Nl33 to Nl33-eth. The eight 
transcripts are formed of five carboxylesterases, two P450s and one multidrug 
resistance-associated protein (ABC transporter). Of this one gene was already known 
to play a role in insecticide resistance in N. lugens, c103228_g2_i1, encoding the P450 
enzyme, CYP6ER1. This is an enzyme that had previously been linked to imidacloprid 
resistance in N. lugens by overexpression of the gene (Bass et al., 2011). Chapter VI 
focuses in detail on the analysis of this gene, however it is included here as it 
represents a useful positive control for our pipeline/analysis.  
  
 
 
 
Table 4.4 Genes of interest (GOIs) after differential expression analysis. FC = Fold change in expression. 
    FC using EdgeR 
Transcript Seq. description 
Bayer-S 
vs Nl33 
BayS vs 
Nl33-eth 
Nl33 vs 
Nl33-eth 
BayS vs 
Nl55 
BayS vs 
Nl55-eth 
c91313_g1_i1 Multidrug resistance-associated protein 193.2 808.4 3.6 401.0 494.6 
c91960_g1_i2 Carboxylesterase-6 195.7 1884.5 3.4 443.2 976.6 
c98716_g1_i1 Carboxylesterase-6 1159.8 11676.1 3.5 2462.4 4258.6 
c101335_g1_i1 Carboxylesterase, partial 263.2 4365.1 5.3 805.7 2299.7 
c103228_g2_i1 Cytochrome P450 CYP6ER1 70.2 49.4 2.9 24.3 68.7 
c103516_g1_i4 Carboxylesterase, partial 2119.5 12197.2 18.8 2098.2 6733.6 
c103516_g1_i6 Carboxylesterase, partial 185.6 1949.4 3.5 415.4 782.2 
c103740_g1_i2 Cytochrome, partial 2000.0 9217.3 4.3 4669.9 5334.9 
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These candidate genes were then further analysed by qRT-PCR (primers, 
Appendix A, Table A2), to correlate with the EdgeR/DESeq2 analysis. Bayer-S was 
used as the reference strain for the qRT-PCR relative gene expression analysis. Again, 
all the candidate genes were highly overexpressed when compared with the 
reference (Table 4.5). Transcripts c101335_g1_i1 (partial CCE) and c103228_g2_i1 
(CYP6ER1) are not included in this analysis. This is because there was no expression 
of c101335_g1_i1 in Bayer-S so it was not possible to generate a relative gene 
expression value for the other strains. For c103228_g2_i1, extensive qRT-PCR studies 
are described in chapter VI, and as it was a known candidate gene it did not need 
further validation here. 
Although the qRT-PCR studies on the candidate genes appeared to correlate 
with the DE analysis conducted on the RNA-Seq data, a few problems arose. Firstly, 
the 95% confidence limits were very large in most of the populations tested. This was 
due to a large amount of variation in gene expression level between biological 
replicates of the populations. If overexpression of a gene was genuinely involved in 
insecticide resistance, then the expectation would be that the variation in expression 
would reduce after insecticide selection, manifested by reduced 95% confidence 
limits (Garrood et al., 2016). Secondly the levels of expression in the reference strain 
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(Bayer-S) were very low, and it is possible that there is no or only very limited 
expression in Bayer-S and this skews the analysis, resulting in huge overexpression 
values.  
Therefore, it was decided to go back to the original FPKM (Fragments Per 
Kilobase Million) values generated from the bowtie mapping of raw reads to the 
transcriptome. The average FPKM values (average of four biological replicates) are 
displayed for the five populations sequenced for the eight candidate genes (Table 
4.6). This showed why such huge overexpression values were being generated in the 
EdgeR/DESeq2/qRT-PCR by revealing negligible FPKM values for seven out of eight of 
the candidate genes in Bayer-S, which then caused the misleading overexpression 
values for the resistant populations. Of the eight candidate genes, only one appeared 
to be a genuine candidate after the FPKM analysis, and this was c103228_g2_i1 
(CYP6ER1), which had already been previously identified as a candidate gene in 
imidacloprid resistance (see above). However, the FPKM values of this gene are a 
useful benchmark for comparing the other candidate genes too. Since the FPKM 
values of c103228_g2_i1 here demonstrate the levels of expression that would be 
expected in a gene causing insecticide resistance, it was used to compare to the other 
candidate genes. None of the other candidate genes’ FPKM values even came close 
to c103228_g2_i1 values. The highest value seen is 61.18 for c103516_g1_i6 in the 
Chapter IV 
78 
 
Nl33-eth population, but this is still significantly lower than the value for 
c103228_g2_i1 in Nl33-eth (522). 
So, it was decided that none of the candidate genes, except c103228_g2_i1, 
were strong candidates for an involvement in insecticide resistance via gene 
overexpression. 
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Table 4.5 Fold change in expression of GOIs in multiple populations of N. lugens when compared with the susceptible reference strain as 
determined by quantitative real time PCR.  
  
  Bayer-S Nl33 Nl55 Nl33-eth Nl55-eth 
Transcript Seq. description 
2^-
∆∆Ct 
95% 
conf. 
limits 
2^-
∆∆Ct 
95% 
conf. 
limits 
2^-
∆∆Ct 
95% 
conf. 
limits 
2^-
∆∆Ct 
95% 
conf. 
limits 
2^-
∆∆Ct 
95% 
conf. 
limits 
c91313_g1_i1 
Multidrug resistance-associated 
protein 
1.1 0.43 39.3 10.9 89.4 109.8 171.3 81.1 95.4 73.9 
c91960_g1_i2 Carboxylesterase-6 1.2 0.9 93.9 75.1 564.3 508.1 1870 1026 911 748 
c98716_g1_i1 Carboxylesterase-6 1.1 0.5 19 18.4 148.7 138.3 657 377 225.7 195.6 
c103516_g1_i4 Carboxylesterase, partial 1.1 0.6 27.1 22.5 250 230 920 540 477 429 
c103516_g1_i6 Carboxylesterase, partial 1.1 0.6 1565 1369 388222 741005 42200 28634 12323 10732 
c103740_g1_i2 Cytochrome, partial 1.3 1 153.2 66 342 321 701 479 545 472 
 
Table 4.6 Average FPKM values per N. lugens population for the GOIs from the RNAseq experiment.  
  
  FPKM 
Transcript Seq. description Bayer-S Nl33 Nl55 Nl33-eth Nl55-eth 
c91313_g1_i1 Multidrug resistance-associated protein 0.03 6.50 12.81 26.10 15.86 
c91960_g1_i2 Carboxylesterase-6 0.02 4.69 9.74 43.65 22.02 
c98716_g1_i1 Carboxylesterase-6 0.00 3.51 7.56 33.10 12.96 
c101335_g1_i1 Carboxylesterase, partial 0.00 2.41 7.29 37.02 20.77 
c103228_g2_i1 Cytochrome P450 CYP6ER1 7.10 192.20 519.22 522.66 362.54 
c103516_g1_i4 Carboxylesterase, partial 0.00 8.50 8.51 45.65 27.09 
c103516_g1_i6 Carboxylesterase, partial 0.02 6.07 12.53 61.18 23.92 
c103740_g1_i2 Cytochrome, partial 0.00 4.10 10.06 18.01 11.19 
Chapter IV 
80 
 
4.3.5 Assembly of insecticide target sites from available transcriptomes 
 
4.3.5.1 Glutamate-gated chloride channel assembly 
As detailed in the introduction, several transcriptomes were available to mine 
for potential genes involved in detoxification of xenobiotics when this PhD was 
started. However, the quality of the assembled transcriptomes was too low to find 
full length genes of interest. This was demonstrated by analysis of the transcriptome, 
specifically looking for genes involved in detoxification (Bao et al., 2012). There were 
only three unigenes covering the GABA-gated chloride channel and one unigene for 
the glutamate-gated chloride channel (151 bp).  
Therefore, an alternative approach was taken, going back to the publicly 
available SRA raw data that the transcriptomes were annotated from. The 
bioinformatics department at Rothamsted created a normalised database of all the 
available SRA files for N. lugens, which contained 31,743,591 single reads. This 
allowed highly conserved AA sequences to be aligned using tera-blastx against this 
archive to return nucleotide sequences that could be assembled into longer reads. 
The first gene this was performed for was the glutamate-gated chloride 
channel. The glutamate-gated chloride channel of several other species of insect 
(Apis mellifera, Laodelphax striatellus, Nasonia vitripennis, and Plutella xylostella) 
were used to BLAST the SRA database. This returned 964 reads, which after assembly 
and further mapping yielded a gene of 1791 bp with a putative CDS of 452 AAs. 
Validation of this gene was carried out by designing primers from this sequence 
(Appendix A, Table A3) and sequencing the channel in the four ethiprole resistant 
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strains and the susceptible strain. Fig. 4.3 shows the CDS and transmembrane 
regions.  
 
 
Fig. 4.3 Amino acid alignment of N. lugens glutamate-gated chloride channel. Also shown 
are the glutamate-gated chloride channel sequences of A. mellifera (accession 
NM_001077809.1), L. striatellus (JQ413991.1), N. vitripennis (FJ851099.1) and P. xylostella 
(JX014231.1). The signal peptide and four transmembrane regions are highlighted. 
 
4.3.5.2 GABA-gated chloride channel assembly 
The N. lugens Rdl gene (encodes the GABA-gated chloride channel) was 
already available from GenBank (accession no KC841916). However, this was used to 
blast against the SRA database to search for any underlying variation in the gene 
which could be potentially be involved in fiprole resistance.  
This revealed an isoform (Nl RDL 9B) which is shown in Fig. 4.4, aligned with 
the publicly available sequence. The novel isoform was submitted to GenBank 
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(accession no KX592155). Although the nucleotide sequence differed considerably 
between the two variants after the third transmembrane region, there is only a single 
amino acid change in the final transmembrane region. One isoform expresses a 
methionine and the other a valine. A more thorough analysis of this gene and the 
consequences for fiprole insecticides efficacy is discussed in chapter V. 
 
Fig. 4.4 Amino acid alignment of N. lugens RDL subunit sequences with the top sequence 
displaying exon 9A and the bottom sequence exon 9B. The four transmembrane regions 
are highlighted.  
 
4.3.5.3 Voltage-gated sodium channel assembly 
The procedure for obtaining the full-length sequence of this gene was the 
same as for assembling the GluCl gene. VGSC’s from four species (Musca domestica, 
P. xylostella, N. vitripennis and Tribolium castaneum) were aligned using tera-blastx 
against the SRA database. This returned 1384 reads, which after assembly and 
mapping gave almost the entire VGSC sequence (with a small gap). Primers were 
designed (Appendix A, Table A3) to this retrieved sequence and sequencing VGSC 
using cDNA isolated from Bayer-S allowed this gap to be bridged and the full VGSC 
assembled (Appendix A, Table A3).  
The resistance mechanism that was thought most likely to be responsible for 
pyrethroid resistance was knockdown resistance (kdr), a commonly seen target site 
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mutation (Williamson et al., 1993, 1996). The sequencing of the VGSC searched for 
all the mutations that have been linked with causing pyrethroid resistance in various 
pest species (Rinkevich, Du and Dong, 2013). Somewhat surprisingly there was not a 
single mutation that has been linked with pyrethroid resistance seen in any of the 
deltamethrin resistant strains (bioassay data not shown) that were sequenced. 
Furthermore, since pyrethroids have now been banned from use against N. lugens, 
there is little field relevance to continued work on N. lugens pyrethroid resistance. 
4.3.6 Transcripts encoding insecticide targets 
The second goal of the RNA-seq study was to identify transcripts encoding 
insecticide target sites, that could then be screened for potential resistance causing 
mutations. Given this PhD focuses on the neonicotinoid and phenylpyrazoles classes 
of insecticides the target sites of most interest were the nAChRs, GABA-gated 
chloride channel and GluCl. However, transcripts encoding various other insecticide 
target sites were also identified to give a complete overview. All contigs provided in 
Table 4.7 were manually curated in Geneious to identify open reading frames (ORFs) 
and allow SNP analysis to be performed. 
The GABA-gated chloride channel, VGSC and GluCl target sites had already 
been assembled using SRA data, discussed in 4.3.1. These three target sites were 
represented in the transcriptome (Table 4.7) covering the whole of their respective 
coding sequences. Of these the VGSC AA sequence aligned to N. vitripennis VGSC 
with pairwise similarity of 81.4%. The RDL contig matched that of the previously 
available RDL sequence in GenBank, whilst the GluCl contig displayed a high (96.3%) 
AA similarity with a GluCl of L. striatella. 
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There were seven contigs (not including the various duplicates Trinity 
produced per gene) that represented the nAChR subunits α1-8 and β1. These 
returned BLAST search hits against a range of insect nAChRs including P. americana, 
L. migratoria, N. vitripennis and already sequenced N. lugens nAChR subunits.  
A previous study had published sequences for nAChR subunits α1-4 and β2 
(accession no AY378698–AY378700, AY378702, and AY378703) (Liu et al., 2005) but 
interestingly none of these sequences were the top BLAST hit for nAChR contigs in 
this transcriptome. This is similar to a previous finding on these sequences, when 
primers designed from the GenBank N. lugens nAChRs could not amplify α1 
fragments in N. lugens field populations (Puinean, Denholm, et al., 2010). Puinean et 
al postulate that the taxonomic complexity of N. lugens, part of a sibling species 
group that are morphologically identical and with overlapping host ranges could 
explain why there is divergence between the sequences. In this analysis, the contig 
assigned an α1 BLAST hit (c98591), had AA sequence identity of 82.5% with P. 
americana α1, 72.3% with the AY378698 α1 sequence and 98.6% with the partial CDS 
α1 sequenced by Puinean et al. The same pattern was seen for α2-4 subunits; all 
show AA similarity to sequences other than those previously sequenced in N. lugens. 
No contig for an α5 subunit was identified in our transcriptome suggesting this 
subunit may not be expressed in N. lugens (there is no gene available in Genbank for 
N. lugens). This correlates with nAChR sequences for P. americana (a top BLAST hit 
species for nAChRs) which does not have an α5 subunit available on GenBank. The 
remaining subunits α6-8 and β1 were all found to have contigs matching previously 
sequenced N. lugens nAChR subunits. Although, contig c110494 aligned to both a 
sequenced N. lugens α6 subunit (99.2% AA similarity) and to a P. americana α7 
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subunit. Most of the BLAST hits for this contig return α7 sequences. Finally, there was 
no contig for a β2 subunit found in the transcriptome. 
The nAChR subunits were screened for two previously identified mutations 
that could cause resistance to neonicotinoids. These were R81T from M. persicae 
(Bass, Puinean, et al., 2011) and Y151S in N. lugens (Liu et al., 2005). Using the RNA-
seq raw reads mapping technique (Chapter II, Section 2.17) the different N. lugens 
populations were screened for these mutations. These mutations were not identified 
in any of the field strains resistant to imidacloprid (Fig. 4.5), and we conclude that 
there is no target-site resistance contributing to imidacloprid resistance in our field 
populations of N. lugens. 
The two remaining target sites screened for in our transcriptome were the 
ryanodine receptor (RyR) and the transient receptor potential (TRP) ion channel 
complex. The contig (c111911) matching RyR aligned to a previously sequenced RyR 
gene in N. lugens. Although insecticides that target RyR are not currently used against 
N. lugens, it is useful to have the target-site sequenced for future reference. The TRP 
contig showed 59% AA similarity to a TRP gene sequenced in Plutella xylostella. This 
is considerably lower AA similarity than seen for all the other target-sites analysed.   
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Table 4.7 BLASTx results of GOIs that encode for known insecticide target sites in N. lugens. 
 
 
 
 
 
 
 
Gene Contig Species Description Accession No % AA Identidy 
RDL c106927 N. lugens RDL KC841916.1 99 
GluCl c100191 L. striatella GluCl KU589277.1 96.3 
VGSC c109417 N. vitripennis VGSC transcript variant 1 NM_001134917.1 81.4 
RyR c111911 N. lugens RyR KJ573636.1 99.4 
TRP c111063 P. xylostella Predicted TRP XM_011562636.1 59.1 
nAChR α1 c98591 P. americana nAChR alpha1 JQ585634.1 82.5 
nAChR α2 c105447_g1_i1 P. americana nAChR alpha2 KP725464.1 84.4 
nAChR α3 c109754 L. migratoria nAChR3 alpha3 KF873581.1 79.8 
nAChR α4 c11527 N. vitripennis  Predicted nAChR alpha 4 transcript variant 1 XM_016981584.1 81.8 
nAChR α5 - - - - - 
nAChR α6/α7 
c110494 N. lugens nAChR alpha6 FJ167396.1 99.2 
c110494 P. americana nAChR alpha7 JX466891.1 84.7 
nAChR α8 c99950 N. lugens nAChR alpha8 FJ481979.1 97.8 
nAChR β1 c105447_g1_i3 N. lugens nAChR beta1 FJ358493.1 99.8 
nAChR β2 - - - - - 
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Fig. 4.5 Amino acid sequence alignment of N. lugens nAChR subunits found with the 
transcriptome. The P. americana α1 subunit is also displayed. The loop domains are 
indicated (A-F) by purple bars above the sequence. The transmembrane regions are 
highlighted by red bars above the sequence. Known mutations involved in neonicotinoid 
resistance (R81T, Y151S) are boxed in red. 
 
4.4 Conclusions 
This study aimed to utilise the available genomic/transcriptomic information 
to provide a resource for unravelling insecticide resistance in N. lugens. This also 
involved the generation of a de novo transcriptome from five different N. lugens 
populations to allow in depth comparisons between insecticide susceptible and 
resistant populations.  
The assembly of three insecticide target sites from publicly available SRA data 
allowed screening for potential mutations (results in chapter V) before the 
availability of the N. lugens genome, or our own specifically designed RNA-seq 
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experiment. The creation of our own transcriptome provided a valuable reference 
for analysing potential genes involved in insecticide resistance. The differential 
expression analysis of transcripts between the susceptible and resistant strains 
identified a single strong candidate for further study, a cytochrome P450 gene, 
CYP6ER1, previously implicated in imidacloprid resistance, by showing significant 
overexpression (24.3-70.2 fold) in all resistant strains compared to Bayer-S. The lack 
of obvious metabolic enzymes involved in ethiprole resistance suggested that this 
resistance could be mediated by a target-site rather than metabolic mechanism. 
Sequences were assembled for all the known major insecticide target sites. 
This will provide a valuable resource for screening for potential mutations both for 
compounds already suffering resistance problems, and any future resistance 
development. Mapping the RNA-seq raw reads to the genes encoding the target 
sites, was used as an effective method of SNP analysis. This technique was routinely 
used throughout this PhD, not just for target site screening but also for searching for 
allelic variation in metabolic enzymes (chapter VI). 
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Chapter V  Target-site resistance to phenylpyrazoles 
in N. lugens 
 
Much of this chapter (introduction, some of the results and most of the discussion) 
have been published in Pesticide Biochemistry and Physiology (reprints attached in 
Appendix C) in a paper drafted and written by me. 
Garrood, W. T., Zimmer, C. T., Gutbrod, O., Lüke, B., Williamson, M. S., Bass, C., 
Nauen, R. and Davies, T. G. E. (2017) ‘Influence of the RDL A301S mutation in the 
brown planthopper Nilaparvata lugens on the activity of phenylpyrazole 
insecticides’, Pesticide Biochemistry and Physiology. Rothamsted Research Ltd, pp. 
1–8. doi: 10.1016/j.pestbp.2017.01.007. 
Note: Some of the data in this chapter was obtained by employees at Bayer 
CropScience: Ralf Nauen, Bettina Lüke and Oliver Gutbrod. Figure/table headings 
indicate their respective contributions. 
 
5.1 Introduction 
The phenylpyrazole (fiprole) insecticides, such as ethiprole and fipronil were 
introduced for N. lugens control after resistance to imidacloprid became 
commonplace (Zhang et al., 2014). Phenylpyrazoles are described as non-
competitive blockers of the gamma-aminobutyric acid (GABA)-gated chloride 
channel, a member of the pentameric transmembrane cys-loop ligand-gated ion 
channel family mediating synapse inhibition in the insect central nervous system 
(Cole, Nicholson and Casida, 1993; Bloomquist, 2001; Knipple and Soderlund, 2010). 
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Fiproles are potent inhibitors of GABA-mediated inhibitory nerve transmission and 
belong to group 2 of the MoA classification scheme of the Insecticide Resistance 
Action Committee (IRAC), that encompasses GABA-gated chloride channel 
antagonists (Sparks and Nauen, 2015). This MoA class also includes much older 
insecticide chemistry, such as the cyclodiene hydrochlorines, which include 
endosulfan and dieldrin (Casida and Durkin, 2013). Ethiprole is structurally similar to 
fipronil, only differing in an ethylsulfinyl substituent replacing the 
trifluoromethylsulfinyl moiety in fipronil (Caboni, Sammelson and Casida, 2003). 
Structural change by replacements of alanine 301 in the GABA-gated chloride 
channel, encoded for by the Rdl (Resistance to dieldrin) gene, has been linked to high 
levels of resistance to insecticidal antagonists, in particular cyclodiene 
organochlorines (ffrench-Constant, 2013). The most common substitution at this 
position, A301S, was first identified in D. melanogaster and shown to cause 4000-
fold resistance to dieldrin (ffrench-Constant et al., 1990, 1993). However, the role of 
this mutation in resistance to the newer fiprole insecticides has been debated (Bass 
et al., 2004; Remnant et al., 2014). Other mutations at this amino acid residue, 
situated in the M2 transmembrane domain, have also been associated with fipronil 
resistance. A 20,000-fold fipronil resistant strain of Drosophila simulans exhibited a 
A301G replacement at this position in combination with a substitution at a second 
site, T350M in the M3 domain (Le Goff et al., 2005). Functional expression of RDL 
GABA receptor subunits in Xenopus oocytes showed that the A301G mutation has 
modest effects on fipronil action, while a receptor variant with both of the mutations 
exhibited higher levels of resistance to fipronil (Le Goff et al., 2005). A third 
substitution at the A301 position, A301N (A2’N), has been recently associated with 
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fipronil resistance in two other rice planthopper species, Sogatella furcifera (white-
backed planthopper) and Laodelphax striatellus (small brown planthopper) (Nakao 
et al., 2010, 2011). In the former species the A301N mutation was identified in 
association with a R357Q mutation in the cytoplasmic loop between M3 and M4 of 
the S. furcifera RDL GABA receptor subunit with membrane potential assays 
suggesting the influence of the double mutation on fipronil resistance was more 
profound than that of the A301N alone (Nakao et al., 2012). This finding parallels that 
of the earlier work in Drosophila suggesting two mutations in the RDL GABA receptor 
subunit, one at AA residue 301 and one elsewhere act in concert to influence the 
level of in vivo resistance to fipronil (Remnant et al., 2014). However, in contrast to 
these findings other electrophysiological in vitro studies have revealed no significant 
differences in fipronil antagonist potency between wildtype and A301S RDL GABA 
receptor variants expressed in Xenopus oocytes (Wolff and Wingate, 1998; Lees et 
al., 2014). 
Very recently the A301S mutation was also identified in N. lugens and 
correlated with low levels of resistance to fipronil (5-fold in the presence of enzyme 
inhibitors and 23-fold without) (Y Zhang et al., 2016). The authors of this study also 
identified a second substitution in TM2 (R299Q) that in combination with A301S, was 
associated with much higher levels of resistance in a laboratory selected strain (96-
fold with synergists, 237-fold without). Expression of recombinant RDL receptors, 
demonstrated that the R299Q mutation has a profound effect on the normal 
functioning of the receptor in response to the endogenous agonist GABA, suggestive 
of a strong fitness cost. However, the deleterious effects of R299Q was reduced in 
the presence of the A301S mutation. Surprisingly, the R299Q substitution was 
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identified at extremely low frequency in field populations of N. lugens suggesting this 
is not the main mechanism of resistance in field populations (Y Zhang et al., 2016). 
Due to the evolution of resistance to fipronil in populations of N. lugens 
throughout Asia, and potential issues with the environmental toxicity of this 
insecticide, most growers subsequently switched to using ethiprole (Bayer 
CropScience, 2007; Sahaya et al., 2010). Unfortunately, the rapid uptake of this 
insecticide has led to recent reports of resistance (Garrood et al., 2016). To date, the 
molecular basis of resistance to this insecticide has not been characterised and the 
potential role of mutations in the GABA-receptor remain unexplored. Metabolic 
resistance has been implicated in an ethiprole resistant N. lugens field strain from 
Thailand (Punyawattoe et al., 2013), though the authors also speculated that GABA 
receptor mutations could play a role in ethiprole resistance. Another study 
implicated two cytochrome P450s, CYP4DE1 and CYP6CW3v2, in ethiprole resistance 
in L. striatellus (Elzaki, Zhang and Han, 2015).  
This chapter discusses the analysis of the phenylpyrazoles target-site, the 
GABA-gated chloride channel (encoded for by the Rdl gene), and its potential role in 
resistance to these compounds. The work implicates a target-site mutation as a key 
mechanism behind ethiprole resistance. Further attempts to discover the fipronil 
resistance mechanism are discussed.  
5.2 Material and Methods 
5.2.1 Drosophila crossing experiments  
The wild type strain Canton-S (#1, wild type) and the A301S strain (#35492, 
Rdl MD-RR) were sourced from the Bloomington Drosophila Stock Center at Indiana 
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University, USA. Strain RDLMD-RR was homozygous for A301S and highly resistant to 
ethiprole. Adult virgin females of Canton-S were collected and crossed with adult 
males of RDLMD-RR. Flies of the F1 generation were then sequenced to check for 
heterozygosity at the A301S location. All crossings were confirmed to be 
heterozygous for A301S, and the F1 generation was left to inbreed to produce an F2 
population heterogeneous at AA 301. The F2 generation was then screened using a 
high dose of ethiprole in a bioassay (Chapter II, Section 2.4). Survivors of this bioassay 
were then screened for the presence of the A301S mutation via sanger sequencing.  
5.2.2 gRNA design, plasmid construction and template oligo for CRISPR/Cas9 
applications 
The two gRNAs, one each for mutations A301S and Q359E, were designed 
using an online platform flyCRISPR (http://flycrispr.molbio.wisc.edu/targetFinder/) 
(Gratz et al., 2014). A region spanning ~200 bp either side of A301S (>3L:9148464-
9148065) and Q359E (>3L:9145138-9144739) were selected for gRNA design. For 
A301S the following gRNA (>3L:9148267-9148286 (- strand) 
CAATGCAACGCCGGCGCGTG) was chosen since it had no off-targets predicted and 
was located 2 bp away from the nucleotide to be mutated. For Q359E the following 
gRNA (>3L:9144953-9144972 (- strand) ATACGCCACGGTCGGCTACA) which was 
predicted to have one off-target event (on the X chromosome), was selected.  
gRNA expression plasmids were generated according to the following 
method. Sense and anti-sense oligos were ordered for the gRNAs designed using 
flyCRISPR (Appendix A, Table A1). The sense oligos had a GTCG overhang added to 
the 5’ end, whilst the anti-sense oligos had an AAAC overhang added to the 5’ end. 
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The oligos were phosphorylated and annealed to their complement in the following 
manner. 1 µL of each sense oligo and anti-sense oligo (100 µM), was combined with 
1 µL 10X T4 ligation buffer (NEB, Ipswich, MA, USA), 0.5 µL T4 PNK (NEB, Ipswich, MA, 
USA) and made up to 10 µL with nuclease free water. The reaction was incubated at 
37oC for 30 min, then 95oC for 5 min before ramping down to 25oC at 5oC/min. The 
plasmid chosen to ligate this product into was the pCFD3: U6:3-gRNA plasmid 
(addgene #49410). This plasmid was linearized prior to the ligation reaction using a 
restriction enzyme, Bbsl. The ligation reaction consisted of 3 µL of linear plasmid, 1 
µL of annealed oligos (1:200 diluted), 1.5 µL 10X T4 ligase buffer (NEB, Ipswich, MA, 
USA), 0.5 µL T4 ligase and nuclease free water to 15 µL. The reaction was incubated 
at 22oC for 20 min then placed on ice. Transformation was performed using DH5α™ 
cells (Thermo Fisher, Waltham, MA, USA). This used 50 µL of DH5α™ cells per 
reaction, placed in a precooled 2 mL microcentrifuge tube. 5 µL of ligation mix was 
added to the cells and gently mixed by flicking the tube. This was left to incubate for 
30 min on ice, before being heat shocked at 42oC for 25 s. Tubes were placed on ice 
for 2 min, before addition of 450 µL of pre-warmed LB lysogeny broth. Cells were left 
to recover for at least 1 h at 37oC with 225 rpm shaking using a shaking incubator 
(Eppendorf, Hamburg, Germany). 100 µL of each transformation mix was spread on 
pre-warmed 100 µg/mL AMP (ampicillin) LB plates and incubated over night at 37oC. 
8 colonies for each gRNA were picked for colony PCR and a colony record was 
created, by touching the tips used to pick the colonies onto a fresh AMP LB plate. 
Colony PCR was performed as previously described (Chapter II, Section 2.13), but 
using 1 µL of T3 primer and the forward oligo (Appendix A, Table A1). Colonies 
confirmed to have the correct insert were then processed through plasmid 
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purification (Chapter II, Section 2.14). After purification plasmids were concentrated 
to at least 1 µg/µL. 
Single stranded oligonucleotides of 110 nt (ssOligo) were synthesized (IDT, 
Coralville, IA, USA) to be the template for Homology Directed Repair (HDR) after the 
protein-9 nuclease (Cas9) induced double strand break in the genome, guided by the 
gRNA plasmids. The template ssOligos (A301S ssOligo and Q359E ssOligo), were both 
designed to have a SNP that would introduce the respective amino acid substitutions 
desired (Fig. 5.1). For A301S ssOligo (Fig.5.1A), this would cause a serine (S) to replace 
the native alanine (A), whilst for Q359E sOligo (Fig. 5.1B) this would introduce a 
glutamic acid (E) in place of the native glutamine (Q). These ssOligos also contained 
a SNP just upstream of the mutation sites to prevent Cas9 from re-cleaving the 
genome after the ssOligo had been incorporated.  
 
Fig. 5.1 Alignment of the 110 nt HDR templates with Rdl. A) The first G/T substitution in 
the gRNA seed sequence (last 12 nt of gRNA), is a designed mismatch to prevent re-
cleavage by Cas9. The second G/T substitution causes an amino acid change from alanine 
(A) to serine (S). B) The first C/G substitution prevents Cas9 re-cleavage, whilst the second 
C/G introduces an amino acid change from glutamine (Q) to glutamic acid (E).  
 
5.2.3 Drosophila embryo injections and screening for CRISPR mediated mutations 
Two strains, a DNA ligase 4 deficient strain (#28877, genotype w1118 Lig4169), 
and strain expressing endonuclease Cas9 (#51324, genotype w1118; 
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PBac{y[+mDint2]=vas-Cas9}VK00027) were crossed and PCR guided sibling mating 
rescued a strain designated ‘lig4 KO Cas9’ (genotype w1118 Lig4169; 
Bac{y[+mDint2]=vas-Cas9}VK00027) (Zimmer et al., 2016). This strain was generated 
by C. Zimmer and maintained in the laboratories at Rothamsted. For the purposes of 
this study, embryos were collected from this strain and injections were performed as 
described previously (Chapter II, Section 2.19). There were two injection mixes used: 
1) A301S 2) A301S + Q359E. For A301S by itself the mix comprised 0.5 x phosphate 
buffer (pH 6.8, 0.05mM sodium phosphate, 2.5mM KCL) containing 200 ng µL-1 gRNA 
expression plasmid, 1 µg uL-1 template ssOligo and 200 mg L-1 fluorescein sodium salt. 
For the A301S + Q359E mix there was 180 ng µL-1 of each gRNA expression plasmid 
and 800 ng µL-1 of both template ssOligos in the 0.5X phosphate buffer with 200 mg 
L-1 fluorescein sodium salt. 
Flies that emerged were crossed to a balancer strain, w TM6B tb (#4148, 
genotype: w1118; PasSC1 gl3/TM6B, glBS1 Tb1) to form generation G0. Flies emerging 
from this generation were crossed again to the balancer strain to form generation 
F1. After display of larval activity the fly taken from the G0 generation was collected 
and screened for the A301S mutation using PCR. When the offspring of the F1 
generation emerged as adult flies they were screened with a low dose (1 mg L-1) of 
dieldrin.   
5.2.4 Emergence bioassays (D. melanogaster) 
Dieldrin (Sigma Aldrich, St. Louis, MO, USA) was added to fly media 
(concentrations – 5, 1, 0.2, 0.04 and 0.008 mg L-1) at 50oC, with 3 virgin females and 
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2 males added per vial and allowed to propagate for a 5-day period before being 
removed. Flies that emerged were scored after 14 days. 
5.2.5 Synergist bioassays (N. lugens) 
Synergist bioassays used the same methodology as for the leaf dip bioassays 
(Chapter III, Section 3.2.2), with the addition of the following steps. Each insect (N. 
lugens) was treated upon the pronotum with 0.2 µL of 100 mg L-1 of an individual 
synergist in acetone (20 ng adult-1). The three synergists used were Piperonyl 
butoxide (PBO), 1-Aminobenzotriazole (1-ABT) and triflumizole. After synergist 
application, the insects were transferred to rice stems treated with fipronil. Mortality 
was assessed at 48 h. 
5.3 Results  
5.3.1 Sequencing and RNA-Seq read mapping of N. lugens GluCl for mutations 
cDNA sequencing was conducted for the N. lugens glutamate-gated chloride 
channel (GluCl), using primers (Appendix A, Table A3) designed from the assembled 
GluCl gene sequence (Chapter IV, Section 4.3.1.1). This was done for the following 
strains: Bayer-S, Nl33, Nl39, Nl40, Nl55, Nl33-eth, Nl39-eth and Nl55-eth. Sequence 
analysis of the GluCl in all these strains revealed that there were no putative 
mutation(s) that could confer resistance compared to the susceptible. This was 
further validated by RNA-Seq read mapping using the GluCl gene as the reference 
sequence, which also demonstrated that there were no mutations of interest in 
resistant strains. 
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5.3.2 Rdl gene structure and expression 
The presence of two isoforms for the Rdl gene (Chapter IV, Section 4.3.5.2) 
was further explored using cDNA sequencing, RNA-Seq read mapping and exon 
calling. Firstly, primers were designed (Appendix A, Table A4) that had a generic 
forward primer and a specific reverse primer for each isoform. All the strains 
mentioned previously (Section 5.3.1) were then sequenced using these primers, 
revealing that both Rdl isoforms were being expressed across the populations.  
The N. lugens genome assembly was searched for scaffolds containing the Rdl 
gene sequence. This returned two scaffolds, 387_19 and 387_20 (accession no 
AOSB01071559-60), that contained most of the CDS sequence for both Rdl isoforms. 
Searching the genome assembly using specific nucleotide sequences for each isoform 
(from where the sequences diverge), highlighted that the two isoforms were 
alternate splice forms of the final exon: 9A and 9B (Fig. 5.2) located on scaffold 
387_20. 
 
Fig. 5.2 The exon organisation of exon 9A and exon 9B of the N. lugens Rdl gene on genome 
scaffold 387_20 
Attempts to quantify the level of expression of these two exons using qRT-
PCR were unsuccessful due to the inability to design sufficiently distinct primer pairs. 
However, using the RNA-Seq raw reads to map back to the exons demonstrated that 
one was clearly more highly expressed than the other (Table 5.1). Across all the 
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strains the 9B exon was the preferred exon expressed, rather than that represented 
in the original GenBank sequence (accession no. KC841916.1).  
Table 5.1 Raw reads aligning to the Rdl alternate exon. 
  No. reads 
  9AExon 9B Exon 
Bayer-S 15 54 
Nl33 16 83 
Nl55 17 43 
Nl33-eth 24 142 
Nl55-eth 10 43 
Total 82 365 
 
Since thisRdl isoform (9B), was the dominant form seen across all the strains, 
this was the isoform employed in the subsequent experiments described in this 
chapter. 
5.3.3 Screening N. lugens Rdl for mutations 
The cDNA sequencing and RNA-Seq read mapping of N. lugens Rdl revealed 
two non-synonymous mutations in the fiprole resistant strains compared to the 
susceptible strain. These were A301S and Q359E (Fig. 5.3). The A301S mutation was 
seen intermittently across all the field populations and in the ethiprole selected 
strains (primers, Appendix A, Table A4). However, Q359E, was only seen in strains 
from India (Nl55, Nl56 and Nl55-eth) and not strains from Vietnam (Nl33, Nl33-eth, 
Nl39 and Nl39-eth). No other mutations (R299Q, A301G/N, T350M and R357Q) that 
had been previously linked with resistance to phenylpyrazoles were seen across the 
highly fiprole resistant populations studied here (primers, Appendix A, Table A4). 
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Fig. 5.3 Amino acid sequence of TM2 and TM3 (TM regions underlined) from N. lugens RDL. 
The alanine and glutamine residues that are mutated in fiprole resistant strains are 
highlighted. 
5.3.4 Genotyping A301S and Q359E via Sanger Sequencing 
The cDNA sequencing performed to screen the Rdl for mutations was a 
combination of pooled insects and cloned PCR products. Therefore, to explore the 
levels of these two mutations in the N. lugens populations, sequencing was done on 
single insects to allow individual genotyping. Since previous sequencing efforts had 
shown that Q359E was only present in Indian strains this genotyping focused on 
Bayer-S, Nl55 and Nl55-eth. 
All strains were analysed for the presence of the A301S mutation by Sanger 
sequencing of an amplified 257 bp sequence from genomic DNA. Genotyping of 
A301S in Bayer-S confirmed the wild type A301 genotype (Table 5.2). In comparison, 
Nl55 displayed a mix of genotypes, with only 12.5% of insects homozygous for 301S 
and 32.5% homozygous for the wildtype genotype. 100% of insects analysed from 
Nl55-eth carried the A301S mutation in the homozygous form. The novel mutation, 
Q359E, was also genotyped for Nl55 and Nl55-eth. Nl55 displayed 7% of individuals 
homozygous for the 359E mutation, with 57% of insects homozygous for the wildtype 
genotype. However, 87% of individuals were homozygous for the Q359E mutation in 
Nl55-eth, while the remaining 13% were heterozygous. Since the A301S mutation 
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reached fixation in Nl55-eth it can be concluded that there are two A301S alleles 
present in that strain, one with and one without the Q359E mutation. The potential 
that these two mutations could be linked (linkage disequilibrium) is discussed later 
as an explanation as to how the Q359E mutation and the A301S come to be seen in 
tandem. 
Table 5.2 Genotypes via Sanger sequencing of N. lugens strains for A301S and Q359E. 
Population 
A301S genotype (%) Q359E genotype (%) 
RR SR SS RR SR SS 
Bayer-S 0 0 100 0 0 100 
Nl55 12.5 55 32.5 7.14 35.71 57.14 
Nl55-eth 100 0 0 86.84 13.16 0 
(Nl55 A301S N=40, Nl55-eth A301S N=40, Nl55 Q359E N=28 and Nl55-eth Q359E N=38) 
5.3.5 SNP calling of A301S and Q359E via RNA-Seq 
For the strains that had been sequenced using Illumina (Chapter IV, Section 
4.2.2), RNA-Seq reads were mapped against the N. lugens Rdl nucleotide sequence 
to observe any non-synonymous mutations, of which there were two: A301S and 
Q359E. Bayer-S displayed 100% of reads containing the wild type genotype at AA 
residue 301 (Table 5.3). Nl33 and Nl55 exhibited 85% and 80% of reads with the wild 
type genotype respectively. For the Nl33-eth and Nl55-eth populations, 100% of 
reads contained the A301S mutation. In agreement with the Sanger sequencing, SNP 
calling of RNA-Seq data showed that the Q359E mutation was only found in Nl55 and 
Nl55-eth (Table 5.3), with 96% of Nl55-eth reads containing the Q359E mutation, 
compared to 27% for Nl55. 
 
 
 
 
Chapter V 
102 
 
Table 5.3 SNP calling via RNA-Seq of N. lugens strains for A301S and Q359E. 
    Nl33 Nl33-eth Nl55 Nl55-eth 
    No. reads % No. reads % No. reads % No. reads % 
A301S 
Total reads 20 - 34 - 10 - 18 - 
G (WT) 17 85 0 0 8 80 0 0 
T (Mut) 3 15 34 100 2 20 18 100 
Q359E 
Total reads 25 - 30 - 11 - 23 - 
C (WT) 25 100 30 100 8 72.73 1 4.35 
G (Mut) 0 0 0 0 3 27.27 22 95.65 
 
5.3.6 Functional validation of A301S and Q359E 
To functionally validate the mutations discovered in Rdl numerous 
experiments were performed. These included electrophysiological studies, D. 
melanogaster insecticide mortality bioassays and crossings, trikinetic measurements 
and attempted CRISPR mediated introduction of the mutations into D. melanogaster. 
Of these it was decided that the Drosophila experiments would be conducted by 
myself, whilst the electrophysiology studies would be organised and performed by 
Bayer CropScience personnel. The electrophysiological studies are not presented in 
the results section but are discussed later. 
5.3.6.1 D. melanogaster fiprole bioassays 
 The RDLMD-RR (carrying Rdl A301S) D. melanogaster strain displayed high levels 
of resistance to ethiprole with a resistance ratio >4000 fold based on the LC50 when 
compared with the wildtype D. melanogaster strain, Canton-S (Table 5.4). Against 
fipronil the RDLMD-RR strain had a resistance ratio of only 6.9-fold. 
The RDLMD-RR strain was sequenced across the A301S region to confirm this 
mutation and to check that there were no other non-synonymous mutations in this 
region. A further region, just after TM3, was also sequenced (primers, Appendix A, 
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Table A4) to ensure that mutations (T350S and M360I) evaluated in a previous study 
(Remnant et al., 2014) were not present in this strain. No other mutations were 
found, confirming that this strain only contained the A301S mutation.
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Table 5.4 Log-dose probit mortality data for fiproles against D. melanogaster strains. 
              Resistance Ratio 
Compound Strain LC50 [mg L-1] 95% CL LC95 [mg L-1] 95% CL Slope (± SD) LC50 LC95 
Ethiprole 
Canton-S 5.73 4.77-6.77 22.39 17.14-33.08 2.777 ± 0.238 1 1 
RDLMD-RR >25000 - >25000 - - >4300 >1100 
Fipronil 
Canton-S 1.27 0.77-1.85 9.04 5.29-25.55 1.931 ± 0.333 1 1 
RDLMD-RR 8.82 5.34-13.7 62.36 33.11-238.1 1.936 ± 0.363 6.9 6.9 
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5.3.6.2 Crossing experiments for Canton-S and RDLMD-RR 
Approximately 200 flies of the F2 generation of the Canton-S x RDLMD-RR strain 
were placed on agar vials spread with 500 mg L-1 ethiprole. From this bioassay, there 
were approximately 50 survivors (25%). Survivors from this insecticide screening 
were collected and 5 flies underwent DNA extraction. PCR sequencing of the DNA 
spanning the A301S region showed that the insecticide screening survivors were all 
homozygous for the A301S mutation (Fig. 5.4). 
 
Fig. 5.4 Genotyping for A301S in ethiprole screened survivors. Sequencing chromatograms 
show that all survivors are homozygous for the A301S mutation. 
 
5.3.6.3 Locomotor activity of ethiprole treated Drosophila strains 
Whilst visiting the Batterham Lab at the University of Melbourne, I had the 
chance to attempt various experiments to study the effects of insecticide resistance 
using D. melanogaster techniques that were unavailable at Rothamsted Research. 
The first of these was monitoring locomotor activity in D. melanogaster (Chapter II, 
Section 2.18) strains in the presence of insecticide.  
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Two strains, Canton-S and RDLMD-RR, were analysed using this trikinetics 
system. The effect on activity of these two strains, in the presence of ethiprole, was 
very different (Fig. 5.5). The Canton-S strain, at 500 mg L-1 ethiprole, displays normal 
activity for the first 10 h before the activity rapidly decreases. There is a slight 
recovery, but no further movement is recorded after 23 h (Fig. 5.5A). In comparison, 
the RDLMD-RR strain always shows movement. It is appreciably lower than the control 
for the first 15 h, however it shows peaks at similar timepoints as the control in this 
period (Fig. 5.5C). After this period the strain recovers to levels above that of the 
control. 
 
 Fig. 5.5 Locomotor activity of Canton-S and RDLMD-RR. A) Canton-S treated with 500 mg L-1 
ethiprole. B) Canton-S treated with 10000 mg L-1 ethiprole. C) RDLMD-RR treated with 500 mg 
L-1 ethiprole. D) RDLMD-RR treated with 10000 mg L-1 ethiprole. Time axis displays the number 
of hours the flies have been on the ethiprole coated food. Locomotor activity displayed is 
the average movement recorded for each of the 5 min sections within a given hour.  
At 10000 mg L-1 ethiprole the response of Canton-S is even more pronounced 
than at 500 mg L-1 with a swift knockdown in movement, followed by a brief increase 
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in movement before movement gradually ceases, with no significant movement 
recorded after 9 h (Fig. 5.5B). For RDLMD-RR the flies movement is closer to that of the 
control when compared at the 10000 mg/L-1 than 500 mg/L-1 ethiprole, and why this 
is the case is not clear. Again there is no time point where no movement is recorded 
(Fig. 5.5D). Also at the end of the experiment (approximately 2 days, data not shown 
here) there is still significant movement occuring in the RDLMD-RR strain despite the 
very high levels of insecticide present. 
5.3.6.4 CRISPR mediated A301S and Q359E replacement in D. melanogaster 
Approximately 300 embryos were injected with each injection mixture 
(A301S alone/A301S + Q359E combined). The flies that emerged from the injected 
embryos (~14%) were then crossed to the chromosome 3 balancer stock (w TM6B 
tb) and maintained on normal fly media. This is designated the G0 generation. 
 Exploratory experiments were done to determine whether insecticide 
screening could be performed on this first fly cross, in the manner previously 
described (Zimmer et al., 2016). However, attempts to find a dieldrin dose that could 
be used to supplement the food which let adults survive, but killing susceptible 
larvae, were unsuccessful. The lowest tested dose that the Lig4 KO Cas9 adult flies 
could survive on was 0.2 mg L-1 (Table 5.5). But at this dose susceptible larvae could 
survive and emerge as adults (Fig. 5.6), so no discriminatory screening was being 
implemented. Higher dieldrin doses led to full mortality of the Lig4 KO Cas9 adult 
flies. It was therefore decided not to use insecticide supplemented media as a 
screening agent for these fly crosses. 
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Fig. 5.6 Concentration-response relationship for an emergence bioassay with Lig4 KO Cas9 
and RDL-MD-RR strains. A.i. = active ingredient. 
 
For the G0 crosses involving flies injected with the A301S + Q359E mix, 40 
adult flies emerging from the original cross were again crossed to the same balancer 
strain to form the F1 generation These new crosses were left to propagate until 
larvae activity was detected then the relevant fly was collected. The flies that were 
collected for PCR analysis were those that had been taken from the G0 generation. 
PCR was run and sequenced to assess introduction of mutations A301S and Q359E 
(primers, Appendix A, Table A4). Sequencing of 42 flies revealed that none contained 
either of the mutations.  
Table 5.5 Mortalities (%) of fly strains to dieldrin after 72 h. 
Concentration (mg L-1) Lig4 KO Cas9 
5 100 
1 100 
0.2 6.6 
0.04 6.6 
0.008 0 
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The same result was obtained for the flies involved in the A301S only cross. 
PCR and sequencing of flies emerging from the original cross confirmed no 
introduction of the A301S mutation. To double check this finding the flies from the 
F1 cross were inbred for a further generation, to allow an insecticide screen to be 
performed. However, no flies from this generation survived a screen with a low dose 
of dieldrin. A few flies from this bioassay were collected for PCR and sequencing 
which again demonstrated no incorporation of the A301S mutation. 
5.3.7 Synergist bioassays  
5.3.7.1 PBO + fipronil 
Synergistic bioassays were conducted with PBO on the highly fipronil resistant 
populations Nl33-eth, Nl39-eth and Nl55-eth to assess whether P450 
monooxygenases (and/or esterases) could potentially be contributing to the 
resistance phenotype observed. The resistance of these strains to fipronil in the 
absence of PBO was displayed previously (Chapter III, Table 3.8), with LC50s over 1000 
mg L-1. The fipronil mortality of all PBO treated populations was under 25% at a 
fipronil concentration of 100 mg L-1 and 500 mg L-1 (Table 5.6). This indicated that 
most of the individuals of all three strains are unaffected by the application of PBO 
prior to exposure to fipronil.  
 
Table 5.6 Mortalities (%) of ethiprole selected populations to fipronil after application of 
0.2 µL of 100 mg L-1 (20 ng adult-1) PBO.  
Strain 100 mg L-1 500 mg L-1 
Nl33-eth 0.2 0.16 
Nl39-eth 0 0.082 
Nl55-eth 0.1 0.24 
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5.3.7.2 1-ABT and triflumizole + fipronil 
Further synergistic bioassays were conducted with two alternative 
compounds: 1-ABT and triflumizole. This was to assess whether other P450 
monooxygenase inhibitors could have any impact on fipronil susceptibility. Nl39-eth 
fipronil mortality was below 15% after the application of 500 mg L-1 fipronil following 
1-ABT treatment (Table 5.7). When triflumizole was applied the mortality at 500 mg 
L-1 fipronil was still below 30%. This is broadly in line with the results seen when the 
fipronil resistant populations were treated with PBO before fipronil exposure. 
Table 5.7 Mortalities (%) of Nl39-eth to fipronil after application of different synergists. 
  Nl39-eth 
Synergist 100 mg L-1 500 mg L-1 
1-ABT 0.05 0.11 
Triflumizole 0.23 0.29 
 
5.3.8 Fipronil sulfone bioassays 
A primary metabolite of fipronil, fipronil sulfone, was also tested against the 
fipronil resistant populations of N. lugens. The Nl55 strain had very low resistance to 
fipronil (RR 3), compared to the ethiprole selected strains (RR >860), and a similar 
trend is apparent for fipronil sulfone. Only a few dose concentrations were tested for 
fipronil sulfone, so an accurate LD50 was not calculated for the strains. However, at 
20 mg L-1 fipronil sulfone Nl55 mortality was 80% (Table 5.8) whilst for the Nl33-eth 
strain only 20% mortality was recorded at the same dose. At 100 mg L-1 all the Nl55 
brown planthoppers were dead whilst there was still considerable survivorship for 
Nl39-eth (63%). It is not possible to compare mortalities at certain 
dose/concentrations between fipronil and fipronil sulfone bioassays due to the 
different bioassay methodology used to assess resistance to these compounds.  
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Table 5.8 Mortalities (%) of N. lugens strains to fipronil sulfone. 
  Fipronil Sulfone   
Strain 20 mg L-1 100 mg l
-1 500 mg L-1 
Nl55 80.9 100 100 
Nl33-eth 21.5 69.9 94.5 
Nl39-eth nt 37.5 70.7 
 
5.4 Discussion 
To date, the molecular basis of ethiprole resistance in N. lugens has remained 
unclear. A previous study linked esterase activity, and to a lesser extent P450s 
activity, to ethiprole resistance in N. lugens in central Thailand, based on the separate 
application of PBO, triphenyl phosphate and diethyl maleate as synergists prior to 
ethiprole exposure (Punyawattoe et al., 2013) . However, to date, no mutation(s) in 
the non-competitive antagonist binding site of the RDL channel has been implicated 
in resistance to ethiprole. In the case of fipronil resistance, a potential novel 
mechanism of resistance was very recently implicated in a laboratory selected strain 
of N. lugens (see introduction to Chapter V), but was not observed at sufficient 
frequency to cause resistance in field populations (Y Zhang et al., 2016) .  
In this chapter, two mutations in Rdl associated with phenylpyrazole 
resistance in two field strains were identified. Field strains, Nl33 (Vietnam) and Nl55 
(India) exhibited high levels of resistance to ethiprole, despite a long period of non-
selection (27 and 18 generations respectively), as discussed in Chapter III. When 
these strains were exposed to continuous ethiprole selection, their resistance 
markedly increased compared to the non-selected populations. Two mutations were 
identified in these strains; the first was the previously reported A301S mutation (Y 
Zhang et al., 2016), which was observed at low frequency in both parental field 
strains but rapidly rose in frequency and became fixed under ethiprole-selection. A 
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further, novel mutation was identified, Q359E, in one of the strains that also 
increased in frequency under selection. Subsequent functional analysis of the role of 
these mutations in resistance to fipronil and ethiprole, provided several lines of 
evidence to support a causal role of the A301S mutation in resistance to ethiprole, 
but not fipronil.  
Firstly, in vivo evidence of the role of this mutation in ethiprole resistance was 
provided by insecticide bioassays of a D. melanogaster RDLMD-RR line with the same 
mutation, which exhibited 4000-fold resistance to ethiprole in comparison to a strain 
(Canton-S) without the mutation. Locomotor activity assays also revealed a 
remarkable difference in susceptibility to ethiprole between these two D. 
melanogaster strains, with the strain carrying A301S being broadly unaffected by 
ethiprole exposure. A simple crossing experiment between RDL MD-RR and Canton-S, 
followed by selection on a high concentration of ethiprole, demonstrated that all 
survivors were homozygous for A301S. Further conclusive evidence was provided 
through expression of recombinant wild-type and A301S RDL receptors in Xenopus 
oocytes followed by electrophysiological assays (Fig. 5.7, conducted by Bayer 
CropScience). These showed that the presence of the A301S mutation reduces the 
sensitivity of the receptor to ethiprole 8-10-fold compared to wild-type, providing 
strong evidence of a role in vitro. 
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Source: (Garrood et al., 2017) 
Fig. 5.7 Effect of GABA and fiprole antagonists on GABA-induced currents in N. lugens RDL 
receptors functionally expressed in Xenopus oocytes. (A) GABA concentration-response 
curves on wildtype (WT) and mutated RDL variants carrying an A301S and A301S+Q359E 
amino acid substitution, respectively. Data are mean values ± SEM (n=3); (B) Typical 
example of electrophysiological oocyte recordings showing the concentration-dependent 
action of GABA (10, 5, 2.5, 1.25, 0.625, 0.313 and 0.156 µM) on functionally expressed 
receptors (Rdl A301S). (C, D) Antagonist concentration-response curves for fipronil and 
ethiprole on the three different RDL variants. The responses were normalised relative to 
the currents induced by 5 µM GABA for each receptor variant. Data are mean values ± SEM 
of 3-5 independent recordings. Data obtained by R. Nauen and B. Lüke (Bayer 
CropScience).  
 
In contrast to the findings with ethiprole very limited evidence was seen for 
a causal role of the A301S mutation in resistance to fipronil.  A low level of resistance 
to fipronil was seen in the D. melanogaster line RDLMD-RR with the A301S mutation 
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(around 7-fold compared to Canton-S). This result is similar to the 13.8-fold 
resistance reported by Remnant et al., 2014 on the same D. melanogaster strain. A 
different strain of D. melanogaster (mel-ser) carrying the same A301S mutation was 
previously reported to show 73-fold resistance to fipronil (Cole, Roush and Casida, 
1995), however, such high levels of resistance to fipronil were not apparent in this 
present study or that carried out previously by Remnant et al 2014. This conclusion 
is reinforced by the Bayer CropScience electrophysiological assays where the 
recombinant A301S RDL receptor showed no significant shift in sensitivity to fipronil, 
with a response broadly similar to that of the wild type receptor. 
As detailed above a second mutation, Q359E, was also observed at low 
frequency in the Nl55 strain sourced from India but was selected for at high 
frequency upon ethiprole selection in the laboratory. All insects identified as having 
the Q359E substitution carried it in combination with A301S. Since this mutation is 
never seen in isolation in the selected N. lugens population, it was decided to focus 
the analysis on the double mutant (A301S + Q359E) via electrophysiology to assess 
the effect of Q359E in tandem with A301S.  
The data provided by Bayer CropScience suggests that in contrast to A301S, 
the Q359E mutation plays no direct role in resistance to either ethiprole or fipronil 
with A301S/Q359E receptors displaying the same level of sensitivity to both 
compounds as the A301S modified receptor. Attempts to analyse Q359E in vivo by 
introducing the mutation into the D. melanogaster Rdl gene were unsuccessful. The 
most likely explanation for the failed integration of the mutation was the 
experimental strategy of trying to insert the A301S and Q359E mutations 
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simultaneously (within the same injection round). Within the D. melanogaster 
genome these two sites are located approximately 3.3 kb apart, and it was presumed 
that this was a sufficient distance to introduce two separate cut sites for HDR. 
However, PCR analysis revealed that these two cut points were close enough to cause 
the entire 3.3 kb region to be excised, and explains why no flies with the desired 
mutations were obtained.  
 A model of the N. lugens RDL GABA-R homo-pentamer (provided by Bayer 
CropScience) places the Q359E mutation at least >40 Å away from the key A301S 
residue which could be a potential reason for its lack of direct impact (Fig. 5.8). 
However, a previous study using the Drosophila Genetic Reference Panel (DGRP) lines 
identified three fipronil resistant strains (A301S + T350S, A301S + T360I and A/S301 
+ M/I360) demonstrating the ability of multiple mutations in the Rdl to cause fipronil 
insensitivity (Remnant et al., 2014).Duplication at the Rdl locus has been described, 
and demonstrated the ability to accrue resistance mutations but maintain wildtype 
functionality in this insecticide target site (Remnant et al., 2013).  
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Source: (Garrood et al., 2017) 
Fig. 5.8 A) Top-view of the RDL GABA-R homo-pentamer (Nl RDL homology model based 
on 3RHW) showing three subunits in yellow, one in green and red, respectively. A301S is 
located in the middle of the M2 transmembrane helices forming the channel pore. Q359E 
is located intracellularly at the end of helix M3 outside the pore region (indicated by an 
arrow). B) Side-view showing two of the RDL subunits and the location of A301S in 
transmembrane pore helix M2, whereas Q359E is located more than 40 Å from this residue 
(the helical structure of the domain is proposed as amino acid positions 337-428 are 
missing in the modelling template 3RHW). Model generated by O. Gutbrod (Bayer 
CropScience). 
 
In the light of these results there are two possible explanations for the 
increase in frequency of the Q359E mutation under ethiprole selection. Firstly, it is a 
random polymorphism that, because of a close proximity to A301S, has hitchhiked to 
high frequency due to the physical linkage (linkage disequilibrium) of the two 
mutations and the adaptive advantage of A301S. Secondly, this mutation, while not 
directly contributing to ethiprole resistance, may have a fitness benefit, to N. lugens 
individuals that carry this mutation in combination with A301S. For example, the 
Q359E mutation might act as a compensatory mutation for A301S as has been 
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recently claimed for the R299Q substitution (see Introduction)..This seems unlikely 
since, A301S has been shown to persist in other insect species at high frequency in 
the absence of insecticide selection (Thompson, Steichen and ffrench-Constant, 
1993), suggesting it may have a minimal fitness penalty. Also, recombinant receptors 
with A301S alone and A301S+Q359E showed the same affinity for the native ligand 
GABA. 
The A301S mutation was one of the first target-site resistance mutations to 
be described in insects and has since appeared in a wide array of different insect 
species (ffrench-Constant, R. H. Anthony et al., 2000). Originally described as the 
primary mechanisms of resistance to cyclodienes, it has also been linked with low 
level cross-resistance to fipronil in Ctenocephalides felis and D. melanogaster (Bass 
et al., 2004; Remnant et al., 2014). The effect of A301S in relation to cyclodiene 
resistance is two-fold, it reduces insecticide binding and destabilises the antagonist 
favoured structure of the RDL channel (Zhang, ffrench-Constant and Jackson, 1994). 
Surprisingly, this mutation has never been previously implicated in ethiprole 
resistance. Fipronil and ethiprole are structurally very similar (Fig. 1.6) and so it is also 
surprising that the A301S mutation can provide such effective resistance against 
ethiprole, but not to the same extent against fipronil.  
The extremely high resistance levels seen in N. lugens strains selected with 
ethiprole, cannot be completely explained by the Rdl A301S mutation. The difference 
between wild-type and A301S RDL receptor constructs in the voltage clamp 
recordings, was not enough to be wholly responsible for the resistance described in 
Chapter III. Therefore, there must be another mechanism of resistance capable of 
Chapter V 
118 
 
causing resistance to ethiprole within the N. lugens populations tested here. One can 
hypothesise that the unknown fipronil resistance mechanism (discussed later) could 
cause cross resistance to ethiprole, and therefore explain the very high levels of 
resistance in these N. lugens strains. 
Zhang et al.’s recent study on R299Q and A301S mutations in the RDL GABA 
receptor and their correlation with fipronil resistance (Y Zhang et al., 2016), has 
similarities with the work discussed in this chapter. The finding of a novel mutation 
existing only in tandem with the A301S mutation is a key finding. However, the new 
mutation they describe (R299Q) appears to increase resistance to fipronil when 
combined with A301S, further than A301S by itself. Although Q359E is a novel 
mutation, it does not have the same direct impact as R299Q. Similar to results 
reported by Zhang et al. the RDL GABA receptor mutations analysed in this current 
study are not the main mechanism of resistance to fipronil in the N. lugens 
populations tested.   
The lack of impact of either of the RDL GABA receptor mutations against 
fipronil led to tests with multiple P450 inhibitors (PBO, 1-ABT and triflumizole) to 
explore if this enzyme system is involved in conferring resistance to this compound. 
In this regard, recent research has used the same approach to implicate metabolic 
mechanisms in resistance to fipronil in N. lugens (Y Zhang et al., 2016). In this current 
study the application of PBO had no noticeable impact on the fipronil resistance of 
the resistant populations, Nl33-eth and Nl55-eth suggesting P450s and/or esterases 
are either not involved in resistance or play a minor role. Further applications with 1-
ABT and triflumizole also had negligible impact on fipronil resistance in the resistant 
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strain, Nl39-eth, strengthening the belief that P450s are not a major driver of fipronil 
resistance. However, Zhang et al. applied a mixture of synergists (PBO, triphenyl 
phosphate and diethyl maleate), so it is possible that other enzyme systems that are 
inhibited by triphenyl phosphate and/or diethyl maleate are involved in resistance 
such as glutathione S-transferases (Y Zhang et al., 2016).  
 Fipronil resistant N. lugens strains were also resistant to a primary metabolite 
of fipronil, fipronil sulfone. Fipronil sulfone also targets the GABA-gated chloride 
channel (Hainzl, Cole and Casida, 1998) and it has been debated whether conversion 
of fipronil to fipronil sulfone is a detoxification process (Zhao et al., 2005). Oxidation 
of fipronil by P450s to fipronil sulfone, has been shown as a detoxifying process, by 
studies showing an increase in fipronil toxicity when pre-treatment with PBO occurs 
(Hainzl and Casida, 1996; Caboni, Sammelson and Casida, 2003). Since the fipronil 
resistant N. lugens strains are also highly resistant to fipronil sulfone compared to a 
unselected field strain (Nl55), there is likely a common resistance mechanism for 
both compounds. Resistance to fipronil sulfone demonstrates that resistance to 
fipronil is not due to downregulation of P450s involved in oxidation of fipronil. 
5.5 Conclusions 
Two mutations (A301S and Q359E) were identified in the Rdl gene of N. 
lugens and assessed for their potential role in resistance to fiproles. The results 
obtained indicate that the common A301S mutation confers resistance to ethiprole, 
a widely-used insecticide for the control of brown planthopper.  However, neither 
this mutation nor the novel mutation Q359E causes significant resistance to fipronil 
based on the in vitro and in vivo studies discussed here. Upregulation of P450s does 
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not appear to play a role in fipronil resistance. Since the A301S mutation cannot fully 
explain the resistance to ethiprole, it is hypothesised that uncharacterised metabolic 
resistance within the N. lugens populations studied here could also provide a 
substantial degree of cross-resistance to ethiprole.  
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Chapter VI Metabolic resistance to neonicotinoids 
and phenylpyrazoles insecticides in N. lugens  
 
Some of the results presented in this chapter have been published in peer reviewed 
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6.1 Introduction 
A variety of mechanisms have been proposed to underlie the widespread 
resistance to neonicotinoids, especially imidacloprid, in N. lugens across Asia. These 
have included both target-site and metabolic mechanisms. The first mechanism 
demonstrated to decrease imidacloprid susceptibility, was a target-site mutation. 
This study was performed before the appearance of widespread control failure in the 
field, and used a laboratory-selected strain of N. lugens. A single point mutation was 
identified (Y151S) at a conserved position in two nAChR subunits, Nlα 1 and Nlα 3, 
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that conferred imidacloprid resistance (Liu et al., 2005). However, this mutation has 
never, to date, been identified in field resistant strains (Gorman et al., 2008; Puinean, 
Denholm, et al., 2010). In contrast, there have been multiple studies indicating that 
heightened cytochrome P450 monooxygenase activity can contribute to 
neonicotinoid resistance in field-collected populations of N. lugens (Liu et al., 2003; 
Wen et al., 2009). The studies of Liu et al and Wen et al primarily used the metabolic 
inhibitor PBO in conjunction with imidacloprid to assess the effect on resistant 
populations. It was seen that there was significant synergism in the resistant strain 
versus the susceptible (2.93 compared to 1.20). Further evidence implicating P450s 
in imidacloprid resistance was provided by Puinean et al, using the artificial substrate, 
7-ethoxycoumarin, to measure P450 activity in N. lugens. Resistant strains displayed 
~5-fold higher levels of total activity when compared to the susceptible strain 
(Puinean et al., 2010).  
However, it was not until 2011-2013 that overexpression of individual P450 
enzymes, CYP6ER1 and CYP6AY1, were proposed as candidates for imidacloprid 
resistance (Bass, Carvalho, et al., 2011; Ding et al., 2013). The first study implicated 
CYP6ER1 after a screen of 32 tentative unique P450s, that had been identified by two 
sequencing projects and degenerate PCR. Using qRT-PCR, expression levels of all 
these P450s was compared between a laboratory susceptible N. lugens strain, and 
moderately and highly resistant populations from China and Thailand, with CYP6ER1 
displaying 40-fold overexpression compared with the susceptible. The resistance of 
the individual populations was significantly correlated with the level of CYP6ER1 
expression (Bass, Carvalho, et al., 2011). CYP6AY1, on the other hand, was seen to be 
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overexpressed, using qRT-PCR, in a laboratory selected strain. This strain underwent 
selection with imidacloprid for 40 generations, and 6 out of 14 P450s assessed 
displayed significant overexpression compared to the susceptible. Of these CYP6AY1 
was the highest at ~18-fold. Further experiments in this study demonstrated that 
CYP6AY1 could metabolise imidacloprid, and RNAi suggested that CYP6AY1 could 
cause resistance to imidacloprid (Ding et al., 2013). 
 Since 2013, multiple studies have been published on CYP6ER1 and CYP6AY1 
to attempt to quantify the potential role of each P450 in imidacloprid resistance in 
N. lugens. Upregulation of CYP6AY1 was suggested to be due to promoter 
polymorphisms which enhanced the promoter activity of a resistant strain versus a 
control strain (Pang et al., 2014). A further study directly comparing CYP6ER1 and 
CYP6AY1 concluded that both were important in imidacloprid resistance, with 
CYP6AY1 the more efficient metaboliser of imidacloprid, but CYP6ER1 upregulated to 
a higher level (Bao et al., 2015). One further study published in 2016 performed a 
functional analysis of CYP6ER1 (Pang et al., 2016). The main findings of this was that 
CYP6ER1 was predominantly expressed in the fat body and midgut, and transgenic 
expression in D. melanogaster causes significant resistance to imidacloprid (Pang et 
al., 2016).  
A novel mechanism of imidacloprid resistance was also proposed in 2015, 
with down regulation of a target site linked to imidacloprid resistance (Y. Zhang et 
al., 2015). There were no mutations linked with resistance, but a reduction in Nlα8 
nAChR subunit protein levels whilst under imidacloprid selection correlated with 
increased resistance to imidacloprid. However, as before the resistance described in 
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the lab-selected strain may not faithfully reflect the primary mechanism of resistance 
in the field which appears to be P450-mediated. 
Chapter V implicated the role of a target-site mutation (A301S) in the RDL 
GABA receptor with ethiprole resistance, but it is thought that this is not the only 
mechanism underlying ethiprole resistance in our N. lugens populations. 
Furthermore, two cytochrome P450s (CYP4DE1 and CYP6CW3v2) have been linked 
with ethiprole resistance in the small brown planthopper (Elzaki, Zhang and Han, 
2015).  
This chapter discusses the potential roles of CYP6ER1 and CYP6AY1 in 
imidacloprid resistance. Multiple lines of evidences are provided for CYP6ER1’s ability 
to provide resistance to imidacloprid in the N. lugens populations that we studied. 
Furthermore, cross-resistance to the phenylpyrazoles is discussed and potential 
metabolic mechanisms in ethiprole resistance are evaluated. The cytochrome P450, 
CYP4DE1, is also assessed for a potential role in phenylpyrazole and neonicotinoid 
resistance.  
6.2 Material and Methods 
6.2.1 Transgenic expression of cytochrome P450 monooxygenases in Drosophila 
melanogaster 
All CYP6ER1 variants, mutant constructs and CYP6AY1 were ordered through 
GeneArt Gene Synthesis (Thermo Fisher, Waltham, MA, USA). CYP4DE1 was PCR 
amplified using primers Nl_DE1_BglII_F and Nl_DE1_Xba1_R (Appendix A, Table A6). 
CYP6ER1vL, CYP6ER1vF and CYP6ER1vA were injected into D. melanogaster by the fly 
facility at the University of Cambridge. All other constructs were ligated into a 
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modified pattB vector. Microinjections were performed as described previously 
(Chapter II, Section 2.19). The PhiC31 system was utilised to transform the clones into 
the germ line of a D. melanogaster strain containing the attP docking site [y w 
M(eGFP, vas-int, dmRFP) ZH-2A; P(CaryP)attp40] (Bischof et al., 2007), at a precise 
chromosomal location on 2L (25C6). Transgenic lines were obtained and balanced 
(#6126, Df(2L) PMA/SM6a). PCR sequencing confirmed integration of transgenes. 
The GAL4/UAS system was used to drive expression of the transgene for the 
bioassays. 
6.2.2 High fidelity PCR 
When high fidelity PCR products were essential a KAPA HiFi PCR kit (KAPA 
Biosystems, Boston, MA, USA) was used. Annealing temperatures for HiFi PCR using 
KAPA are recommended to be between 60-72oC, so primers had to be designed with 
a higher Tm than for standard PCR (Chapter II, section 2.9). A typical HiFi PCR reaction 
(25 µL) contained 5 µL 5X KAPA HIFI buffer, 0.75 µL KAPA dNTP mix, 0.75 µL forward 
primer (10 µM), 0.75 µL reverse primer (10 µM), 2 µL of template cDNA/gDNA and 
made up to 25 µL with sterile distilled water. Cycling conditions were 95oC for 3 min 
(initial denaturation) followed by 25-35 cycles of 98oC for 20 s (denaturation), 60-
72oC for 20 s (annealing), 72oC for 1 min/kb (extension) and a final extension step of 
72oC for 1 min/kb.  
6.2.3 Wiggle index 
The full protocol for the Wiggle Index (WI) is described in the literature 
(Denecke et al., 2015) and a condensed version is presented here. The bioassay is 
broken into several parts. 
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6.2.3.1 Gathering third instar larvae and insecticide dilution 
60 2-5 day old virgin females of line HR-GAL4 (Daborn et al., 2012) were 
crossed to 20 males containing a P450 transgene under the control of a UAS 
promoter. The HR-GAL4 strain drives expression in the midgut, Malpighian tubules 
and fat body when crossed to a strain containing a UAS promoter. Flies were left in 
the vial of maize meal medium for a period of 24 h at 25oC before being transferred 
to a fresh vial. Once cleared of adult flies a vial was left for a further 68 h to allow 
development of a population of 3rd instar larvae. Larvae were harvested from the vial 
by addition of 30 mL of 20% w/v sucrose, and gentle agitation of the top food layer 
to free the larvae. These then float to the top of the solution which is then filtered 
through a fine mesh to recover the larvae, which are then dried and placed on a grape 
agar plate (Flystuff, San Diego, CA, USA). Here larvae (~5mm in length) were picked 
and placed into a cell culture 24 well plate (25 larvae per well). The wells contained 
200 µL 5% w/v sucrose (Chem Supply, Australia). Larvae were dosed with 50 µL of 5X 
insecticide stock solution per well, mixed, and then 50 µL of the solution in the well 
removed. Imidacloprid (200 g L-1 Confidor®, Bayer CropScience) was diluted to 120 
mg L-1 in distilled water to generate the 5X stock solution.  
6.2.3.2 Filming 
Videos (10 s in duration) were taken at 15, 30, 60 and 120 min after the 
addition of imidacloprid and these were then compared to videos taken before 
insecticide addition. Videos captured 4 wells at a time, which were then all processed 
separately in the downstream analysis. Recording was done by placing the plate on 
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an LED light box (Huion, Shenzhen, China) and filming with a Panasonic 3CCD Ultra-
CompactTM Digital Palmcorder® (Panasonic, Kadoma, Japan). 
6.2.3.3 Video processing and analysis 
Videos were converted into jpeg images using Video Jpg Converter 
(DVDVideoSoft), with 250 frames produced per 10 s video. These were then 
processed on a server using the Fiji distribution of ImageJ (Schindelin et al., 2012) to 
run the WI script. A basic summary of this script is that it measures movement per 
well, by assigning values to each pixel’s light intensity over the different time points. 
The precise code and mathematics of this script can be found in (Denecke et al., 
2015).  This script produced WI values which could then be used to formulate relative 
movement ratios (RMR). This was done by dividing a WI value at a certain time point 
by the WI value given for the larvae before the addition on imidacloprid.  
6.3 Results 
6.3.1 General qRT-PCR of CYP6ER1 vs CYP6AY1 
As previously mentioned, there have been two cytochrome P450s implicated 
in imidacloprid resistant N. lugens laboratory and field populations. To assess the 
potential role of both cytochrome P450s, CYP6ER1 and CYP6AY1, in resistance in the 
field, expression levels of these two genes were analysed in a range of N. lugens 
populations (primers, Appendix A, Table A5). 12 field populations were tested, 
sourced from a range of countries in Asia, collected between 2009 and 2012 (Chapter 
II, Table 2.1). These 12 strains were selected due to their obvious resistance to 
imidacloprid, highlighted by their reduced mortality in discriminating dose bioassays 
(Garrood et al., 2016). CYP6ER1 was consistently significantly overexpressed 
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compared to the laboratory susceptible strain (Fig. 6.1). All field populations tested 
demonstrated this overexpression of CYP6ER1, ranging from ten- to 90-fold. This was 
in direct contrast with the expression levels of CYP6AY1, which was downregulated 
in ten of the populations when compared with the laboratory susceptible strain. Only 
one population showed significant overexpression of CYP6AY1 - NL59 (3.5-fold). 
However, the same population demonstrated 71-fold overexpression of CYP6ER1. To 
further investigate the expression of these two genes, and judge whether selection 
with imidacloprid could increase expression of CYP6ER1 or CYP6AY1, two strains 
were put under selection pressure as described previously (Chapter III, Section 3.2.3). 
When the expression level of CYP6ER1 in NL9 (unselected) and NL9-imi (selected) 
were compared there had been a significant increase in expression from ~11-fold to 
33-fold (compared against the reference susceptible strain). In contrast the 
expression level of CYP6AY1 was still downregulated compared to the lab 
susceptible, even if it had increased from 0.24 in NL9 to 0.29 in Nl9-imi. A similar 
result was observed for Nl39 (unselected) and NL39-imi (selected), with an increase 
in CYP6ER1 expression from 43- to 103-fold. Again, CYP6AY1 was not significantly 
overexpressed, only increasing from 0.28 in NL39 to 0.91 in NL39-imi, which was still 
downregulated compared to the lab susceptible. The 95% confidence limits were 
significantly reduced in the selected populations when compared with their 
unselected populations for CYP6ER1 expression levels. 
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Fig. 6.1 Fold change in expression of CYP6ER1 and CYP6AY1 in 14 resistant N. lugens strains 
compared with the susceptible reference Bayer-S as determined by qRT-PCR. Error bars 
display 95% confidence intervals. 
 
Since the values for CYP6AY1 differed remarkably from those previously 
reported (Ding et al., 2013), the primer pair used in that study was also tested. The 
populations in Table 6.1 were retested by qRT-PCR to assess expression of CYP6AY1. 
The result of this concurred with the initial findings (Fig 6.1), with all the populations 
being downregulated when compared with the lab susceptible, including the two 
imidacloprid selected strains. 
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Table 6.1 Fold change in expression of CYP6AY1 in five imidacloprid-resistant N. lugens 
strains compared with the susceptible reference Bayer-S as determined by qRT-PCR.  
Strain Fold Change (2^-∆∆Ct) 95% confidence level 
Bayer-S 1.055 0.451 
Nl9 0.296 0.096 
Nl9-imi 0.203 0.284 
Nl39 0.251 0.062 
Nl39-imi 0.504 0.343 
Nl59 0.783 0.345 
 
6.3.2 Sequencing of CYP6ER1 
Previous sequencing of CYP6ER1 had revealed amino acid substitutions 
between the imidacloprid resistant strains and the susceptible strain (Bass, Carvalho, 
et al., 2011). Resequencing of this gene (primers, Appendix A, Table A6) revealed new 
variants that had not been seen in the previous study performed by Bass et al. The 
sequencing was performed on pools of cDNA from a broad range of N. lugens 
populations. This included populations that had been selected on ethiprole in the 
laboratory up to 100 mg L-1. The result of this was curation of eight unique coding 
sequences seen from the sequencing of CYP6ER1 (Fig. 6.2). CYP6ER1vL is the 
sequence derived from the laboratory susceptible strain, and is displayed here as the 
reference sequence. CYP6ER1vF was originally seen in the Nl9 population, the 
imidacloprid resistant population previously that displayed overexpression of 
CYP6ER1 (Bass, Carvalho, et al., 2011). The remaining six variants; CYP6ER1vA, 
CYP6ER1vB, CYP6ER1vC, CYP6ER1vD1, CYP6ER1vD2 and CYP6ER1vE were new 
variants that had not previously been seen. Two of these variants showed a 
particularly profound alteration, both CYP6ER1vA and CYP6ER1vB, differed from the 
other variants in that they have a 3bp deletion resulting in the deletion of a single 
amino acid as well as multiple other substitutions. For CYP6ER1vA this deletion 
Chapter VI 
131 
 
occurs at AA 375 (alanine), and is immediately followed by an additional amino acid 
substitution, A376G. This deletion and substitution is in the predicted 5th substrate 
recognition site (SRS-5). CYP6ER1vB also contains a deletion in SRS-5, however is at 
377 (proline) and has no substitution at 376. 
 
Fig. 6.2 Amino acid alignment of the CYP6ER1 gene sequence from the laboratory 
susceptible and imidacloprid resistant N. lugens strains. Dots represent identical residues. 
Deletions are represented by dashes and substitutions are highlighted. Conserved domains 
to cytochrome P450 monooxygenases are indicated (oxygen binding motif and the heme-
binding motif). The proposed substrate recognition sites (SRSs) are also marked. 
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6.3.3 Variant specific qRT-PCR of CYP6ER1 
Since the qRT-PCR analysis displayed in Fig. 6.1 was using a generic primer 
pair for CYP6ER1, it only gave information on overexpression of the predominant 
CYP6ER1 variant expressed in each strain of N. lugens tested. The sequencing of 
CYP6ER1 demonstrated that there were far more variants than previously thought in 
the N. lugens populations (Fig. 6.2). However, expression of each individual variant 
had not been analysed at this point. To address this primer pairs were designed that 
were specific to a CYP6ER1 variant (Appendix A, Table A7 and Fig. A1), and qRT-PCR 
was performed. This was performed for ten N. lugens populations and the laboratory 
susceptible as a reference (Fig. 6.3). The qRT-PCR results are displayed as 1/∆Ct. It 
was not possible to calculate 2^-∆∆Ct values, because some of the variants were not 
expressed in the reference strain (Bayer-S). The 1/∆Ct values allow a comparison of 
which CYP6ER1 variants are most expressed in the resistant strains. The first 
observation from the qRT-PCR is that despite there being eight sequenced variants 
of CYP6ER1, only two of these are commonly highly expressed in the N. lugens field 
populations sampled. These two variants are CYP6ER1vA and CYP6ER1vB, the two 
variants with the AA deletion in SRS-5. Nl9 and Nl9-imi showed low levels of 
expression of CYP6ER1vF, but significantly higher expression of CYP6ER1vA in 
comparison. Similarly, Nl39 and Nl39-imi both showed greater expression of 
CYP6ER1vA than any other CYP6ER1 variant. As with the previous qRT-PCR (Section 
6.3.1), there were higher levels of expression of CYP6ER1 (CYP6ER1vA in this case) in 
the imidacloprid selected populations compared to their unselected counterparts. 
Interestingly this phenomenon was also seen when comparing ethiprole selected 
populations with their unselected populations (Nl33 vs Nl33-eth/Nl39 vs Nl39-eth). 
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Nl55 and Nl55-eth differed from the other populations in that they over-expressed 
CYP6ER1vB, rather than CYP6ER1vA.  
Each resistant N. lugens population only significantly expresses one of the 
main CYP6ER1 variants, since there are no populations that significantly express both 
CYP6ER1vA and CYP6ER1vB. Furthermore, the expression of CYP6ER1vA or 
CYP6ER1vB can be linked to geographical location. CYP6ER1vB was seen in Nl55 
(India) and analysis of another Indian population (Nl59) revealed it also expressed 
CYP6ER1vB. In contrast CYP6ER1vA was seen in populations from Thailand (Nl9) and 
Vietnam (Nl33 and Nl39).  
 
Fig. 6.3 1/∆Ct values of CYP6ER1 variants in ten imidacloprid and ethiprole resistant strains 
and the laboratory susceptible as determined by qRT-PCR. 
 
6.3.4 RNA-seq read mapping to CYP6ER1 variants 
To further explore which CYP6ER1 variants were seen in which N. lugens populations 
the RNA-seq reads described in Chapter IV were mapped back to variant-specific 
CYP6ER1 fragments of sequence. The reads that aligned to CYP6ER1vF were so 
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limited (Table 6.2) that it is probable that this variant is not being expressed in any of 
these populations, supporting results seen in the qRT-PCR (Section 6.3.3). The 
findings for CYP6ER1vA and CYP6ER1vB also agree with the trend seen in the qRT-
PCR. Nl33 and Nl33-eth aligned significantly only to the CYP6ER1vA fragment, with 
some reads in the Nl55 and Nl55-eth populations aligning to this fragment also. 
However, the number of reads aligning to CYP6ER1vB for Nl55 and Nl55-eth was far 
higher than for the CYP6ER1vA.  
Table 6.2 RNA-seq reads aligned to CYP6ER1 variants. 
  Reads aligned 
Variant Bayer-S Nl33 Nl33-eth Nl55 Nl55-eth 
CYP6ER1vL 644 0 0 3 0 
CYP6ER1vF 53 3 1 11 2 
CYP6ER1vA 15 5016 15594 856 435 
CYP6ER1vB 11 24 18 16659 12045 
 
6.3.5 D. melanogaster bioassays of CYP6ER1 variants and CYP6AY1 strains 
Functional expression of CYP6ER1 variants was performed to analyse whether 
there was a qualitative effect as well as the quantitative effect demonstrated in the 
qRT-PCR studies. The CYP6ER1 variants tested were CYP6ER1vL, CYP6ER1vF, 
CYP6ER1vA, CYP6ER1vB and CYP6ER1vC. The remaining variants (CYP6ER1vD1, 
CYP6ER1vD2 and CYP6ER1vE) were rejected for functional analysis since there was 
no noticeable expression of any of these three variants in the qRT-PCR analysis 
compared to the susceptible strain. CYP6AY1 was also included in the functional 
analysis, to assess whether it could have any impact on insecticide resistance.  
Against imidacloprid (Fig 6.4 andTable 6.3), there was a significant difference 
in resistance across the variants tested.  CYP6ER1vA and CYP6ER1vB had similar LC50s 
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of 608 and 579 respectively, which equated to a RR of ~4.5 against the control strain. 
CYP6ER1vF also showed partial resistance, with a RR of 2.55 at LC50. However, 
CYP6AY1 was only marginally more resistant than the control strain (RR 1.7), as was 
CYP6ER1vC (RR 1.2). The variant from the susceptible (Bayer-S), CYP6ER1vL was much 
lower than the control (RR 0.4).   
Fig 6.4 Resistance ratios for D. melanogaster strains against imidacloprid  
Table 6.3 Log-concentration probit mortality data for imidacloprid against D. melanogaster 
strains containing CYP6ER1 variants or CYP6AY1. 
          Resistance Ratio 
Compound Strain 
LC50 
[mg/L-1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Imidacloprid 
Control 135 36-330 0.888 ± 0.167 1.0 2.5 
CYP6ER1vL 53.1 31.4-82.6 1.864 ± 0.328 0.4 1.0 
CYP6ER1vF 344 275.6-431 2.164 ± 0.187 2.5 6.5 
CYP6ER1vA 608 333-1111 1.721 ± 0.306 4.5 11.5 
CYP6ER1vB 579 439-761 2.416 ± 0.823 4.3 10.9 
CYP6ER1vC 168.4 82.6-339 2.046 ± 0.474 1.2 3.2 
CYP6AY1 223.6 135.4-366 1.846 ± 0.297 1.7 4.2 
 
Thiacloprid testing revealed only one strain showing a significantly high RR at LC50, 
which was CYP6ER1vB at 3.82 (Fig. 6.5 and Table 6.4). CYP6ER1vA was only slightly 
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more resistant than the control (RR 1.58). All other strains displayed no resistance 
compared to the control at all. 
 
Fig. 6.5 Resistance ratios for D. melanogaster strains against thiacloprid 
Table 6.4 Log-concentration probit mortality data for thiacloprid against D. melanogaster 
containing CYP6ER1 variants or CYP6AY1. 
          Resistance Ratio 
Compound Strain 
LC50 [mg/L-
1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Thiacloprid 
Control 553 358-824 2.153 ± 0.366 1.0 1.2 
CYP6ER1vL 442.6 nc 6.4 ± 16.2 0.8 1.0 
CYP6ER1vF 216 110-398 1.154 ± 0.174 0.4 0.5 
CYP6ER1vA 871 677-1122 2.069 ± 0.194 1.6 2.0 
CYP6ER1vB 2115 1420-3174 2.056 ± 0.304 3.8 4.8 
CYP6ER1vC 360 116-987 1.303 ± 0.319 0.7 0.8 
CYP6AY1 438 287-664 1.826 ± 0.246 0.8 1.0 
 
The response to nitenpyram (Fig. 6.6 and Table 6.5) was different from that 
of imidacloprid and thiacloprid, with strain CYP6ER1vL showing the highest LC50 (446, 
RR 2.6). Strain CYP6ER1vA had an LC50 of 457, however the lack of 95% confidence 
limits undermines the reliability of the LC50. When there is large variation between 
the biological replicates it is not always possible to formulate 95% confidence limits 
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in probit analysis. Also, if there is a large change in mortality between two 
concentrations (taking the response far from the linear relationship expected) then 
95% confidence limits will be incalculable. Of the other strains CYP6ER1vB, 
CYP6ER1vC and CYP6AY1 all had similar LC50, but CYP6ER1vF had no significant 
resistance. 
Strains CYP6ER1vA and CYP6ER1vB showed resistance to clothianidin, RRs of 
5.1 and 4.3 at LC50 respectively. CYP6AY1 and CYP6ER1vL also demonstrated some 
resistance (RR 3 and 2.8 at LC50), but CYP6ER1vF showed no resistance compared to 
the control. Dinotefuran testing demonstrated no strain displaying high resistance. 
CYP6ER1vL had the highest RR of 2 at LC50. Thiamethoxam saw a similar trend to 
clothianidin, with CYP6ER1vA having the highest RR at 5.9 at LC50, followed by 
CYP6ER1vB (RR 3.4) and CYP6ER1vL (RR 3.3). Acetamiprid was unique, in that no 
strain displayed any resistance, all having LC50s below that of the control strain. 
 
Fig. 6.6 Resistance ratios for D. melanogaster strains against the other neonicotinoids 
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Table 6.5 Log-concentration probit mortality data for other neonicotinoids against D. 
melanogaster containing CYP6ER1 variants or CYP6AY1. 
 
 
          Resistance Ratio 
Compound Strain 
LC50 
[mg/L-
1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Nitenpyram 
Control 171 142.2-206.2 5.322 ± 0.923 1.0 0.4 
CYP6ER1vL 446.1 370.4-537.5 5.389 ± 0.929 2.6 1.0 
CYP6ER1vF 205.3 120-337 2.962 ± 0.738 1.2 0.5 
CYP6ER1vA 457.8 nc 0 2.7 1.0 
CYP6ER1vB 417.3 287.9-602 3.555 ± 0.756 2.4 0.9 
CYP6ER1vC 405.5 280.8-586 3.56 ± 0.754 2.4 0.9 
CYP6AY1 366.1 293-457 3.925 ± 0.588 2.1 0.8 
Clothianidin 
Control 5.07 nc 8.2 ± 13.8 1.0 0.4 
CYP6ER1vL 14.05 nc 8.4 ± 16.2 2.8 1.0 
CYP6ER1vF 6.02 5.3-6.9 3.516 ± 0.324 1.2 0.4 
CYP6ER1vA 26.02 nc 7.1 ± 11.6 5.1 1.9 
CYP6ER1vB 21.66 nc 7.3 ± 10.5 4.3 1.5 
CYP6ER1vC 9.54 5.9-15.2 3.44 ± 0.801 1.9 0.7 
CYP6AY1 15.48 10-23.7 2.254 ± 0.39 3.1 1.1 
Dinotefuran 
Control 22.32 nc 7.1 ± 13.8 1.0 0.5 
CYP6ER1vL 44.72 37.4-53.5 5.247 ± 0.527 2.0 1.0 
CYP6ER1vF 21.66 nc 7.3 ± 10.5 1.0 0.5 
CYP6ER1vA 41.27 35.2-48.8 4.771 ± 0.446 1.8 0.9 
CYP6ER1vB 35.72 31.9-40.1 3.38 ± 0.22 1.6 0.8 
CYP6ER1vC 28.77 nc 8.1 ± 11.3 1.3 0.6 
CYP6AY1 29.71 nc 8.7 ± 14.2 1.3 0.7 
Thiamethoxam 
Control 9.69 8.2-11.4 4.771 ± 0.445 1.0 0.3 
CYP6ER1vL 31.63 26.3-38.4 3.689 ± 0.435 3.3 1.0 
CYP6ER1vF 15.42 nc 7.4 ± 12.2 1.6 0.5 
CYP6ER1vA 56.7 32.8-97.9 2.181 ± 0.431 5.9 1.8 
CYP6ER1vB 33.2 28.5-39.1 3.839 ± 0.379 3.4 1.0 
CYP6ER1vC 23.56 nc 7.4 ± 11.7 2.4 0.7 
CYP6AY1 16.4 12.9-20.9 2.436 ± 0.26 1.7 0.5 
Acetamiprid 
Control 131 nc 7.2 ± 11 1.0 2.7 
CYP6ER1vL 47.9 21.4-129 2.368 ± 0.686 0.4 1.0 
CYP6ER1vF 121.6 94-149.9 2.99 ± 0.374 0.9 2.5 
CYP6ER1vA 122 nc 7.2 ± 12.6 0.9 2.5 
CYP6ER1vB 63.92 nc 9.4 ± 14.1 0.5 1.3 
CYP6ER1vC 93.5 67.5-129.3 3.038 ± 0.525 0.7 2.0 
CYP6AY1 41.27 33.4-51.7 4.771 ± 0.588 0.3 0.9 
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Since it was seen that selection with ethiprole could cause CYP6ER1 
expression to increase compared to an unselected population, it was decided to test 
the CYP6ER1 variants and CYP6AY1 against the fiproles. In the ethiprole bioassay (Fig. 
6.7), CYP6ER1vA showed high resistance (RR 6.9), whereas all the other CYP6ER1 
variants had LC50s below that of the control strain (Table 6.6). CYP6AY1 had a RR of 
1.8 at LC50, however this was still ~4-fold lower than that seen by CYP6ER1vA.  
 
Fig. 6.7 Resistance ratios for D. melanogaster strains against ethiprole 
Table 6.6 Log-concentration probit mortality data for ethiprole against D. melanogaster 
containing CYP6ER1 variants or CYP6AY1. 
     Resistance Ratio 
Compound Strain 
LC50 
[mg/L-1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Ethiprole 
Control 53.1 24.3-110 1.325 ± 0.245 1.0 2.2 
CYP6ER1vL 23.9 11.3-42.1 1.452 ± 0.244 0.5 1.0 
CYP6ER1vF 37.61 33.2-42.7 3.546 ± 0.257 0.7 1.6 
CYP6ER1vA 369 11.7-1115 1.431 ± 0.542 6.9 15.4 
CYP6ER1vB 44.39 36.7-53.6 3.181 ± 0.32 0.8 1.9 
CYP6ER1vC 37.4 25.8-54 2.007 ± 0.265 0.7 1.6 
CYP6AY1 94.9 68.7-131.1 2.387 ± 0.319 1.8 4.0 
 
In comparison, none of the strains demonstrated any resistance against 
fipronil (Fig. 6.8 and Table 6.7). It was not possible to calculate an LC50 for CYP6ER1vA, 
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since it saw full mortality at all tested doses of fipronil. There was also considerable 
difference in the lethality between ethiprole and fipronil, fipronil producing a far 
lower LC50 for the controlled compared to ethiprole, 2.695 vs 53.1 respectively. 
 
Fig. 6.8 Resistance ratios for D. melanogaster strains against fipronil 
Table 6.7 Log-concentration probit mortality data for fipronil against D. melanogaster 
containing CYP6ER1 variants or CYP6AY1. 
          Resistance Ratio 
Compound Strain 
LC50 
[mg/L-
1] 
95% CL Slope (± SD) To Control 
To 
CYP6ER1vL 
Fipronil 
Control 2.695 nc 4.9 ± 13.3 1.0 9.0 
CYP6ER1vL 0.299 0.002-1.07 1.068 ± 0.304 0.1 1.0 
CYP6ER1vF 1.441 nc 4.1 ± 12.9 0.5 4.8 
CYP6ER1vA Nc nc nc nc nc 
CYP6ER1vB 2.638 nc 5.3 ± 11.1 1.0 8.8 
CYP6AY1 3.371 nc 5.8 ± 12.4 1.3 11.3 
 
6.3.6 Wiggle index bioassays 
The CYP6ER1 variants and CYP6AY1 were overexpressed in the midgut, 
Malpighian tubules and fat body and tested with 24 mg L-1 imidacloprid. A line that 
overexpressed CYP6ER1vA showed significantly less response to imidacloprid than 
compared to a line overexpressing CYP6ER1vL (Fig 6.9).  
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Fig. 6.9 Response curves for CYP6ER1vA and CYP6ER1vL after treatment with 24 mg L-1 
imidacloprid. Points represent mean RMR values with 95% confidence intervals. 
In comparison a line overexpressing CYP6AY1 was only significantly different 
from the CYP6ER1vL line at one timepoint (60 min). At all other timepoints it 
overlapped with the CYP6ER1vL line in its response to imidacloprid (Fig. 6.10).  
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Fig. 6.10 Response curves for CYP6AY1 and CYP6ER1 vS after treatment with 24 mg L-1 
imidacloprid. Points represent mean RMR values with 95% confidence intervals. 
 
In contrast to the previous wiggle indexes (Fig. 6.9 and Fig. 6.10) the final 
wiggle index bioassay did not give a clear trend. For previously discussed wiggle 
indexes there was a large drop in RMR between the 0 and 15 min time points. 
However, this was not seen for the bioassay involving CYP6ER1vB, CYP6ER1vF and 
CYP6ER1vL (Fig. 6.11). CYP6ER1vL took significantly longer to see a reduction in 
movement after imidacloprid exposure, and its final RMR is approximately three-fold 
higher than previous bioassays. Likewise, CYP6ER1vB and CYP6ER1vF appear broadly 
unaffected by the addition of imidacloprid, with the RMR at 120 min being near to 
that of 0 min. It would appear something went wrong with this bioassay run and so 
is difficult to state whether there is a significant difference between CYP6ER1vB and 
CYP6ER1vF compared to the susceptible line here.  
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Fig. 6.11 Response curves for CYP6ER1vB, CYP6ER1vF and CYP6ER1vL after treatment with 
24 mg L-1 imidacloprid. Points represent mean RMR values with 95% confidence intervals. 
 
6.3.7 Locomotor activity level monitoring with imidacloprid and ethiprole 
Five strains (CYP6ER1vL, CYP6ER1vF, CYP6ER1vA, CYP6ER1vB and CYP6AY1) were 
tested further using locomotor activity monitoring, to assess resistance to 
imidacloprid and ethiprole. CYP6ER1vL, CYP6ER1vF and CYP6ER1vB all showed a 
reduction in activity and no longer followed the profiles of their respective controls 
when exposed to imdiacloprid (Fig. 6.12). However, CYP6ER1vA showed a similar 
profile to its control displaying that this strain was not adversly affected by 
imidacloprid, as shown in the wiggle index and fly mortality bioassays. CYP6AY1 was 
also able to maintain activity levels similar to the control, but to a lesser extent than 
seen for CYP6ER1vA.  
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Fig. 6.12 Locomotor activity of CYP6ER1 variants and CYP6AY1 when exposed to 100 mg L-
1 imidacloprid. Time displays the number of hours the flies have been on the imidacloprid 
treated food. Locomotor activity displayed is the average movement recorded for each of 
the 5 min sections within a given hour. 
 
When four CYP6ER1 variants were exposed to ethiprole there was a significant 
difference in locomotor activity displayed. CYP6ER1vL and CYP6ER1vF were both 
disrupted and within 40 hours both strains displayed no movement, whilst their 
respective controls were still active. CYP6ER1vA, the only strain to display resistance 
to ethiprole in the fly mortality bioassays, again showed an ability to survive ethiprole 
exposure (Fig. 6.13). This strain broadly tracks the profile of it’s control and at no 
point is there zero movement recorded. Surprisingly CYP6ER1vB also showed 
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resistance to ethiprole, and was able to remain active throughout the 72 h recording 
period.  
 
Fig. 6.13 Locomotor activity of CYP6ER1 variants when exposed to 1000 mg L-1 ethiprole. 
Time displays the number of hours that the flies have been on the ethiprole coated food. 
Locomotor activity displayed is the average movement recorded for each of the 5 min 
sections within a given hour. 
 
6.3.8 Mutant CYP6ER1 constructs and D. melanogaster bioassays 
The results of the variant specific qRT-PCR and D. melanogaster bioassays 
showed that CYP6ER1vA and CYP6ER1vB are the key resistance conferring variants. 
The coding sequence of these genes were analysed by mapping known important 
conserved P450 motifs and substrate recognition sites in order to predict which AA 
substitutions/deletions are likely to confer resistance to imidacloprid. This suggested 
the deletions/substitutions occurring in SRS-5 and a further T to S change in the SRS-
4 which was only seen in CYP6ER1vA and CYP6ER1vB were strong candidates as gain-
of-function mutations. To test this, mutant constructs were created that introduced 
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various combinations of the deletions/substitutions of predicted importance in 
imidacloprid resistance. The alterations were made to CYP6ER1vL, which had shown 
far lower resistance to imidacloprid in the preceding D. melanogaster insecticide 
bioassays. The five constructs created are shown (Fig. 6.14), in comparison with the 
CYP6ER1vL, CYP6ER1vA and CYP6ER1vB sequences. 
 
Fig. 6.14 Amino acid alignment highlighting the mutant constructs created with the 
mutations introduced to CYP6ER1vL. 
The constructs generated (Fig. 6.14) were injected into D. melanogaster and 
bioassays were performed with seven neonicotinoids and ethiprole, with the help of 
a postdoctoral scientist and technician. Of the seven neonicotinoids used, the 
response to imidacloprid was the most striking. Three of the strains produced near 
identical LC50 values and gave RRs of 20-fold against CYP6ER1vL strain (Table 6.8). 
These were ER1vL_S_AA (CYP6ER1vB-like), ER1vL_S (serine substitution in SRS-4 
only, no other mutations) and ER1vL_T_GP (No serine substitution in SRS-4, 
CYP6ER1vA deletion and substitution in SRS-5). Of the two remaining mutant 
constructs, ER1vL_T_AA (no serine substitution in SRS-4, CYP6ER1vB deletion in SRS-
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5) had a lower RR at LC50 of 4.5, whereas ER1vL_S_GP (CYP6ER1vA-like) had a very 
high RR at LC50 of 35.  
For thiacloprid there was a lower level of resistance, compared to 
imidacloprid, for all the mutant constructs (Fig. 6.15 and Table 6.9). ER1vL_S_AA and 
ER1vL_T_AA had LC50s near identical to each other, whereas the most resistant strain 
against imidacloprid, ER1vl_S_GP, had lower resistance than CYP6ER1vL. The 
remaining two constructs, ER1vL_S and ER1vL_T_GP displayed very slight levels of 
resistance with RRs at LC50 of 1.8-fold against the CYP6ER1vL strain.  
For nitenpyram, clothianidin, dinotefuran and thiamethoxam (Table 6.10) 
none of the mutant constructs showed significant resistance, with all strains having 
RR at LC50 below 2-fold against CYP6ER1vL. For acetamiprid ER1vL_T_GP had a RR at 
LC50 of 3.3, showing low resistance, in contrast to the other mutant constructs that 
did not demonstrate such resistance.  
 
 
Fig. 6.15 Resistance ratios for D. melanogaster strains against imidacloprid 
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Table 6.8 Log-concentration probit mortality data for imidacloprid against D. melanogaster 
strains containing CYP6ER1 mutants. 
          Resistance Ratio 
Compound Strain 
LC50 [mg/L-
1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Imidacloprid 
Control  111.1 45-233 1.373 ± 0.287 1.0 2.1 
CYP6ER1vL 53.1 31.4-82.6 1.864 ± 0.328 0.4 1.0 
ER1vL_S 1062 531-2292 1.103 ± 0.183 9.6 20.0 
ER1vL_S_AA 1063 442-2680 1.54 ± 0.356 9.6 20.0 
ER1vL_S_GP 1857 905-4229 1.448 ± 0.293 16.7 35.0 
ER1vL_T_AA 237 101.4-520 1.324 ± 0.262 2.1 4.5 
ER1vL_T_GP 1062 752-1501 2.082 ± 0.264 9.6 20.0 
 
 
 
Fig 6.16 Resistance ratios for D. melanogaster strains against thiacloprid 
 
Table 6.9 Log-concentration probit mortality data for thiacloprid against D. melanogaster 
strains containing CYP6ER1 mutants. 
          Resistance Ratio 
Compound Strain 
LC50 [mg/L-
1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Thiacloprid 
Control  198 6-1199 0.71 ± 0.248 1.0 0.4 
CYP6ER1vL 442.6 nc 6.4 ± 16.2 0.8 1.0 
ER1vL_S 781 381-1651 1.284 ± 0.227 3.9 1.8 
ER1vL_S_AA 201 132.6-302 1.642 ± 0.204 1.0 0.5 
ER1vL_S_GP 414 nc 0.754 ± 0.284 2.1 0.9 
ER1vL_T_AA 203 82-426 1.264 ± 0.224 1.0 0.5 
ER1vL_T_GP 814 348-1628 2.051 ± 0.477 4.1 1.8 
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Fig. 6.17 Resistance ratios for D. melanogaster strains against other neonicotinoids 
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Table 6.10 Log-concentration probit mortality data for other neonicotinoids against D. melanogaster strains containing CYP6ER1 mutants. 
          Resistance Ratio 
Compound Strain LC50 [mg/L-1] 95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Nitenpyram 
Control 362.3 nc 12.2 ± 22 1.0 0.8 
CYP6ER1vL 446.1 370.4-537.5 5.389 ± 0.929 2.6 1.0 
ER1vL_S 575.3 471.2-694 4.566 ± 0.647 1.6 1.3 
ER1vL_S_AA nt nt nt nt nt 
ER1vL_S_GP 632.5 582.1-687 6.452 ± 0.527 1.7 1.4 
ER1vL_T_AA 202.4 141.2-287.7 4.23 ± 0.986 0.6 0.5 
ER1vL_T_GP 176 128.7-238.6 3.612 ± 0.691 0.5 0.4 
Clothianidin 
Control 15.4 nc 8.5 ± 11.4 1.0 1.1 
CYP6ER1vL 14.05 nc 8.4 ± 16.2 2.8 1.0 
ER1vL_S 20.4 16.8-24.8 3.041 ± 0.322 1.3 1.5 
ER1vL_S_AA 14.6 nc 8.1 ± 13.4 0.9 1.0 
ER1vL_S_GP 18.4 nc 7 ± 10.9 1.2 1.3 
ER1vL_T_AA 16.85 12.1-23.4 3.147 ± 0.571 1.1 1.2 
ER1vL_T_GP 17.43 nc 7.22 ± 9.74 1.1 1.2 
Dinotefuran 
Control 34.83 23.6-52.5 3.499 ± 0.737 1.0 0.8 
CYP6ER1vL 44.72 37.4-53.5 5.247 ± 0.527 2.0 1.0 
ER1vL_S 28.39 nc 8.4 ± 11.5 0.8 0.6 
ER1vL_S_AA 24.64 nc 6.9 ± 13.7 0.7 0.6 
ER1vL_S_GP 38.17 26.3-55.4 2.76 ± 0.477 1.1 0.9 
ER1vL_T_AA 31.64 nc 9.2 ± 9.8 0.9 0.7 
ER1vL_T_GP 14.34 9-22.7 2.86 ± 0.617 0.4 0.3 
  
 
Thiamethoxam 
Control 18.92 nc 6.9 ± 13.6 1.0 0.6 
CYP6ER1vL 31.63 26.3-38.4 3.689 ± 0.435 3.3 1.0 
ER1vL_S 24.35 15.6-37.8 2.629 ± 0.507 1.3 0.8 
ER1vL_S_AA 21.06 nc 7.51 ± 9.56 1.1 0.7 
ER1vL_S_GP 28.74 23.6-35.2 3.444 ± 0.422 1.5 0.9 
ER1vL_T_AA 20 nc 6.6 ± 10.9 1.1 0.6 
ER1vL_T_GP 17.33 nc 6.9 ± 10.3 0.9 0.5 
Acetamiprid 
Control 56 48.1-65.1 3.38 ± 0.29 1.0 1.2 
CYP6ER1vL 47.9 21.4-129 2.368 ± 0.686 0.4 1.0 
ER1vL_S 73.6 48.5-110.7 3.148 ± 0.672 1.3 1.5 
ER1vL_S_AA 97.5 nc 7.6 ± 13.6 1.7 2.0 
ER1vL_S_GP 107.9 78.2-148.9 3.075 ± 0.535 1.9 2.3 
ER1vL_T_AA 28.74 23.6-35.2 3.444 ± 0.422 0.5 0.6 
ER1vL_T_GP 158.1 131.7-192.1 3.689 +0.434 2.8 3.3 
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The final bioassay with ethiprole (Table 6.11) showed two strains (ER1vL_S 
and ER1vl_S_AA) with moderate resistance to ethiprole. This was surprising since 
ER1vL_S_AA is most like CYP6ER1vB, which did not show significant resistance to 
ethiprole in the fly mortality bioassays (Table 6.6). However, CYP6ER1vB did 
demonstrate an ability to survive ethiprole in the locomotor activity assays compared 
to CYP6ER1vL, which correlates with our finding here (Table 6.11).  
 In contrast the construct most like CYP6ER1vA, ER1vL_S_GP, did not show 
any resistance to ethiprole, whereas CYP6ER1vA had shown significant resistance to 
ethiprole in both the fly mortality bioassay and the locomotor activity assay. Fipronil 
was not tested since none of the original CYP6ER1 variants displayed any resistance 
against this compound. 
 
Fig. 6.18 Resistance ratios for D. melanogaster strains against ethiprole 
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Table 6.11 Log-concentration probit mortality data for ethiprole against D. melanogaster 
strains containing CYP6ER1 mutants. 
          Resistance Ratio 
Compound Strain 
LC50 [mg/L-
1] 
95% CL Slope (± SD) 
To 
Control 
To 
CYP6ER1vL 
Ethiprole 
Control 74.8 45.4-122.9 2.103 ± 0.37 1.0 3.1 
CYP6ER1vL 23.9 11.26-42.1 1.452 ± 0.244 0.5 1.0 
ER1vL_S_AA 107.9 67.7-172 2.031 ± 0.328 1.4 4.5 
ER1vL_S 117.4 nc 7.5 ± 14.5 1.6 4.9 
ER1vL_S_GP 17.46 9.25-31.5 1.979 ± 0.418 0.2 0.7 
ER1vL_T_AA 69.5 53.8-89.9 2.317 ± 0.244 0.9 2.9 
ER1vL_T_GP 27.39 20.82-36 2.283 ± 0.254 0.4 1.1 
 
6.3.9 CYP4DE1 sequencing 
Two cytochrome P450s were linked with ethiprole resistance in the small 
brown planthopper (Elzaki, Zhang and Han, 2015), and these were assessed for their 
potential to cause ethiprole resistance in N. lugens. CYP4DE1 could be assembled 
using the transcriptome generated from the RNA-Seq done in this PhD. The other 
gene, CYP6CW3v2 could not be found or assembled, and so no further analysis was 
performed on this gene. A subsequent study by Lao et al, also assembled the 
CYP4DE1 gene, and submitted it to NCBI (accession no KM217042.1), (Lao et al., 
2015). There were no AA substitutions/deletions between the Bayer-S population 
and any of the ethiprole resistant populations for CYP4DE1, in contrast with the 
variation seen previously with CYP6ER1. 
6.3.10 CYP4DE1 qRT-PCR 
qRT-PCR analysis for CYP4DE1 was done on six N. lugens populations, 
including three populations that had undergone laboratory selection with ethiprole. 
The overexpression of CYP4DE1 is shown (Fig. 6.19), using Bayer-S as the reference 
strain. All populations overexpressed CYP4DE1 compared to Bayer-S, with 
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overexpression ranging from 4.05 to 8.52-fold. Unlike with CYP6ER1, where 
insecticide selection caused an increase in expression, this was not the case for 
CYP4DE1. The ethiprole selected populations were not significantly higher than their 
unselected counterparts. For two of the populations, Nl39-eth and Nl55-eth, their 
expression values were lower than their unselected populations, Nl39 and Nl55. 
 
Fig. 6.19 Fold change in expression of CYP4DE1 in six ethiprole resistant N. lugens strains 
compared with the laboratory susceptible reference Bayer-S as determined by qRT-PCR. 
Error bars display 95% confidence intervals. 
 
6.3.11 CYP4DE1 D. melanogaster bioassays 
 The CYP4DE1 gene was injected into D. melanogaster using the same 
methodology as described previously. The strain created was then tested against two 
fiproles and two neonicotinoids (Table 6.12). For ethiprole there was high resistance 
displayed, with a RR at LC50 of 4.37. As with CYP6ER1vA, the high resistance to 
ethiprole did not coincide with resistance to fipronil. It was not possible to calculate 
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an LC50 for fipronil, since there was full mortality at all doses tested. For the 
neonicotinoid testing, the response to imidacloprid and thiacloprid was similar with 
RRs at LC50 of ~2-fold. So CYP4DE1 displayed slight resistance to these two 
neonicotinoids, but was below that seen by CYP6ER1vA and CYP6ER1vB.  
 
 
Table 6.12 Log-dose probit mortality data for neonicotinoids and fiproles against D. 
melanogaster strains . 
Compound Strain LC50 [mg/L-1] 95% CL Slope (± SD) 
Resistance 
ratio 
Ethiprole 
Control 89 51.6-153 1.491 ± 0.219 1.0 
CYP4DE1 389 247.1-616 2.276 ± 0.403 4.4 
Fipronil 
Control 2.722 2.38-3.03 5.648 ± 0.452 1.0 
CYP4DE1 Nc nc nc nc 
Imidacloprid 
Control 445 267-739 1.473 ± 0.202 1.0 
CYP4DE1 884 549-1445 1.405 ± 0.18 2.0 
Thiacloprid 
Control 321 88-828 1.117 ± 0.269 1.0 
CYP4DE1 598 219-1675 1.011 ± 0.216 1.9 
 
 
6.4 Discussion 
The widespread use of imidacloprid since the mid-1990s as a control agent 
for N. lugens has led to high levels of resistance being seen across Asia. Given that 
resistance was first seen in 2003 (Matsumura et al., 2008), many mechanisms of 
resistance to imidacloprid have since been proposed. The aim of this chapter was to 
evaluate the numerous proposed mechanisms of resistance to imidacloprid, and see 
if any of these mechanisms provided cross-resistance to other neonicotinoids. The 
metabolic mechanisms were also assessed for potential cross-resistance to fiproles, 
and a P450 previously linked with ethiprole resistance was also assessed.  
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The enhanced production of cytochrome P450 monooxygenases is a common 
route of resistance to neonicotinoids in insect pests (Karunker et al., 2008; Puinean, 
Foster, et al., 2010), and resistance to neonicotinoids in N. lugens has long been 
linked to enhanced detoxification mediated by P450s (Liu et al., 2005; Nauen and 
Denholm, 2005; Wen et al., 2009). In N. lugens two P450 enzymes have been linked 
to imidacloprid resistance through over-expression; CYP6ER1 (Bass, Carvalho, et al., 
2011) and CYP6AY1 (Ding et al., 2013). Of the 12 resistant populations tested for 
these two genes I found that CYP6ER1 was significantly overexpressed in all of them, 
compared to the susceptible reference strain. Whereas, CYP6AY1 was under 
expressed in ten of the strains and showed low overexpression (3.5-fold) in only one 
strain (Nl59). The increase in CYP6ER1 expression when a population was selected 
with imidacloprid provided further evidence that this gene was involved in 
imidacloprid resistance. Another notable point was that variation in the biological 
replicates for CYP6ER1 decreased after selection with imidacloprid (shown by the 
reduced 95% confidence limits). This suggested that selection with imidacloprid 
reduced the genetic heterogeneity within these two selected populations, and that 
the CYP was being expressed highly in all replicates. Such an increase in expression 
was not seen for CYP6AY1, with the imidacloprid selected populations still showing 
under expression of this CYP compared to the susceptible population. There was also 
significant variation in expression of this CYP across biological replicates.  
These findings further reinforced the view that CYP6ER1 was the major P450 
mediating imidacloprid resistance in the N. lugens populations I studied. The lack of 
expression of CYP6AY1 was surprising given the findings in the original study (Ding et 
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al., 2013), so further qRT-PCR was performed using the primers designed in the 
original study. Again, results correlated with our initial findings, that this CYP was 
under expressed compared to the susceptible. The study that implicated CYP6AY1 
had used a strain selected in the laboratory for 40 generations, and provided no 
comparison to an unselected parental line of the resistant strain. The populations 
that Ding et al saw the overexpression (4-9-fold) of CYP6AY1 in were all from China. 
It is therefore possible that this CYP is overexpressed in populations from China, but 
not from the rest of Asia. We have been unable to obtain any field samples from 
China to test since the implication of the Nagoya protocol (effective October 2014), 
and so are unable to verify this. However, we had strong evidence that over 
expression of CYP6ER1 contributed to imidacloprid resistance in N. lugens, and a 
logical next step was to functionally validate this CYP’s ability to detoxify 
imidacloprid.  
In the original study on CYP6ER1 (Bass, Carvalho, et al., 2011), it was noted 
that there were several polymorphisms in the coding sequence of CYP6ER1 between 
the imidacloprid resistant strains and the susceptible strain. These highlighted four 
conserved AA substitutions in these resistant strains, and discussed that further work 
was necessary to determine if these changes could have functional significance in 
how CYP6ER1 detoxifies imidacloprid. Therefore, we sequenced CYP6ER1 in a range 
of N. lugens populations to see if there was further differentiation in the coding 
sequences of CYP6ER1 across the resistant populations and the susceptible. This 
revealed that there was significant variation, even more extensive than seen in the 
original study, with eight CYP6ER1 variants being present in the populations. A study 
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reported in 2015 detailed the role that allelic variation of P450s could play in 
insecticide resistance (Ibrahim et al., 2015). Two genes, CYP6P9a and CYP6P9b, were 
found to have variations in the coding sequence between pyrethroid resistant 
populations and a susceptible population of Anopheles funestus. The P450s in the 
resistant strains were shown to be undergoing directional selection and had 
accumulated mutations that proved beneficial to pyrethroid metabolism. Multiple 
lines of evidence were provided including metabolism assays, modelling and docking 
simulations and transgenic expression in D. melanogaster which, taken together, 
demonstrated that the observed allelic variation was a key driver of pyrethroid 
resistance (Ibrahim et al., 2015). Seeing such significant variation in the CYP6ER1 
gene across the N. lugens populations led to the hypothesis that allelic variation 
could play a role in imidacloprid resistance in a similar way to the study by Ibrahim 
et al above. The extent to which certain alleles were selectively expressed over others 
and the role of quantitative vs qualitative in CYP6ER1 comprised most of the analysis 
of metabolic resistance in N. lugens. 
  Since it seemed implausible that all these variants were being overexpressed 
it was decided to perform variant specific qRT-PCR to determine which were the key 
CYP6ER1 variants. This clearly demonstrated that there were two key CYP6ER1 
variants that were highly expressed in insecticide resistant field populations of N. 
lugens: CYP6ER1vA and CYP6ER1vB. These are never significantly expressed together 
within a strain and it appears that the variant expressed depends on geographical 
location. The CYP6ER1vB variant is only ever seen in India, whilst CYP6ER1vA is seen 
across Southeast Asia. Both variants differ from the other sequenced variants in that 
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they have a profound polymorphism – a 3bp indel that results in the loss of an amino 
acid in SRS-5.  
To establish the extent to which different natural CYP6ER1 variants could 
provide resistance to neonicotinoids, several variants were transformed into D. 
melanogaster. CYP6AY1 was also included in this analysis to see whether it could 
metabolise imidacloprid, despite its low expression levels in resistant N. lugens. This 
showed that two fly strains that overexpressed CYP6ER1vA and CYP6ER1vB 
respectively, were significantly more resistant than a control fly strain when tested 
with imidacloprid and the CYP6ER1 variant seen in the susceptible strain of N. lugens 
- which conferred no resistance in flies. This correlated with the fact that these were 
the two CYP6ER1 variants highly expressed in resistant N. lugens populations, and 
demonstrated unequivocally the ability of CYP6ER1 to confer imidacloprid resistance. 
A recent study also found that transgenic expression of CYP6ER1 in D. melanogaster 
caused significant resistance to imidacloprid (Pang et al., 2016). Although not 
discussed by the authors this study appears to use a CYP6ER1 variant that is like the 
CYP6ER1vA seen in our N. lugens imidacloprid resistant strains, and came from a 
strain captured from Guangxi, China. 
 Issues were seen with the D. melanogaster insecticide bioassays in that the 
control strain always showed significant resistance to imidacloprid, meaning very 
high doses of insecticide were necessary to obtain LC50s and 95% confidence limits. 
This is likely due to CYP6G1, a P450 naturally expressed in D. melanogaster that 
provides resistance to a range of insecticides including imidacloprid (Daborn, J. L Yen, 
et al., 2002). However, we also found that mortality of a fly strain could be 
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significantly lower than that of the control strain, for example, a strain expressing 
CYP6ER1vL is much less resistant to imidacloprid than the control strain. So, it 
appears that expressing a transgene that does not contribute to resistance causes a 
significant fitness cost in that fly strain. Comparing resistant fly strains to the strain 
expressing CYP6ER1vL shows an even higher level of resistance demonstrated by 
strains expressing CYP6ER1vA and CYP6ER1vB. To strengthen the D. melanogaster 
insecticide bioassay results, a different bioassay and locomotor activity monitoring 
were performed to see whether CYP6ER1vA conferred resistance in these assays. The 
wiggle index bioassays again showed that CYP6ER1vA could provide significant 
resistant compared to a strain expressing CYP6ER1vL. The locomotor activity assays 
are more complex to interpret and do not yield easily comparable statistics, like RRs. 
However, the overall profile of the locomotor activity assay with imidacloprid 
showed that the CYP6ER1vA strain was the least disrupted by exposure to 
imidacloprid. These bioassays provide convincing evidence that changes in the 
coding sequence of CYP6ER1 was also a significant part of resistance to imidacloprid, 
rather than just overexpression of the gene.  
Interestingly the fly strain expressing CYP6ER1vA was also able to provide 
significant resistance to ethiprole, suggesting this enzyme can provide cross-
resistance. Instances of P450s providing cross resistance to insecticides involving 
neonicotinoids have been noted before in D. melanogaster (Daborn et al., 2001) and 
M. persicae (Bass et al., 2014). However, whether CYP6ER1vA contributes a 
significant role in ethiprole resistance in N. lugens populations is somewhat unclear. 
There does appear to be an increase in expression of CYP6ER1vA in strains that are 
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selected with ethiprole, however the Nl55-eth strain (which is highly resistant to 
ethiprole) carries CYP6ER1vB instead, and this variant showed no resistance in fly 
mortality bioassays with ethiprole. Surprisingly, the locomotor activity assays 
demonstrated that CYP6ER1vB could potentially provide minor ethiprole resistance. 
However, the unexplained fipronil mechanism is a more likely candidate in ethiprole 
resistance, but it is still possible that CYP6ER1vA/CYP6ER1vB can contribute towards 
ethiprole resistance, though if so it would only be in a minor capacity. This is partly 
because the LC50 for ethiprole in Nl39-imi (23.27) is significantly less than that for 
Nl39-eth (>5000). If CYP6ER1vA was a significant driver of ethiprole resistance in N. 
lugens, I would have expected the LC50 from the ethiprole bioassay for Nl39-imi to be 
considerably higher. 
Given we now knew which were the key CYP6ER1 variants, we wanted to 
isolate which were the key changes in the coding sequence that contributed to 
imidacloprid resistance. Mapping of substrate recognition sites revealed the deletion 
at position 377 and the resulting AA changes occur in SRS-5. Furthermore, a second 
threonine to serine replacement was also observed in SRS-4 within the oxygen 
binding motif.  
Threonine is generally substituted by polar or small amino acids, especially 
serine due to similarity between the two amino acids. A substitution of Ser for Thr 
could cause more flexibility in the conformations that the main chain can adopt, since 
Thr is C-beta branched and has restrictions on structural conformation (Betts and 
Russell, 2003).  The deletion of an alanine and further substitution of an alanine for 
a glycine (PAAP to PGP) would have considerable impact on protein structure. Gly 
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allows much more conformational flexibility, allowing tight turns in structures, that 
other amino acids find impossible to adopt (Betts and Russell, 2003). The deletion of 
a proline (PAAP to PAA) could prevent the polypeptide from changing direction, since 
Pro is unable to adopt many main chain conformations (due to ring structure) and so 
is usually found in tight turns of protein structure (Betts and Russell, 2003). 
 Constructs that encoded the CYP6ER1vL sequence with AA changes around 
position 377, to make the sequence more like CYP6ER1vA/CYP6ER1vB, were tested 
using the D. melanogaster insecticide bioassays. This identified that the change from 
PAAP to PGP (deletion and substitution), provided the most resistance to 
imidacloprid. PGP is seen in the CYP6ER1vA variant. The crucial CYP6ER1vB change 
(deletion of 377P) also conferred resistance, but not as high as the GP change. A 
further key AA substitution was seen at T318S, with the serine replacement also able 
to confer significant resistance to imidacloprid.  
 Given the abundance of examples demonstrating that overexpression of 
P450s causes resistance to insecticides there are comparatively few examples 
available showing qualitative changes in P450s correlating with resistance. A CYP 
from D. melanogaster (CYP6A2) has been linked to DDT resistance in a strain (RDDTR) 
(Amichot et al., 2004). There three point mutations (R335S, L336V and V476L) within 
CYP6A2 were correlated with enhanced metabolism of DDT compared to a wild-type 
version of CYP6A2. A more recent example was discussed above involving allelic 
variation in CYPs causing pyrethroid resistance in A. funestans (Ibrahim et al., 2015). 
Multitudes of described examples are available for human P450s, with extraordinary 
diversity seen within this gene super family. For example, CYP2C9 has a recorded 33 
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variants and further series of subvariants (Zhou, Liu and Chowbay, 2009). Within this 
there have been 520 SNPs isolated from the upstream, intron and exonic sequence. 
Different variants have different levels of activity and ability to metabolise 
xenobiotics depending on which SNPs are present in regulatory and coding regions 
(Zhou, Liu and Chowbay, 2009).   
 Research conducted by colleagues at Exeter university has revealed a fuller 
picture of the CYP6ER1 gene, and has concluded that the gene has been duplicated 
in the neonicotinoid resistant populations of N. lugens. This duplication occurred 
before the introduction of imidacloprid for field control, so the duplication is not a 
novel mutation occurring due to insecticide use. However, the additional copy was 
not evolutionarily constrained and so was able to accrue mutations that were not 
possible in single copy populations. These mutations caused the enzyme to become 
an effective metaboliser of imidacloprid and so caused resistance to this compound. 
Another P450, CYP4DE1, was also assessed for a contribution to insecticide 
resistance in N. lugens. This gene was originally linked to ethiprole resistance in the 
small brown planthopper through overexpression of this CYP (Elzaki, Zhang and Han, 
2015). Studies using qRT-PCR on ethiprole resistant N. lugens populations did show 
over expression (4-9-fold) of this gene compared to the susceptible. However, the 
fold change is significantly lower than that seen for CYP6ER1, as a comparison, and 
selection with ethiprole had no change in the expression of this gene. When CYP4DE1 
was expressed in a fly strain it did cause significant resistance to ethiprole (4-fold) 
compared to the control strain. However, as with CYP6ER1vA and ethiprole 
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resistance, it is unclear whether CYP4DE1 has a biologically significant role in 
ethiprole resistance within N. lugens.   
6.5 Conclusions 
This study aimed to evaluate the potential metabolic mechanisms behind 
neonicotinoid and fiprole resistance. This involved assessing expression levels of 
multiple P450s across a range of N. lugens populations. The P450s were all then 
functionally validated to provide evidence of their potential role in detoxification of 
insecticidal compounds.  
CYP6ER1 was implicated as a major contributor to imidacloprid resistance, 
rather than other proposed CYPs and target-site mutations/down-regulation. Crucial 
changes in the coding sequence of CYP6ER1 were identified that confer an ability to 
metabolise imidacloprid. This gene was extensively studied to understand why it 
could be such a potent mechanism in imidacloprid resistance. 
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Chapter VII General Discussion 
 
This chapter provides a general discussion and summary of the findings of this 
PhD. The resistance to phenylpyrazole and neonicotinoid compounds is discussed 
and the implications that this has for field management of N. lugens is briefly touched 
upon. Potential future work that could be conducted in this area is also highlighted.  
7.1 Fiprole resistance in N. lugens 
Prior to the start of this PhD, high levels of resistance to ethiprole and fipronil 
had been reported in various N. lugens field populations (Wang et al., 2009; Zhao et 
al., 2011; Punyawattoe et al., 2013) collected in the Asia Pacific region. In Chapter III, 
N. lugens populations sourced from across Asia were tested for fiprole resistance and 
high levels of resistance were found in all the field strains examined, correlating with 
the results of previous monitoring studies. Further selection of a population in the 
laboratory with ethiprole caused the resistance to ethiprole to greatly increase. 
However, it also caused the levels of resistance to fipronil to markedly increase. This 
was seen for three separate N. lugens populations, and gave weight to the hypothesis 
that there could be a cross-resistance mechanism between these two compounds. 
The structural similarity between ethiprole and fipronil (Caboni, Sammelson and 
Casida, 2003) further reinforced the notion of a cross-resistance mechanism.  
Within the field populations of N. lugens held at Rothamsted it was 
discovered that in some individual brown planthoppers there were mutations 
present within the Rdl gene, which encodes the GABA-gated chloride channel that 
harbour’s the fiprole binding site, that could be conferring resistance to fiproles. 
These included a common mutation, A301S, that was originally identified as being 
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responsible for high levels of resistance to dieldrin in D. melanogaster (ffrench-
Constant et al., 1990, 1993). This mutation has also been tentatively linked to fipronil 
cross-resistance in N. lugens (Y Zhang et al., 2016). A further (novel) mutation, Q359E, 
was identified within an Indian field population. This novel mutation was not situated 
within the transmembrane region of the GABA-gated chloride channel, but rather in 
a region that had previously been linked with fipronil resistance. An adjacent R357Q 
mutation (in tandem with A301N) was reported to cause fipronil resistance in S. 
furcifera (Nakao et al., 2012), whilst a T360I mutation (in tandem with A301S) caused 
fipronil resistance in D. melanogaster (Remnant et al., 2014).  
The A301S mutation became fixed in populations that were further selected 
with ethiprole in the laboratory. The Q359E mutation also increased in frequency 
after the selection with ethiprole of the Nl55-eth population, originally sourced from 
India. However, only the A301S mutation proved to have a significant link to ethiprole 
resistance from the in vivo data collected in this PhD. It was interesting that this 
mutation had not previously been linked to ethiprole resistance. However, this is 
likely due to the fact that there has been limited research published on ethiprole 
resistance, and these previous studies tended to conclude that the mechanism was 
probably metabolic rather than target-site resistance (Punyawattoe et al., 2013; 
Elzaki, Zhang and Han, 2015). In this thesis, despite the very high levels of ethiprole 
resistance seen in a fly strain carrying the A301S mutation (sourced from the 
Bloomington collection), it was thought that this mutation could not be the only 
mechanism behind ethiprole resistance. This was based on the in vitro 
electrophysiological studies conducted by Bayer CropScience on this mutation. These 
concluded that the difference between the A301S and the wild-type RDL constructs 
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in the voltage clamp recordings, with ethiprole, could not completely explain the 
resistance seen in the selected strains (Nl33-eth, Nl39-eth and Nl55-eth) (Garrood et 
al., 2017).  This led to the hypothesis that the undiscovered fipronil mechanism could 
potentially cause cross-resistance between the phenylpyrazoles compounds fipronil 
and ethiprole.  
The possibility of metabolic mechanisms being involved in fiprole resistance 
was explored. There was no significant effect on fipronil resistance in N. lugens when 
synergists that disrupt P450s were applied, suggesting that P450s don’t contribute to 
fipronil resistance. Analysis of the CYP6ER1 variants that were assessed for a possible 
role in neonicotinoid resistance (Chapter VI) demonstrated that two of these variants 
(CYP6ER1vA and CYP6ER1vB) could cause resistance to ethiprole. These were also the 
variants that were implicated in imidacloprid resistance in N. lugens. Whether there 
is genuine biological significance (i.e. can cause ethiprole resistance in N. lugens) for 
the finding that these two variants can cause ethiprole resistance when expressed in 
D. melanogaster needs further analysis. The lack of resistance shown to fipronil by D. 
melanogaster strains expressing CYP6ER1vA or CYP6ER1vB further highlights the 
difference in response to the two phenylpyrazoles, despite their structural similarity 
(Caboni, Sammelson and Casida, 2003).  
 Cross-resistance within an insecticide class has been shown to be relatively 
common (Gorman et al., 2010). Indeed, the field strains studied in this thesis 
displayed resistance to both ethiprole and fipronil, but it became clear that there was 
very limited cross-resistance associated with the main ethiprole resistance 
mechanism (A301S). However, it is rarer to see cross-resistance occur between 
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distinct classes, where the chemical structures will be considerably different. 
Examples of this include CYP6G1 causing resistance to DDT and imidacloprid in D. 
melanogaster (Daborn et al., 2001), and a P450, CYP6CM1 causing cross-resistance 
between pymetrozine and neonicotinoids in B. tabaci (Gorman et al., 2010; Nauen et 
al., 2013). Whether CYP6ER1vA and/or CYP6ER1vB do the same between ethiprole 
and imidacloprid would need further studies.  
7.2 Neonicotinoid resistance in N. lugens 
Target-site resistance to neonicotinoids has previously been reported, with 
mutations in nAChR linked to a reduced sensitivity to neonicotinoids. These include 
a Y151S mutation in an nAChr α1 subunit found in N. lugens (Liu et al., 2005), and an 
R81T mutation in the nAChR β subunit of M. persicae (Bass, Puinean, et al., 2011). 
However, in this thesis, screening of the N. lugens nAChR subunits in imidacloprid 
resistant brown planthoppers (Chapter IV, using the RNA-seq mapping technique), 
reveal that neither of these mutations were present in our N. lugens populations. 
This correlated with previous research on neonicotinoid resistance in N. lugens, that 
was unable to identify the Y151S mutation (Gorman et al., 2008; Puinean, Denholm, 
et al., 2010).   
The role of cytochrome P450 monooxygenases in neonicotinoid resistance 
has been previously well established across many insect pests. For N. lugens there 
was significant evidence that overexpression of P450s was the mechanism behind 
field resistance to imidacloprid (Liu et al., 2003; Wang et al., 2009). Of the two P450s 
(CYP6ER1 and CYP6AY1) (Bass, Carvalho, et al., 2011; Ding et al., 2013) most 
prominently linked to imidacloprid resistance in N. lugens, it was found that only 
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CYP6ER1 was significantly overexpressed in the field populations held at Rothamsted. 
The original study of CYP6AY1 (Ding et al., 2013) did not include CYP6ER1 in the qRT-
PCR studies. Also, all strains assessed in that study were from China, whilst our N. 
lugens collection did not include populations from this region, so there was a 
possibility that CYP6AY1 was only overexpressed in Chinese populations, whilst 
CYP6ER1 was overexpressed in populations from across the rest of Asia. However, 
subsequent analysis of imidacloprid resistant Chinese populations has revealed that 
CYP6ER1 is indeed overexpressed in these populations (Bao et al., 2015; Pang et al., 
2016; Yixi Zhang et al., 2016). These studies have all provided ample evidence that 
CYP6ER1 performs a key role in imidacloprid resistance in N. lugens. However, there 
has been no analysis conducted into whether coding sequence variations between 
imidacloprid susceptible and resistant insects has a contribution to this well-
established resistance. 
This PhD follows on from the original work conducted on CYP6ER1, that 
highlighted that there was coding sequence variation between the laboratory 
susceptible and the field resistant N. lugens populations (Bass, Carvalho, et al., 2011). 
At the time the conclusions drawn were that overexpression of CYP6ER1 was the 
main mechanism responsible for imidacloprid resistance. However, it is now clear 
that there is a much more complex picture of resistance involving this enzyme. The 
sequencing of this gene across various N. lugens populations revealed that there 
were eight variants of CYP6ER1 present. Of these, two (CYP6ER1vA and CYP6ER1vB) 
were found to be the dominantly expressed variants, demonstrated by variant 
specific qRT-PCR studies and by aligning RNA-Seq reads to specific fragments of 
sequence. These two variants were unique in that they both contained a mutation in 
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the SRS-5 region of CYP6ER1 and a further substitution in SRS-4. These mutations 
occur in regions predicted to be responsible for binding of imidacloprid, as shown for 
CYP6CM1vQ in B. tabaci (Karunker et al., 2009). Of the five CYP6ER1 variants 
expressed in D. melanogaster, these two variants conferred the most significant 
resistance to imidacloprid. The CYP6ER1vL variant from the susceptible N. lugens 
strain was considerably less resistant to imidacloprid, even more so than the control 
D. melanogaster strain used in the fly studies. This provides clear evidence that it is 
the coding sequence alterations in CYP6ER1 that has enabled this enzyme to confer 
imidacloprid resistance, rather than just overexpression as had been previously 
reported (Bass, Carvalho, et al., 2011; Garrood et al., 2016). Furthermore, when the 
mutations in SRS-4 and SRS-5 were introduced into CYP6ER1vL and the modified P450 
subsequently expressed in D. melanogaster, there was a highly significant resistance 
displayed to imidacloprid compared to the CYP6ER1vL expressing D. melanogaster 
strain.  This identification of key amino acid changes in P450 enzymes provides a rare 
example of qualitative, rather than quantitative metabolic resistance to an 
insecticide.  
7.3 The problems for insecticide resistance management of N. lugens 
The key findings of this PhD are that, in the N. lugens populations studied, 
A301S causes significant resistance to ethiprole, whilst certain variants of CYP6ER1 
cause resistance to imidacloprid.  
The A301S mutation, conferring resistance to ethiprole, can be simply 
screened for in field populations, as the monitoring can be conducted on DNA, which 
allows for a more high-throughput molecular diagnostic than RNA. It also allows 
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simpler transportation and storage of the insects than that required for material that 
is destined for RNA studies. A similar approach could be taken for CYP6ER1 
imidacloprid resistance monitoring. Current dogma is that overexpression of this 
gene is the key reason for imidacloprid resistance. However, we have found that 
qualitative changes in the coding sequence are more important to resistance than 
overexpression. Therefore, a molecular diagnostic could be designed that screens for 
the deletion in SRS-5, and this could be performed on DNA. 
Current guidelines for insecticide resistance management for rice hoppers are 
based on the assumption that there is no cross-resistance between insecticides used 
for control (IRAC, 2013). The findings of this PhD have important implications for 
resistance management strategies for N. lugens. Firstly, there is clear evidence that 
selection with ethiprole also causes a rise in fipronil resistance. Therefore, regions 
that are seeing field control failure with ethiprole should not be treated with fipronil, 
since it will likely be ineffective for control of N. lugens. A possible mechanism of 
cross-resistance between imidacloprid (Class 4 insecticide) and ethiprole (Class 2B 
insecticide) is seen in the form of a P450, CYP6ER1. There is a slim possibility that a 
N. lugens field population that was resistant to imidacloprid could then subsequently 
be resistant to ethiprole. However, the use of imidacloprid would not lead to a rise 
in fipronil resistance. It would also depend on whether CYP6ER1 was responsible for 
the imidacloprid resistance present, since multiple P450s have now been implicated 
in imidacloprid resistance in N. lugens (Yixi Zhang et al., 2016). The studies on 
CYP6ER1 in this PhD indicate that it is not able to cause widespread resistance across 
the neonicotinoid class of insecticides. However, there is now resistance to most of 
the neonicotinoids being reported in the field (Matsumura et al., 2013; Zhang et al., 
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2014, 2017; X. Zhang et al., 2015; Mu et al., 2016) and the mechanisms behind this 
resistance are not yet clear. There is no reported cross-resistance between 
imidacloprid and pymetrozine (Class 9 insecticide), another important chemical for 
N. lugens control (Yang et al., 2016). 
 Given that resistance to ethiprole and imidacloprid is now so well established 
within N. lugens field populations (Garrood et al., 2016), it is debatable if there will 
come a point in the future where these compounds will once again become viable 
control agents for N. lugens. A large determining factor will be whether the 
mechanisms associated with the resistance carry a fitness cost in the absence of the 
xenobiotic. In the case of ethiprole resistance it is unlikely that the A301S mutation 
has a significant fitness cost, since this mutation has been shown to be retained in a 
pest population even in the absence of insecticide selection (Thompson, Steichen and 
ffrench-Constant, 1993). It would normally be expected that P450 mediated 
resistance would carry a fitness cost in the absence of insecticide selection, however 
this could potentially not be the case with CYP6ER1. Firstly, N. lugens populations 
kept in the laboratory remained resistant to imidacloprid long after the last exposure 
to imidacloprid. However, predicting fitness costs effects in the field from laboratory 
populations is fraught with pitfalls, since a variety of other factors (temperature 
fluctuations, predation, intra-species competition, exposure to other chemistries and 
host plant variety) cannot be considered.  Secondly, given that CYP6ER1 mediated 
resistance is predominantly due to changes in the coding sequence that have caused 
certain variants (CYP6ER1vA and CYP6ER1vB) to become highly efficient metabolisers 
of imidacloprid, rather than overexpression, this could reduce the associated fitness 
cost.  
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 A new compound for N. lugens control has recently become available called 
triflumezopyrim, and belongs to group 4E of IRAC’s MoA classification system (Singh 
et al., 2016). This was developed by DuPont Crop Protection and is very effective 
against N. lugens, even those with high imidacloprid resistance (Cordova et al., 2016). 
This is currently the only new compound being registered for N. lugens control. 
However, the manufacturers hope that since triflumezopyrim should provide long 
lasting control, then less applications will be necessary. This would benefit natural 
enemies and so improve the rice ecology that has been seriously disrupted by heavy 
insecticide use (Singh et al., 2016). 
 Integrated Pest Management strategies for rice have been designed for 
decades, with a book produced on the topic in the 1980s (Reissig et al., 1988) The 
basis of IPM for rice now emphasises the importance of allowing natural enemies to 
flourish, primarily through a reduction in insecticide use (Matteson, 2000). This 
strategy is now favoured, in part, because most compounds for N. lugens control are 
now unable to give the requisite level of control that farmers desire. IRRI specifically 
state that indiscriminate use of insecticides must be avoided and that mechanical 
and biological methods should be the primary strategy for managing the brown 
planthopper (IRRI, 2017). The use of rice cultivars that are resistance to N. lugens 
should also be used (Brar et al., 2009; IRRI, 2017). Way and Heong discuss a system 
whereby multiple cultivars with different resistant mechanisms to pests are used, 
within a patchwork of fields to prevent build-up of pest resistance to these cultivars 
(Way and Heong, 1994). A more recent appraisal of the brown planthopper problems 
and methods to control it our provided by Bottrell and Schoenly. Of their many 
suggestions for N. lugens control that do not rely on heavy use of pesticides, the need 
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for an Asia-wide effort to formulate an effective strategy with long-term 
sustainability is emphasised (Bottrell and Schoenly, 2012). Such a strategy would be 
a huge undertaking, but it is necessary, given that the evidence has for decades 
shown that insecticide use cannot fully control N. lugens and has been argued 
exacerbates the problem. Given that a point has now been reached where the 
arsenal of compounds used to control N. lugens has dwindled to only a few, there 
must be a concerted effort driven to limit the effect of this destructive pest.  
7.4 Future work 
1. The unidentified mechanism behind fipronil resistance in N. lugens could be 
further explored. Synergist bioassays have suggested that this mechanism in 
unlikely to be P450 related, and there are no mutations in Rdl that correlate 
with significant resistance to fipronil. Further synergists could be tested to 
establish if CCEs/GSTs have any potential role in this resistance. Penetration 
resistance could be investigated to see whether a reduced uptake of fipronil 
contributes to fipronil resistance. Any mechanism discovered that links to 
fipronil resistance would also need to be tested against ethiprole, to test the 
hypothesis that the unexplained fipronil resistance mechanism confers cross-
resistance to ethiprole. 
2. The transcriptome generated in Chapter IV could be complemented by the 
generation of a transcriptome using genome guided assembly. This would 
significantly improve the gene annotation and would allow a more 
meaningful differential gene expression analyses to be conducted. This would 
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provide a useful resource to help identify the unexplained fipronil resistance 
mechanism.  
3. The RDL mutation, Q359E, was not fully analysed within this PhD. Further 
studies could be conducted using CRISPR/Cas9 to introduce the mutation into 
D. melanogaster. A fly strain containing both A301S and Q359E should ideally 
be generated, since the Q359E mutation never occurs independently. Fly 
mortality bioassays with fipronil and ethiprole should confirm whether the 
Q359E mutation can confer any resistance to phenylpyrazoles compounds.  
4. Further studies on CYP6ER1 variants and ethiprole resistance could be 
performed. The new climbing assay for D. melanogaster at Rothamsted could 
be used to see if certain CYP6ER1 variants can provide significant levels of 
resistance to ethiprole.  
5. Low resistance to pymetrozine in field populations of N. lugens has recently 
been reported. Although resistance is hard to quantify for this compound 
(due to different bioassay methods used in the monitoring efforts) it would 
be interesting to study field strains that had been linked to control failure 
using pymetrozine. A starting point would be analysing the TRP gene in the 
field strain for the presence of novel mutations, by comparing to the TRP gene 
in older field strains (not exposed to pymetrozine) and the laboratory 
susceptible strain.  
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Appendix A Primer sequences and qRT-PCR melt peaks 
 
Table A1. Cloning primers and CRISPR gRNAs. 
Primer name Sequence 5'-3' 
M13(-20)_F GTAAAACGACGGCCAGT 
M13(-24)_R AACAGCTATGACCATG 
T7_F TAATACGACTCACTATAGG 
T3_R AATTAACCCTCACTAAAGGG 
Dm_301_gRNA_F GTCGCAATGCAACGCCGGCGCGTG 
Dm_301_gRNA_R AAACCACGCGCCGGCGTTGCATTG 
Dm_359_gRNA_F GTCGATACGCCACGGTCGGCTACA 
Dm_359_gRNA_R AAACTGTAGCCGACCGTGGCGTAT 
 
 
Table A2. RNA-Seq candidate genes qRT-PCR primers. 
 
Primer name Sequence 5'-3' 
c91313_g1_i1 F AATCGTGGGCAGGAGGAGAT 
c91313_g1_i1 R TGCAACCTTCCCTTTTTCGATG 
c91960_g1_i2 F CACCAACACATCGGCGTAG 
c91960_g1_i2 R GTATGTGAGATGGGATGGACA 
c98716_g1_i1 F CCTCCTTCTCTCTCAGTTTGTG 
c98716_g1_i1 R GAAGAATTGGTGACTCGATGC 
c103516_g1_i4 F CTAGAGTATCAGTATCGTGGGTA 
c103516_g1_i4 R CAGGCGATAGCGGACAAATAC 
c103516_g1_i6 F GTGGAGCATAAGTACCGTGAG 
c103516_g1_i6 R TCATGAAACCGAGGGGTCC 
c103740_g1_i2 F CCATCGGATTACATATTGTTTGG 
c103740_g1_i2 R CCTTCGGCTTCACATAATTTTC 
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Table A3. GluCl and VGSC sequencing primers. 
 
Primer name Sequence 5'-3' 
Nl_GluCl_pri_F TAATCGCATGCCATGTGTGC 
Nl_GluCl_pri_R GATGTCGCTAGCCGCTTGAT 
Nl_GluCl_sec-F TAGACAGAGCTGAATCCCGC 
Nl_GluCl_sec_R CTTAGTCGCCGACGCTAGTC 
Nl_GluCl_seq_F CTGAGGCCAACAGAGTCTGG 
Nl_VGSC_gap_F TGGGCTTTCCTCTCAGCTTTTC 
Nl_VGSC_gap_R GGAGTTGCGACTAGATCGTG 
Nl_VGSC_homologous_repeat_II_F TCGACATCTTCTGCGTGTGGG 
Nl_VGSC_homologous_repeat_II_R GTAAGATCGAGGTCAGTGTCTC 
Nl_VGSC_homologous_repeat_III_F AATGCTCGGACTGGTGAAGG 
Nl_VGSC_homologous_repeat_III_R GGTCACAGTCGTCCTCGTTT 
Nl_VGSC_homologous_repeat_III_seq_F GCGTCGATACAAATGGCACC 
Nl_VGSC_homologous_repeat_III_seq_R CATTGCGGTCTGGGATGATC 
 
Table A4. Rdl sequencing primers. 
 
Primer name Sequence 5'-3' 
Nl_Rdl_generic_1_F GATGAGGCGCACGTTGGCC 
Nl_Rdl_generic_2_F ATCCAGTTCGTGCGTTCGATG 
Nl_Rdl_generic_R ATCCAGTACATGAGGTTGAAGC 
Nl_Rdl_GenBank_R AGGTCTACTTATCCTCTTCGAG 
Nl_Rdl_Alternate_R GGCCTCCTTACTTATCCGGCT 
Nl_Rdl_A301S_R AGCAACGACGCGAACACCAT 
Nl_Rdl_Q359E_F AGTACGCAACAGTGGGCTAC 
Nl_Rdl_Q359E_R TCCGAAAGCGCTCTACATGA 
Dm_Rdl_A301S_F ATTCAGTTCGTGCGTTCGATG 
Dm_Rdl_A301S_R ACCATAACGAAGCATGTTCCCA 
Dm_Rdl_Q359E_F GTATACGAAACCCACCCGCA 
Dm_Rdl_Q359E_R CACCTCCTGGAACAAGGGTC 
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Table A5. Generic CYP6ER1, CYP6AY1 and reference gene qRT-PCR primers. 
 
Primer name Sequence 5'-3' 
Nl_Actin_F TAACGAGAGGTTCCGTTGCC 
Nl_Actin_R GACAGGACAGTGTTGGCGTA 
Nl_α2_tubulin_F CCACCCTGGAACACTCTGAC 
Nl_α2_tubulin_R CGAAGCAGTGATCGAGGACA 
Nl_ER1_generic_F TCCTGGTGCGCAACTATGAC 
Nl_ER1_generic_R CATCTTGCGGTGCTGATCAC 
Nl_AY1_Bass_F TGCTGAGGCAGAAGATTTCA 
Nl_AY1_Bass_R GACGTCACGCATTTCCAGTA 
Nl_AY1_Ding_F CCAATCACCGCACACCTGGTCAACC 
Nl_AY1_Ding_R GCTTGAGCTGCTATAACACTCTCTG 
 
Table A6. CYP6ER1 and CYP4DE1 high fidelity primers and CYP4DE1 qRT-PCR primers. 
 
Primer name Sequence 5'-3' 
Nl_ER1_Hifi_F ATGTGGGAAAACTCGTGGTTGGCCTA 
Nl_ER1_Hifi_R AGTGTGAGGTCCTTGTAAGGGTTCAAA 
Nl_DE1_BglII_F TTGGAGATCTATGCGCTTCAAACAGCTATTGG 
Nl_DE1_XbaI_R TACCTCTAGACTAAAAATATGTATCCTCAACAACAGGTG 
Nl_DE1_qPCR_F CACACAGAAGGGTAAAGAACAAG 
Nl_DE1_qPCR_R CATCTGTTTCATCGGACGACA 
 
 
Table A7. CYP6ER1 variants qRT-PCR primers 
 
Primer name Sequence 5'-3' 
Nl_ER1_vF_F CATCCATGAGGTCTACGAAG 
Nl_ER1_vF_R GAGTGCTGAACAGATGGTGT 
Nl_ER1_vA_F CTTTCTTCACCCCCGCCC 
Nl_ER1_vA_R CCTGCATGGTCTCGAACATG 
Nl_ER1_vB_F TCTTGTCACAATCCTGTTGCTG 
Nl_ER1_vB_R TGGATGCATTTCTTGGACAATACG 
Nl_ER1_vC_F GAGACTACTTCTGCATCTTTGT 
Nl_ER1_vC_R GGAAACCATTGGGAAGAATGA 
Nl_ER1_vD_F AGATCAAATCGGCGGATGGA 
Nl_ER1_vD_R CGGAATCATCACTTGAGTTCC 
Nl_ER1_vE_F CCGGAATCATTACTTGAGTTCC 
Nl_ER1_vE_R GTATGATGAGATCAGATCTGTGA 
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Fig. S1. Nucleotide sequence of the CYP6ER1 variants and the primer pairs utilised for 
qRT-PCR 
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Table A8. Melt peaks (C) for CYP6ER1 variant specific qRT-PCR. 
 
Gene 
Melt 
peak 
Actin 86.5 
Tubby 86.7 
CYP6ER1vF 87.3 
CYP6ER1vA 88.3 
CYP6ER1vB 84.5 
CYP6ER1vC 82.7 
CYP6ER1vD 82.5 
CYP6ER1vE 82 
 
 
 
Table A9. Top twenty over expressed genes between Bayer-S and Nl33 
Bayer-S vs Nl33 
Transcript Blast description 
c91225_g1_i1 hypothetical protein TcasGA2_TC030635 
c102198_g2_i2 platelet-activating factor acetylhydrolase ib subunit beta-like protein 
c90362_g1_i5 single-stranded dna-binding protein 3-like isoform 1 
c105136_g2_i1 glucose-6-phosphate isomerase 
c100403_g2_i1 regulator of ribosome biosynthesis 
c109701_g1_i1 ccr4-not transcription complex subunit 1 isoform x2 
c94447_g1_i3 PREDICTED: uricase 
c59655_g1_i1 lipase 3-like 
c95618_g3_i4 androgen-induced proliferation inhibitor 
c91360_g1_i1 adrenodoxin 
c92995_g2_i2 fructose-bisphosphate aldolase-like isoform x1 
c88625_g1_i1 cullin 
c104747_g2_i1 low quality protein: de-cadherin 
c101465_g1_i3 v-atpase d 
c104523_g1_i7 Putative imidazolonepropionase 
c107384_g1_i5 PREDICTED: uncharacterized protein LOC103578838 isoform X1 
c100102_g1_i1 trypsin-10 
c105545_g1_i4 heterogeneous nuclear ribonucleoprotein l 
c110744_g1_i1 pr domain zinc finger protein 1 
c91248_g1_i3 cell wall-associated hydrolase 
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Table A10. Top twenty over expressed genes between Bayer-S and Nl33-eth 
Bayer-S vs Nl33-eth 
Transcript Blast description 
c93514_g1_i1 PREDICTED: thioredoxin-2-like 
c111588_g2_i3 arylalkylamine n-acetyltransferase 
c101021_g2_i1 nadp-dependent malic enzyme 
c100139_g1_i1 hypothetical protein HELRODRAFT_186595 
c95047_g1_i2 apolipoprotein d 
c102636_g1_i1 easter-9 
c88625_g1_i1 cullin 
c105136_g2_i1 glucose-6-phosphate isomerase 
c93223_g1_i1 camp-dependent protein kinase catalytic subunit-like 
c97572_g2_i1 PREDICTED: uncharacterized protein LOC101893139 
c103516_g1_i4 carboxylesterase, partial 
c98716_g1_i1 carboxylesterase-6 
c94260_g1_i3 hypothetical protein CERSUDRAFT_40589, partial 
c95257_g1_i1 hypothetical protein TcasGA2_TC012174 
c107731_g1_i1 PREDICTED: hypothetical protein LOC100744451 
c97030_g1_i1 easter-6 
c103830_g1_i2 rna recognition motif-containing protein 
c92358_g1_i1 hypothetical protein YQE_11485, partial 
c99285_g1_i1 
serine threonine-protein phosphatase pp1-gamma catalytic subunit-like 
isoform x1 
c104244_g1_i5 3-ketoacyl- mitochondrial 
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Table A.11. Top twenty over expressed genes between Nl33 and Nl33-eth 
Nl33 vs Nl33-eth 
Transcript Blast description 
c93514_g1_i1 thioredoxin-like protein 
c95628_g1_i2 glycine cleavage system h mitochondrial-like 
c105273_g1_i2 histone deacetylase 
c102776_g3_i1 cell division cycle protein 27 homolog 
c103092_g1_i4 
lipopolysaccharide-induced tumor necrosis factor-alpha factor 
homolog 
c103756_g1_i2 ras-related protein rab-11a 
c99429_g2_i2 serine protease 10 
c102396_g1_i2 kelch-like ech-associated protein 1 
c99008_g1_i2 PREDICTED: uncharacterized protein LOC101234332 
c96181_g2_i8 
uncharacterized abhydrolase domain-containing protein 
ddb_g0269086-like isoform x2 
c107868_g1_i3 telomerase-binding protein est1a-like 
c111137_g1_i3 oxidoreductase glyr1 homolog 
c107699_g1_i2 thyroid receptor-interacting protein 11-like 
c99765_g2_i2 retrotransposon protein 
c107401_g1_i6 nocturnin isoform x2 
c103143_g1_i3 nucleoredoxin-like protein 2 
c102684_g2_i13 protein phosphatase 1 regulatory subunit 12a 
c95074_g1_i2 transferrin-like isoform x2 
c104060_g4_i3 pab-dependent poly -specific ribonuclease subunit 3-like 
c110064_g1_i3 oxysterol-binding protein 1 isoform x2 
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Table A12. Top twenty over expressed genes between Bayer-S and Nl55 
Bayer-S vs Nl55 
Transcript Blast description 
c83110_g1_i1 polyprotein 
c104193_g1_i3 4-coumarate-- ligase 3-like 
c101021_g2_i1 nadp-dependent malic enzyme 
c89218_g1_i1 rna polymerase 
c24277_g1_i1 major core capsid protein 
c51844_g1_i1 136.6KD protein 
c88625_g1_i1 cullin 
c85378_g1_i1 130kd protein 
c90362_g1_i5 single-stranded dna-binding protein 3-like isoform 1 
c23626_g1_i1 nonstructural protein 
c92995_g2_i2 fructose-bisphosphate aldolase-like isoform x1 
c105136_g2_i1 glucose-6-phosphate isomerase 
c97428_g3_i2 pyrroline-5-carboxylate reductase 
c103334_g1_i1 106.4KD protein 
c104747_g2_i1 low quality protein: de-cadherin 
c100139_g1_i1 hypothetical protein HELRODRAFT_186595 
c109685_g2_i1 tricarboxylate transport 
c97638_g4_i1 cdgsh iron-sulfur domain-containing protein 2 homolog isoform x1 
c93223_g1_i1 camp-dependent protein kinase catalytic subunit-like 
c65564_g1_i1 major outer capsid protein 
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Table A13. Top twenty over expressed genes between Bayer-S and Nl55-eth 
Bayer-S vs Nl55-eth 
Transcript Blast description 
c83110_g1_i1 polyprotein 
c101021_g2_i1 nadp-dependent malic enzyme 
c88625_g1_i1 cullin 
c97428_g3_i2 pyrroline-5-carboxylate reductase 
c44171_g1_i1 5 -amp-activated protein kinase catalytic subunit alpha-2 
c92995_g2_i2 fructose-bisphosphate aldolase-like isoform x1 
c100139_g1_i1 hypothetical protein HELRODRAFT_186595 
c90362_g1_i5 single-stranded dna-binding protein 3-like isoform 1 
c104193_g1_i3 4-coumarate-- ligase 3-like 
c93223_g1_i1 camp-dependent protein kinase catalytic subunit-like 
c92358_g1_i1 hypothetical protein YQE_11485, partial 
c97030_g1_i1 easter-6 
c103516_g1_i4 carboxylesterase, partial 
c97572_g2_i1 PREDICTED: uncharacterized protein LOC101893139 
c95047_g1_i2 apolipoprotein d 
c91169_g1_i1 hemolymph protease 2 
c107731_g1_i1 PREDICTED: hypothetical protein LOC100744451 
c103740_g1_i2 cytochrome partial 
c97638_g4_i1 
cdgsh iron-sulfur domain-containing protein 2 homolog isoform 
x1 
c104244_g1_i5 3-ketoacyl- mitochondrial 
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Table A14. Top twenty over expressed genes between Nl55 and Nl55-eth 
Nl55 vs Nl55-eth 
Transcript Blast description 
c109701_g1_i1 ccr4-not transcription complex subunit 1 
c82591_g2_i2 ornithine decarboxylase 1-like 
c105804_g1_i4 hypothetical protein HELRODRAFT_159370 
c105894_g1_i1 pdz domain-containing protein 2 
c96852_g1_i2 transcription factor sp4-like 
c111720_g1_i2 unconventional myosin-xv isoform x1 
c108948_g1_i1 lamin-b receptor 
c110971_g1_i5 coiled-coil domain-containing protein cg32809 isoform x10 
c109988_g1_i3 gpi transamidase component pig-s 
c109363_g3_i3 transient receptor potential cation channel trpm-like 
c94005_g4_i12 calcium-dependent secretion activator 
c109903_g1_i7 
phospholysine phosphohistidine inorganic pyrophosphate 
phosphatase 
c98304_g2_i1 tyrosine-protein phosphatase non-receptor type 14 
c105313_g1_i1 dedicator of cytokinesis protein 9 
c100622_g1_i1 PREDICTED: uncharacterized protein LOC100680266 isoform X3 
c92531_g2_i2 venom protease-like 
c107958_g1_i4 fad synthase 
c111460_g1_i1 cartilage oligomeric matrix protein 
c90079_g1_i1 myb-like protein d 
c98169_g2_i2 u4 tri-snrnp-associated protein 1 
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